
<html lang="en"     class="pb-page"  data-request-id="f9578c41-9ea3-4dc0-9578-e197e739c8f0"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text;issue:issue:10.1021/jmcmar.2016.59.issue-19;article:article:10.1021/acs.jmedchem.6b00939"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Discovery of Dihydrobenzoxazepinone (GS-6615) Late Sodium Current Inhibitor (Late INai), a Phase II Agent with Demonstrated Preclinical Anti-Ischemic and Antiarrhythmic Properties" /></meta><meta name="dc.Creator" content="Jeff A.  Zablocki" /></meta><meta name="dc.Creator" content="Elfatih  Elzein" /></meta><meta name="dc.Creator" content="Xiaofen  Li" /></meta><meta name="dc.Creator" content="Dmitry O.  Koltun" /></meta><meta name="dc.Creator" content="Eric Q.  Parkhill" /></meta><meta name="dc.Creator" content="Tetsuya  Kobayashi" /></meta><meta name="dc.Creator" content="Ruben  Martinez" /></meta><meta name="dc.Creator" content="Britton  Corkey" /></meta><meta name="dc.Creator" content="Haibo  Jiang" /></meta><meta name="dc.Creator" content="Thao  Perry" /></meta><meta name="dc.Creator" content="Rao  Kalla" /></meta><meta name="dc.Creator" content="Gregory T.  Notte" /></meta><meta name="dc.Creator" content="Oliver  Saunders" /></meta><meta name="dc.Creator" content="Michael  Graupe" /></meta><meta name="dc.Creator" content="Yafan  Lu" /></meta><meta name="dc.Creator" content="Chandru  Venkataramani" /></meta><meta name="dc.Creator" content="Juan  Guerrero" /></meta><meta name="dc.Creator" content="Jason  Perry" /></meta><meta name="dc.Creator" content="Mark  Osier" /></meta><meta name="dc.Creator" content="Robert  Strickley" /></meta><meta name="dc.Creator" content="Gongxin  Liu" /></meta><meta name="dc.Creator" content="Wei-Qun  Wang" /></meta><meta name="dc.Creator" content="Lufei  Hu" /></meta><meta name="dc.Creator" content="Xiao-Jun  Li" /></meta><meta name="dc.Creator" content="Nesrine  El-Bizri" /></meta><meta name="dc.Creator" content="Ryoko  Hirakawa" /></meta><meta name="dc.Creator" content="Kris  Kahlig" /></meta><meta name="dc.Creator" content="Cheng  Xie" /></meta><meta name="dc.Creator" content="Cindy Hong  Li" /></meta><meta name="dc.Creator" content="Arvinder K.  Dhalla" /></meta><meta name="dc.Creator" content="Sridharan  Rajamani" /></meta><meta name="dc.Creator" content="Nevena  Mollova" /></meta><meta name="dc.Creator" content="Daniel  Soohoo" /></meta><meta name="dc.Creator" content="Eve-Irene  Lepist" /></meta><meta name="dc.Creator" content="Bernard  Murray" /></meta><meta name="dc.Creator" content="Gerry  Rhodes" /></meta><meta name="dc.Creator" content="Luiz  Belardinelli" /></meta><meta name="dc.Creator" content="Manoj C.  Desai" /></meta><meta name="dc.Description" content="Late sodium current (late INa) is enhanced during ischemia by reactive oxygen species (ROS) modifying the Nav 1.5 channel, resulting in incomplete inactivation. Compound 4 (GS-6615, eleclazine) a n..." /></meta><meta name="Description" content="Late sodium current (late INa) is enhanced during ischemia by reactive oxygen species (ROS) modifying the Nav 1.5 channel, resulting in incomplete inactivation. Compound 4 (GS-6615, eleclazine) a n..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="October 3, 2016" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.6b00939" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2016 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.6b00939" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.6b00939" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.6b00939" /></link>
        
    
    

<title>Discovery of Dihydrobenzoxazepinone (GS-6615) Late Sodium Current Inhibitor (Late INai), a Phase II Agent with Demonstrated Preclinical Anti-Ischemic and Antiarrhythmic Properties | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.6b00939" /></meta><meta property="og:title" content="Discovery of Dihydrobenzoxazepinone (GS-6615) Late Sodium Current Inhibitor (Late INai), a Phase II Agent with Demonstrated Preclinical Anti-Ischemic and Antiarrhythmic Properties" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-19/acs.jmedchem.6b00939/20161007/images/large/jm-2016-00939m_0019.jpeg" /></meta><meta property="og:description" content="Late sodium current (late INa) is enhanced during ischemia by reactive oxygen species (ROS) modifying the Nav 1.5 channel, resulting in incomplete inactivation. Compound 4 (GS-6615, eleclazine) a novel, potent, and selective inhibitor of late INa, is currently in clinical development for treatment of long QT-3 syndrome (LQT-3), hypertrophic cardiomyopathy (HCM), and ventricular tachycardia–ventricular fibrillation (VT–VF). We will describe structure–activity relationship (SAR) leading to the discovery of 4 that is vastly improved from the first generation late INa inhibitor 1 (ranolazine). Compound 4 was 42 times more potent than 1 in reducing ischemic burden in vivo (S–T segment elevation, 15 min left anteriorior descending, LAD, occlusion in rabbits) with EC50 values of 190 and 8000 nM, respectively. Compound 4 represents a new class of potent late INa inhibitors that will be useful in delineating the role of inhibitors of this current in the treatment of patients." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.6b00939"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.6b00939">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.6b00939&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.6b00939&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.6b00939&amp;href=/doi/10.1021/acs.jmedchem.6b00939" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2016</span><span class="cit-fg-volume">, 59</span><span class="cit-fg-issue">, 19</span><span class="cit-fg-pageRange">, 9005-9017</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/59/19" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.6b00908" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.6b00944" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Discovery of Dihydrobenzoxazepinone (GS-6615) Late Sodium Current Inhibitor (Late <i>I</i><sub>Na</sub>i), a Phase II Agent with Demonstrated Preclinical Anti-Ischemic and Antiarrhythmic Properties</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jeff+A.++Zablocki">Jeff A. Zablocki</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Elfatih++Elzein">Elfatih Elzein</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Xiaofen++Li">Xiaofen Li</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Dmitry+O.++Koltun">Dmitry O. Koltun</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Eric+Q.++Parkhill">Eric Q. Parkhill</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Tetsuya++Kobayashi">Tetsuya Kobayashi</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ruben++Martinez">Ruben Martinez</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Britton++Corkey">Britton Corkey</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Haibo++Jiang">Haibo Jiang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Thao++Perry">Thao Perry</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Rao++Kalla">Rao Kalla</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Gregory+T.++Notte">Gregory T. Notte</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Oliver++Saunders">Oliver Saunders</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Michael++Graupe">Michael Graupe</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yafan++Lu">Yafan Lu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Chandru++Venkataramani">Chandru Venkataramani</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Juan++Guerrero">Juan Guerrero</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jason++Perry">Jason Perry</a></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Mark++Osier">Mark Osier</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Robert++Strickley">Robert Strickley</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Gongxin++Liu">Gongxin Liu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>#</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Wei-Qun++Wang">Wei-Qun Wang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>#</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Lufei++Hu">Lufei Hu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>#</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Xiao-Jun++Li">Xiao-Jun Li</a></span><span class="author-xref-symbol author-aff-symbol"><sup>#</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Nesrine++El-Bizri">Nesrine El-Bizri</a></span><span class="author-xref-symbol author-aff-symbol"><sup>#</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ryoko++Hirakawa">Ryoko Hirakawa</a></span><span class="author-xref-symbol author-aff-symbol"><sup>#</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kris++Kahlig">Kris Kahlig</a></span><span class="author-xref-symbol author-aff-symbol"><sup>#</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Cheng++Xie">Cheng Xie</a></span><span class="author-xref-symbol author-aff-symbol"><sup>#</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Cindy+Hong++Li">Cindy Hong Li</a></span><span class="author-xref-symbol author-aff-symbol"><sup>#</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Arvinder+K.++Dhalla">Arvinder K. Dhalla</a></span><span class="author-xref-symbol author-aff-symbol"><sup>#</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Sridharan++Rajamani">Sridharan Rajamani</a></span><span class="author-xref-symbol author-aff-symbol"><sup>#</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Nevena++Mollova">Nevena Mollova</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Daniel++Soohoo">Daniel Soohoo</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Eve-Irene++Lepist">Eve-Irene Lepist</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Bernard++Murray">Bernard Murray</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Gerry++Rhodes">Gerry Rhodes</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Luiz++Belardinelli">Luiz Belardinelli</a></span><span class="author-xref-symbol author-aff-symbol"><sup>#</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Manoj+C.++Desai">Manoj C. Desai</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-text"><sup>†</sup>Medicinal Chemistry, <sup>‡</sup>Drug Metabolism, <sup>§</sup>Drug Safety Evaluation, <sup>∥</sup>Formulation and Process Development, and <sup>⊥</sup>Structural Chemistry, Gilead Sciences Inc., 333 Lakeside Drive, Foster City, California 94404, United States</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">#</span> <span class="aff-text">Biology, Gilead Sciences Inc., 7601 Dumbarton Circle, Fremont, California 94555, United States</span></div><div class="corresp-info"><strong>*</strong>Phone: 650-522-6360. E-mail: <a href="/cdn-cgi/l/email-protection#c68ca3a0a0e89ca7a4aaa9a5adaf8681afaaa3a7a2e8a5a9ab"><span class="__cf_email__" data-cfemail="7e341b181850241f1c12111d15173e3917121b1f1a501d1113">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.6b00939&amp;href=/doi/10.1021%2Facs.jmedchem.6b00939" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2016</span></span><span class="cit-volume">, 59</span><span class="cit-issue">, 19</span><span class="cit-pageRange">, 9005–9017</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">September 22, 2016</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>23 June 2016</li><li><span class="item_label"><b>Published</b> online</span>3 October 2016</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 13 October 2016</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.6b00939" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b00939</a></div><div class="article_header-article-copyright"><strong>Copyright © 2016 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D9005%26pageCount%3D13%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DJeff%2BA.%2BZablocki%252C%2BElfatih%2BElzein%252C%2BXiaofen%2BLi%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D59%26issueNum%3D19%26contentID%3Dacs.jmedchem.6b00939%26title%3DDiscovery%2Bof%2BDihydrobenzoxazepinone%2B%2528GS-6615%2529%2BLate%2BSodium%2BCurrent%2BInhibitor%2B%2528Late%2BINai%2529%252C%2Ba%2BPhase%2BII%2BAgent%2Bwith%2BDemonstrated%2BPreclinical%2BAnti-Ischemic%2Band%2BAntiarrhythmic%2BProperties%26numPages%3D13%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D9017%26publicationDate%3DOctober%2B2016">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.6b00939"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1831</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">21</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.6b00939" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Discovery of Dihydrobenzoxazepinone (GS-6615) Late Sodium Current Inhibitor (Late INai), a Phase II Agent with Demonstrated Preclinical Anti-Ischemic and Antiarrhythmic Properties&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Jeff&quot;,&quot;last_name&quot;:&quot;A. Zablocki&quot;},{&quot;first_name&quot;:&quot;Elfatih&quot;,&quot;last_name&quot;:&quot;Elzein&quot;},{&quot;first_name&quot;:&quot;Xiaofen&quot;,&quot;last_name&quot;:&quot;Li&quot;},{&quot;first_name&quot;:&quot;Dmitry&quot;,&quot;last_name&quot;:&quot;O. Koltun&quot;},{&quot;first_name&quot;:&quot;Eric&quot;,&quot;last_name&quot;:&quot;Q. Parkhill&quot;},{&quot;first_name&quot;:&quot;Tetsuya&quot;,&quot;last_name&quot;:&quot;Kobayashi&quot;},{&quot;first_name&quot;:&quot;Ruben&quot;,&quot;last_name&quot;:&quot;Martinez&quot;},{&quot;first_name&quot;:&quot;Britton&quot;,&quot;last_name&quot;:&quot;Corkey&quot;},{&quot;first_name&quot;:&quot;Haibo&quot;,&quot;last_name&quot;:&quot;Jiang&quot;},{&quot;first_name&quot;:&quot;Thao&quot;,&quot;last_name&quot;:&quot;Perry&quot;},{&quot;first_name&quot;:&quot;Rao&quot;,&quot;last_name&quot;:&quot;Kalla&quot;},{&quot;first_name&quot;:&quot;Gregory&quot;,&quot;last_name&quot;:&quot;T. Notte&quot;},{&quot;first_name&quot;:&quot;Oliver&quot;,&quot;last_name&quot;:&quot;Saunders&quot;},{&quot;first_name&quot;:&quot;Michael&quot;,&quot;last_name&quot;:&quot;Graupe&quot;},{&quot;first_name&quot;:&quot;Yafan&quot;,&quot;last_name&quot;:&quot;Lu&quot;},{&quot;first_name&quot;:&quot;Chandru&quot;,&quot;last_name&quot;:&quot;Venkataramani&quot;},{&quot;first_name&quot;:&quot;Juan&quot;,&quot;last_name&quot;:&quot;Guerrero&quot;},{&quot;first_name&quot;:&quot;Jason&quot;,&quot;last_name&quot;:&quot;Perry&quot;},{&quot;first_name&quot;:&quot;Mark&quot;,&quot;last_name&quot;:&quot;Osier&quot;},{&quot;first_name&quot;:&quot;Robert&quot;,&quot;last_name&quot;:&quot;Strickley&quot;},{&quot;first_name&quot;:&quot;Gongxin&quot;,&quot;last_name&quot;:&quot;Liu&quot;},{&quot;first_name&quot;:&quot;Wei-Qun&quot;,&quot;last_name&quot;:&quot;Wang&quot;},{&quot;first_name&quot;:&quot;Lufei&quot;,&quot;last_name&quot;:&quot;Hu&quot;},{&quot;first_name&quot;:&quot;Xiao-Jun&quot;,&quot;last_name&quot;:&quot;Li&quot;},{&quot;first_name&quot;:&quot;Nesrine&quot;,&quot;last_name&quot;:&quot;El-Bizri&quot;},{&quot;first_name&quot;:&quot;Ryoko&quot;,&quot;last_name&quot;:&quot;Hirakawa&quot;},{&quot;first_name&quot;:&quot;Kris&quot;,&quot;last_name&quot;:&quot;Kahlig&quot;},{&quot;first_name&quot;:&quot;Cheng&quot;,&quot;last_name&quot;:&quot;Xie&quot;},{&quot;first_name&quot;:&quot;Cindy&quot;,&quot;last_name&quot;:&quot;Hong Li&quot;},{&quot;first_name&quot;:&quot;Arvinder&quot;,&quot;last_name&quot;:&quot;K. Dhalla&quot;},{&quot;first_name&quot;:&quot;Sridharan&quot;,&quot;last_name&quot;:&quot;Rajamani&quot;},{&quot;first_name&quot;:&quot;Nevena&quot;,&quot;last_name&quot;:&quot;Mollova&quot;},{&quot;first_name&quot;:&quot;Daniel&quot;,&quot;last_name&quot;:&quot;Soohoo&quot;},{&quot;first_name&quot;:&quot;Eve-Irene&quot;,&quot;last_name&quot;:&quot;Lepist&quot;},{&quot;first_name&quot;:&quot;Bernard&quot;,&quot;last_name&quot;:&quot;Murray&quot;},{&quot;first_name&quot;:&quot;Gerry&quot;,&quot;last_name&quot;:&quot;Rhodes&quot;},{&quot;first_name&quot;:&quot;Luiz&quot;,&quot;last_name&quot;:&quot;Belardinelli&quot;},{&quot;first_name&quot;:&quot;Manoj&quot;,&quot;last_name&quot;:&quot;C. Desai&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2016&quot;,&quot;month&quot;:&quot;10&quot;,&quot;day&quot;:&quot;03&quot;,&quot;issue&quot;:&quot;19&quot;,&quot;volume&quot;:&quot;59&quot;,&quot;pages&quot;:&quot;9005-9017&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.6b00939&quot;},&quot;abstract&quot;:&quot;Late sodium current (late INa) is enhanced during ischemia by reactive oxygen species (ROS) modifying the Nav 1.5 channel, resulting in incomplete inactivation. Compound 4 (GS-6615, eleclazine) a novel, potent, and selective inhibitor of late INa, is currently in clinical development for treatment of long QT-3 syndrome (LQT-3), hypertrophic cardiomyopathy (HCM), and ventricular tachycardia–ventricular fibrillation (VT–VF). We will describe structure–activity relationship (SAR) leading to the discovery of 4 that is vastly improved from the first generation late INa inhibitor 1 (ranolazine). Compound 4 was 42 times more potent than 1 in reducing ischemic burden in vivo (S–T segment elevation, 15 min left anteriorior descending, LAD, occlusion in rabbits) with EC50 values of 190 and 8000 nM, respectively. Compound 4 represents a new class of potent late INa inhibitors that will be useful in delineating the role of inhibitors of this current in the treatment of patients.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b00939&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b00939" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b00939&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b00939" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b00939&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b00939" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.6b00939&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b00939&amp;href=/doi/10.1021/acs.jmedchem.6b00939" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.6b00939" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.6b00939" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (2 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b00939&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.6b00939%26sid%3Dliteratum%253Aachs%26genre%3Darticle%26aulast%3DZablocki%26date%3D2016%26atitle%3DDiscovery%2Bof%2BDihydrobenzoxazepinone%2B%2528GS-6615%2529%2BLate%2BSodium%2BCurrent%2BInhibitor%2B%2528Late%2BINai%2529%252C%2Ba%2BPhase%2BII%2BAgent%2Bwith%2BDemonstrated%2BPreclinical%2BAnti-Ischemic%2Band%2BAntiarrhythmic%2BProperties%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D59%26issue%3D19%26spage%3D9005%26epage%3D9017%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291011" title="High-performance liquid chromatography">High-performance liquid chromatography</a>,</li><li><a href="/action/doSearch?ConceptID=291350" title="Assays">Assays</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=291251" title="Sodium">Sodium</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/59/19" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-19/jmcmar.2016.59.issue-19/20161013/jmcmar.2016.59.issue-19.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-19/acs.jmedchem.6b00939/20161007/images/medium/jm-2016-00939m_0019.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-19/acs.jmedchem.6b00939/20161007/images/large/jm-2016-00939m_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00939&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Late sodium current (late <i>I</i><sub>Na</sub>) is enhanced during ischemia by reactive oxygen species (ROS) modifying the Na<sub>v</sub> 1.5 channel, resulting in incomplete inactivation. Compound <b>4</b> (GS-6615, eleclazine) a novel, potent, and selective inhibitor of late <i>I</i><sub>Na</sub>, is currently in clinical development for treatment of long QT-3 syndrome (LQT-3), hypertrophic cardiomyopathy (HCM), and ventricular tachycardia–ventricular fibrillation (VT–VF). We will describe structure–activity relationship (SAR) leading to the discovery of <b>4</b> that is vastly improved from the first generation late <i>I</i><sub>Na</sub> inhibitor <b>1</b> (ranolazine). Compound <b>4</b> was 42 times more potent than <b>1</b> in reducing ischemic burden in vivo (S–T segment elevation, 15 min left anteriorior descending, LAD, occlusion in rabbits) with EC<sub>50</sub> values of 190 and 8000 nM, respectively. Compound <b>4</b> represents a new class of potent late <i>I</i><sub>Na</sub> inhibitors that will be useful in delineating the role of inhibitors of this current in the treatment of patients.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_86612" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_86612" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The high prevalence (7%) of ischemic heart disease (IHD) in the United States (US) is a result of a western diet coupled with lack of exercise, resulting in atherosclerotic obstruction of coronary vessels.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Angina, a condition that afflicts nine million people in the US, is a symptomatic manifestation of IHD that causes chest pain.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> Ranolazine <b>1</b> (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>) was approved in the US in 2006 for the treatment of chronic angina.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> Although the mechanism of <b>1</b>‘s antianginal effect has not been determined, at therapeutic concentrations, <b>1</b> does inhibit cardiac late sodium current. Reactive oxygen species (ROS) generated during ischemia can modify the cardiac sodium channel resulting in incomplete inactivation of the channel allowing repetitive opening of the inactivation gate resulting in a persistent sodium current that occurs late in the action potential, thus termed late <i>I</i><sub>Na</sub> current (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>).<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> Late <i>I</i><sub>Na</sub> current leads up to a 50% increase in cytoplasmic sodium that subsequently leads to Ca<sup>2+</sup> overload through activity of the reverse mode Na–Ca<sup>2+</sup> exchanger.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> Compound <b>1</b> inhibits late <i>I</i><sub>Na</sub> current, thereby lowering the ischemic burden (calcium imbalance and sequelae).<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> At its therapeutic concentration (2–8 μM in plasma), <b>1</b> inhibits a number of cardiac ion currents (e.g., human <i>Ether-à-go-go</i>-related gene, hERG) and has β-blocker activity as well.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> In preclinical models of ischemia, <b>1</b> has been shown to inhibit S–T segment elevation, a finding analogous to its ability to inhibit S–T segment changes in IHD patients with angina undergoing exercise treadmill testing (Monotherapy Assessment of Ranolazine In Stable Angina, MARISA Study).<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> We describe the discovery of a second-generation late <i>I</i><sub>Na</sub> inhibitor with improved properties relative to <b>1</b> with less hERG and β-blockade.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-19/acs.jmedchem.6b00939/20161007/images/medium/jm-2016-00939m_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-19/acs.jmedchem.6b00939/20161007/images/large/jm-2016-00939m_0002.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Gilead late sodium channel current (late <i>I</i><sub>Na</sub>) inhibitors progressed from <b>1</b> to a modified screening hit <b>2</b> with a narrow CNS margin, then to <b>3</b> with a wider CNS margin but a metabolic liability, followed by the development candidate <b>4</b> that meets all criteria.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-19/acs.jmedchem.6b00939/20161007/images/large/jm-2016-00939m_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00939&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-19/acs.jmedchem.6b00939/20161007/images/medium/jm-2016-00939m_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-19/acs.jmedchem.6b00939/20161007/images/large/jm-2016-00939m_0003.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Late sodium current (Late <i>I</i><sub>Na</sub>) in a control experiment (a) or enhanced with aid of 1 nM (b) or 3 nM (c) ATX-II.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-19/acs.jmedchem.6b00939/20161007/images/large/jm-2016-00939m_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00939&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In site directed mutagenesis studies where the key phenylalanine or tyrosine of the lidocaine site have been independently mutated to alanine, <b>1</b> loses its inhibitory effect on late <i>I</i><sub>Na</sub> current, thus suggesting <b>1</b> binds at this site.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> In vitro late <i>I</i><sub>Na</sub> current can be generated by the addition of toxins sea anemone toxin II (ATX-II) or tefluthrin that bind to an external binding site that does not overlap with the lidocaine binding site (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>).<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> Compound <b>1</b> (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>) has an IC<sub>50</sub> of 6.9 μM for ATX-II induced late <i>I</i><sub>Na</sub> inhibition (single cell manual patch).<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> Peak <i>I</i><sub>Na</sub> current (peak cardiac sodium current) is responsible for the propagation of the action potential from cell to cell starting from the pacemaker sinoatrial (SA) node through the atria and ventricles. To avoid pro-arrhythmic effects, it is critical to have an adequate separation of late <i>I</i><sub>Na</sub> inhibition from peak <i>I</i><sub>Na</sub> current. Compound <b>1</b> has a separation of >50-fold for inhibition of late <i>I</i><sub>Na</sub> current relative to peak <i>I</i><sub>Na</sub> current, and it is important to maintain this separation.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a></div><div class="NLM_p last">Herein, we describe our efforts to discover a potent late <i>I</i><sub>Na</sub> current blocker selective against peak <i>I</i><sub>Na</sub> current and demonstrate the antiarrhythmic and anti-ischemic effects of our clinical candidate molecule <b>4</b> (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>) in isolated heart, in vivo S–T ischemia model, and ischemia induced ventricular arrhythmia model. To avoid hERG and β-blockade, we screened a small diverse library of in-house heterocyclic compounds (approximately 800 compounds) without a basic group for their late <i>I</i><sub>Na</sub> inhibitory activity using an automatic patch clamp system (h Na<sub>v</sub>1.5 α-subunit human embryonic kidney cell, HEK-293, Q-Patch system). The ensuing hit-to-lead effort resulted in discovery of triazolopyridine <b>2</b> (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>).<a onclick="showRef(event, 'ref10 ref11'); return false;" href="javascript:void(0);" class="ref ref10 ref11">(10, 11)</a> The potent late <i>I</i><sub>Na</sub> current inhibitor <b>2</b> (GS-458967,<a onclick="showRef(event, 'ref10 ref11'); return false;" href="javascript:void(0);" class="ref ref10 ref11">(10, 11)</a> IC<sub>50</sub> of 333 nM) was found to have a good separation of late <i>I</i><sub>Na</sub> current inhibition from peak sodium current but did not have a favorable central nervous system (CNS) window due to high brain penetration and high activity at brain sodium isoforms (Na<sub>v</sub>1.1, 1.2, 1.3).<a onclick="showRef(event, 'ref10 ref11'); return false;" href="javascript:void(0);" class="ref ref10 ref11">(10, 11)</a> We subsequently discovered <b>3</b> (GS-462808,<a onclick="showRef(event, 'ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref12 ref13">(12, 13)</a><a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>), with an increased polar surface area from 50 to 84 Å by adding a carbonyl to the core that helped lower the brain penetration and serendipitously decreased activity at the brain sodium isoforms resulting in a more favorable CNS window (20-fold).<a onclick="showRef(event, 'ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref12 ref13">(12, 13)</a> Unfortunately, <b>3</b> was found to have a metabolic liability, leading to liver lesions in 7 day rat toxicology studies that may be due to oxadiazole cleavage or glutathione addition to the core.<a onclick="showRef(event, 'ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref12 ref13">(12, 13)</a> We will describe the SAR leading to the discovery of 3,4-dihydrobenz[<i>f</i>][1,4]oxazepin-5(2<i>H</i>)-one <b>4</b> (GS-6615,<a onclick="showRef(event, 'ref14 ref15'); return false;" href="javascript:void(0);" class="ref ref14 ref15">(14, 15)</a><a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>) and its improved properties relative to <b>1</b>.<a onclick="showRef(event, 'ref14 ref15'); return false;" href="javascript:void(0);" class="ref ref14 ref15">(14, 15)</a></div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_43544" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_43544" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i3" class="anchor-spacer"></div><h3 class="article-section__title" id="_i3"> Chemistry</h3><div class="NLM_p">The general route to all of the late <i>I</i><sub>Na</sub> inhibitors in this article utilized an alkylation step of the amide nitrogen and a palladium mediated Suzuki–Miyaura coupling, as illustrated in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a> for compound <b>15</b>. The benzotriazinone synthesis commenced with commercially available compound <b>6</b> (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>).<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> Diazotization and in situ ring closure to the benzotriazinone core was invoked by treatment with sodium nitrite and hydrochloric acid. The 5-bromoquinazolin-4(3<i>H</i>)-one and 5-bromophthalazin-1(2<i>H</i>)-one cores were prepared from commercial starting materials (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>). The lactam core was prepared by a Beckmann rearrangement initiated by treatment with sodium azide and methanesulfonic acid (<a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>).<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> 3,4-Dihydrobenzo[<i>f</i>][1,4]oxazepin-5(2<i>H</i>)-one core commenced with commercially available 6-bromochroman-4-one that underwent ring expansion by Beckmann rearrangement. The order of Suzuki–Miyaura coupling and <i>N</i>-alkylation is interchangeable and depended on the focus of the SAR effort (routes 1 and 2, <a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>).</div><figure id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-19/acs.jmedchem.6b00939/20161007/images/medium/jm-2016-00939m_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-19/acs.jmedchem.6b00939/20161007/images/large/jm-2016-00939m_0009.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Preparation of Benzotriazinone <b>15</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-19/acs.jmedchem.6b00939/20161007/images/large/jm-2016-00939m_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00939&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) NaN<sub>3</sub>, 2N aq HCl; (b) 4-CF<sub>3</sub>OC<sub>6</sub>H<sub>4</sub>B(OH)<sub>2</sub>, Pd(dppf)Cl<sub>2</sub>·CH<sub>2</sub>Cl<sub>2</sub>, K<sub>2</sub>CO<sub>3</sub>, toluene/<i>i</i>-PrOH/H<sub>2</sub>O; (c) 3-(chloromethyl)-5-cyclopropyl-1,3,4-oxadiazole, DMF, K<sub>2</sub>CO<sub>3</sub>, Et<sub>3</sub>N.</p></p></figure><figure id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-19/acs.jmedchem.6b00939/20161007/images/medium/jm-2016-00939m_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-19/acs.jmedchem.6b00939/20161007/images/large/jm-2016-00939m_0010.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Preparation of Quinazolin-4(3<i>H</i>)-one and Phthalazin-1(2<i>H</i>)-one Derivatives<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-19/acs.jmedchem.6b00939/20161007/images/large/jm-2016-00939m_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00939&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) R<sup>1</sup>PhB(OH)<sub>2</sub>, Pd(dppf)Cl<sub>2</sub>·CH<sub>2</sub>Cl<sub>2</sub>, NaHCO<sub>3</sub>, DMF; (b) R<sup>2</sup>-X, X = Cl or Br, NaH, DMF, 80 °C, 24 h.</p></p></figure><figure id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-19/acs.jmedchem.6b00939/20161007/images/medium/jm-2016-00939m_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-19/acs.jmedchem.6b00939/20161007/images/large/jm-2016-00939m_0011.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Preparation of Lactam Core Derivatives<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-19/acs.jmedchem.6b00939/20161007/images/large/jm-2016-00939m_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00939&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) NaN<sub>3</sub>, MeSO<sub>3</sub>H, 0 °C; (b) R<sup>1</sup>PhB(OH)<sub>2</sub>, Pd(dppf)Cl<sub>2</sub>·CH<sub>2</sub>Cl<sub>2</sub>, NaHCO<sub>3</sub>, DMF; (c) R<sup>2</sup>-X, X = Cl or Br, NaH, DMF, 80 °C, 24 h.</p></p></figure><figure id="sch4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-19/acs.jmedchem.6b00939/20161007/images/medium/jm-2016-00939m_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-19/acs.jmedchem.6b00939/20161007/images/large/jm-2016-00939m_0012.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Preparation of 3,4-Dihydrobenzo[<i>f</i>][1,4]oxazepin-5(2<i>H</i>)-one Derivatives<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-19/acs.jmedchem.6b00939/20161007/images/large/jm-2016-00939m_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00939&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) NaN<sub>3</sub>, MeSO<sub>3</sub>H, 0 °C; (b) R<sup>1</sup>PhB(OH)<sub>2</sub>, Pd(dppf)Cl<sub>2</sub>·CH<sub>2</sub>Cl<sub>2</sub>, NaHCO<sub>3</sub>, DMF; (c) R<sup>2</sup>-X, X = Cl or Br, NaH, DMF, 80 °C, 24 h.</p></p></figure><div class="NLM_p">Initially, we stayed close to the [1,2,4]triazolo[4,3-<i>a</i>]pyridin-3(2<i>H</i>)-one core of <b>3</b> by adding another nitrogen to make the 6,6-benzo[<i>d</i>][1,2,3]triazin-4(3<i>H</i>)-one core of <b>15</b>, but we replaced the 3-methyl-1,2,4-oxadiazol-5-yl)methyl D-ring of <b>3</b> with a less metabolic labile 5-cyclopropyl-1,3,4-oxadiazol-2-yl)methyl D-ring (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>). Compound <b>15</b> retained the high polar surface area of 84 Å, had a lower brain to plasma ratio than <b>3</b> (0.84 versus 1.5), and demonstrated anti-ischemic activity in vivo with an EC<sub>50</sub> of 970 nM in the rabbit S–T model (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>).<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> The benzotriazinone series had a number of highly active compounds in the rabbit S–T model and the lowest brain to plasma ratios as a class. However, we were not comfortable developing a compound from the benzotriazinone class due to the lack of precedence in pharmaceutical development and the inherent low solubility (1–4 μM). We tried removing a nitrogen to the more generally accepted quinazolin-4(3<i>H</i>)-one <b>16</b> and phthalazin-1(2<i>H</i>)-one <b>17</b> (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>) that retained inhibition of late <i>I</i><sub>Na</sub> current, but unfortunately this resulted in much higher brain to plasma ratios 15.0 and 4.4, respectively.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Fused Rings Comparison: Benzo[<i>d</i>][1,2,3]triazin-4(3<i>H</i>)-one, Quinazolin-4(3<i>H</i>)-one, and Phthalazin-1(2<i>H</i>)-one</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-19/acs.jmedchem.6b00939/20161007/images/medium/jm-2016-00939m_0013.gif" alt="" id="fx1" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"><b>15</b></th><th class="colsep0 rowsep0" align="center"><b>16</b></th><th class="colsep0 rowsep0" align="center"><b>17</b></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">late <i>I</i><sub>Na</sub>, % block at 1 μM</td><td class="colsep0 rowsep0" align="left">51</td><td class="colsep0 rowsep0" align="left">48</td><td class="colsep0 rowsep0" align="left">39</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Δ<i>S</i>-T EC<sub>50</sub>, nM</td><td class="colsep0 rowsep0" align="left">970</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">B:P, fold</td><td class="colsep0 rowsep0" align="left">0.86</td><td class="colsep0 rowsep0" align="left">15</td><td class="colsep0 rowsep0" align="left">4.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PSA, Å<sup>2</sup></td><td class="colsep0 rowsep0" align="left">84</td><td class="colsep0 rowsep0" align="left">80</td><td class="colsep0 rowsep0" align="left">80</td></tr></tbody></table></div></div><div class="NLM_p">To enhance water solubility for potential use as an intravenous agent, we tried to break the planarity of the unsaturated ring system and switch to a partially saturated 6,6 lactam system exemplified by <b>18</b> and <b>19</b> (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>) and that did indeed result in improved water solubility to 28 and 60 μM, respectively, and retained inhibition of late <i>I</i><sub>Na</sub> current in cells. Both compounds had good metabolic stability, but neither compound was very active in reversing the effects of ATX-II induced late <i>I</i><sub>Na</sub> on monophasic action potential duration<sub>90</sub> (MAPD<sub>90</sub>) in isolated hearts (IH assay described in detail below). The addition of an oxygen and expanding to a seven-membered 3,4-dihydrobenzo[1,4]oxazepinone ring as in compounds <b>20</b> and <b>4</b> resulted in retaining good solubility and inhibition of late <i>I</i><sub>Na</sub> current both in cells and isolated heart preparations (62% reversal at 1 μM). It appears that the late <i>I</i><sub>Na</sub> inhibitor pharmacophore prefers a H-bond acceptor at this position consistent with series like the 3,4-dihydrobenzo[1,4]oxazepinone, providing good activity in isolated heart and downstream anti-ischemic assays (rabbit S–T). Both <b>20</b> and <b>4</b> had a 10-fold separation of inhibition of late <i>I</i><sub>Na</sub> current in cells at the cardiac Na<sub>v</sub>1.5 channel from the inhibition of high frequency 25 Hz (Hz) brain isoform Na<sub>v</sub>1.1. Compound <b>4</b> with the 4-trifluoromethoxyphenyl had better human microsomal metabolic stability than the 4-trifluoromethylphenyl analogue <b>20</b>, and it became the development compound based on this stability and subsequent activities in downstream assays (e.g., rabbit ΔS–T).</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Sodium Channel Blocking Properties of Lactam versus 3,4-Dihydrobenzo[1,4]oxazepinone Compounds</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-19/acs.jmedchem.6b00939/20161007/images/medium/jm-2016-00939m_0014.gif" alt="" id="fx2" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center" char="."> </th><th class="colsep0 rowsep0" align="center" char="."> </th><th class="colsep0 rowsep0" align="center" char="."> </th><th class="rowsep1 colsep0" colspan="3" align="center" char=".">microsomal <i>t</i><sub>1/2</sub>, min</th><th class="colsep0 rowsep0" align="center" char="."> </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center">R<sup>1</sup></th><th class="colsep0 rowsep0" align="center" char=".">late <i>I</i><sub>Na</sub> block, IC<sub>50</sub>, μM</th><th class="colsep0 rowsep0" align="center" char=".">solubility, μM</th><th class="colsep0 rowsep0" align="center" char=".">peak Na<sub>v</sub>1.1, % block at 10 μM</th><th class="colsep0 rowsep0" align="center" char=".">h</th><th class="colsep0 rowsep0" align="center" char=".">r</th><th class="colsep0 rowsep0" align="center" char=".">d</th><th class="colsep0 rowsep0" align="center" char=".">isolated heart (1 μM), ΔAPD<sub>90</sub>, %</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18</b></td><td class="colsep0 rowsep0" align="left">4-CF<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char=".">2.07</td><td class="colsep0 rowsep0" align="char" char=".">28</td><td class="colsep0 rowsep0" align="char" char=".">15</td><td class="colsep0 rowsep0" align="char" char=".">304</td><td class="colsep0 rowsep0" align="char" char=".">354</td><td class="colsep0 rowsep0" align="char" char=".">320</td><td class="colsep0 rowsep0" align="char" char=".">–25</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19</b></td><td class="colsep0 rowsep0" align="left">4-CF<sub>3</sub>O</td><td class="colsep0 rowsep0" align="char" char=".">2.31</td><td class="colsep0 rowsep0" align="char" char=".">60</td><td class="colsep0 rowsep0" align="char" char=".">23</td><td class="colsep0 rowsep0" align="char" char=".">395</td><td class="colsep0 rowsep0" align="char" char=".">150</td><td class="colsep0 rowsep0" align="char" char=".">157</td><td class="colsep0 rowsep0" align="char" char=".">–6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>20</b></td><td class="colsep0 rowsep0" align="left">4-CF<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char=".">1.08</td><td class="colsep0 rowsep0" align="char" char=".">87</td><td class="colsep0 rowsep0" align="char" char=".">60</td><td class="colsep0 rowsep0" align="char" char=".">348</td><td class="colsep0 rowsep0" align="char" char=".">211</td><td class="colsep0 rowsep0" align="char" char=".">371</td><td class="colsep0 rowsep0" align="char" char=".">–62</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4</b></td><td class="colsep0 rowsep0" align="left">4-CF<sub>3</sub>O</td><td class="colsep0 rowsep0" align="char" char=".">0.88</td><td class="colsep0 rowsep0" align="char" char=".">24</td><td class="colsep0 rowsep0" align="char" char=".">53</td><td class="colsep0 rowsep0" align="char" char=".">395</td><td class="colsep0 rowsep0" align="char" char=".">200</td><td class="colsep0 rowsep0" align="char" char=".">354</td><td class="colsep0 rowsep0" align="char" char=".">–62</td></tr></tbody></table></div></div><div class="NLM_p">We next explored ring C SAR to determine whether the 4-trifluoromethoxyphenyl substituent of <b>4</b> was optimal. The 3-trifluoromethoxyphenyl analogue <b>21</b> has less late <i>I</i><sub>Na</sub> inhibition (2×), is less metabolically stable in human microsomes, and is less active in reversing the effects of ATX-II induced late <i>I</i><sub>Na</sub> MAPD<sub>90</sub> in isolated hearts (<a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>). The 2- trifluoromethoxyphenyl analogue <b>22</b> is much less active in late <i>I</i><sub>Na</sub> inhibition relative to the 4-trifluoromethoxyphenyl of <b>4</b>. Similarly, the 3-trifluoromethylphenyl analogue <b>23</b> has less late <i>I</i><sub>Na</sub> inhibition (3×) than the 4-trifluoromethylphenyl <b>20</b>. The 4-chlorophenyl derivative <b>24</b> has less late <i>I</i><sub>Na</sub> inhibition (2×) than <b>4</b>, and it was less metabolically stable in human microsomes. The importance of the electronic and lipophilic effect of the 4-trifluoromethoxyphenyl of <b>4</b> can be noted when comparing late <i>I</i><sub>Na</sub> inhibitory activity for the 4-methoxyphenyl analogue <b>25</b> and the unsubstituted derivative <b>26</b> that were found to be much less active (clogD of <b>4</b> is 3.56 vs 3.01 for <b>25</b>). The CF<sub>3</sub>O– group has been referred to as a pseudohalogen with a Pauling electronegativity of 3.7 that lies between F −4.0 and Cl −3.0, and it is quite lipophilic with a π of 1.04.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> The CH<sub>3</sub>O– is much less electron withdrawing, having a Pauling electronegativity of 2.7 (closer to Br −2.8) with a π of −0.02.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> In addition, the conformation of the two groups are different based on analysis of Cambridge Crystallographic Database data, CH<sub>3</sub>O– carbon typically lies within the plane of the phenyl, but the CF<sub>3</sub>O– carbon lies closer to 90° out of plane.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> This was confirmed by single crystal X-ray for <b>4</b>, where the carbon of the CF<sub>3</sub>O– group lies on average 83° out of plane of the phenyl ring (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>). The CF<sub>3</sub>– group has a comparable Pauling electronegativity of 3.5 to the CF<sub>3</sub>O– group, and it is quite lipophilic with a π of 0.88, so it is consistent that <b>20</b> would have similar late <i>I</i><sub>Na</sub> inhibitory to <b>4</b> (cLogD of <b>20</b> is 3.37).<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> The 4-CHF<sub>2</sub>O– group of <b>27</b> imparts a decreased late <i>I</i><sub>Na</sub> inhibition that may be imparted due to the decreased lipophilicity (cLogD 3.2) and the conformational effects where the CHF<sub>2</sub>O– θ typically lies between 0° and 50°.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> Also, the 4-CHF<sub>2</sub>– group of <b>28</b> imparts a decreased late <i>I</i><sub>Na</sub> inhibition that may be imparted due to the decreased lipophilicity (<b>28</b> cLogD 2.95).<a onclick="showRef(event, 'ref18 ref19'); return false;" href="javascript:void(0);" class="ref ref18 ref19">(18, 19)</a> Highly polar groups such as 4-MeSO<sub>2</sub>– led to loss of late <i>I</i><sub>Na</sub> inhibition for <b>29</b> consistent with the phenyl substituent binding in a hydrophobic pocket. The 4-Cl,3-F-phenyl derivative <b>30</b> was 2× less active than <b>4</b> in cells but retained good late <i>I</i><sub>Na</sub> inhibition in the isolated heart assay. Adding an <i>ortho</i>-F group (<b>31</b>) to <b>4</b> led to comparable late <i>I</i><sub>Na</sub> inhibition but resulted in lower human microsomal stability. Adding a <i>meta</i>-Cl (<b>32</b>) to <b>4</b> led to good activity, retention of metabolic stability, but decreased activity in ex vivo assay (IH). As expected, the addition of a 2-acetamido group to <b>4</b> affording <b>33</b> resulted in a considerable loss of late <i>I</i><sub>Na</sub> inhibition. The 4-trifluoromethoxyphenyl group of <b>4</b> provided the best overall properties, so this was fixed and we explored the D ring SAR (<a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a>). Prior to changing the D ring, we checked the linker length. We found that longer linkers led to a loss in metabolic stability as exemplified by the ethyl linker <b>34</b> (propyl was also less stable, not shown). The pyridyl D ring analogue <b>35</b> (a one nitrogen change from <b>4</b>), resulted in retaining late <i>I</i><sub>Na</sub> inhibition, a slight increase in peak sodium inhibition, and a decrease in metabolic stability. Addition of a 5-trifluoromethyl to <b>35</b> afforded <b>36</b> with improved metabolic stability, but the solubility decreased below 1 μM. Replacing the 5-trifluoromethyl group with 5-fluoro <b>37</b> resulted in a very potent late <i>I</i><sub>Na</sub> inhibitor, but the inhibition of peak Na<sub>v</sub>1.1 was too high and the metabolic stability decreased substantially. The addition of a 3-methoxy <b>38</b> or 3-amino <b>39</b> to the D ring led to an increase in the inhibition of peak Na<sub>v</sub>1.1. A highly polar group with H bond donors was not well tolerated on the D ring (<b>40</b>). The compounds of <a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a> and <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a> begin to illustrate how challenging it is to optimize all the properties of late <i>I</i><sub>Na</sub> inhibitors. The original 4-trifluoromethoxyphenyl C ring and unsubstituted pyrimidine D ring of <b>4</b> turned out to be optimal.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Sodium Channel Blocking Properties of 3,4-Dihydrobenzo[<i>f</i>][1,4]oxazepin-5(2<i>H</i>)-one Compounds</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-19/acs.jmedchem.6b00939/20161007/images/medium/jm-2016-00939m_0015.gif" alt="" id="fx3" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="center" /></col><col align="center" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="center" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center" char="."> </th><th class="rowsep1 colsep0" colspan="3" align="center" char=".">microsomal <i>t</i><sub>1/2</sub>, min</th><th class="colsep0 rowsep0" align="center" char="."> </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center">R<sup>1</sup></th><th class="colsep0 rowsep0" align="center">late <i>I</i><sub>Na</sub> block, IC<sub>50</sub> (or % at 1 μM)</th><th class="colsep0 rowsep0" align="center">peak Na<sub>v</sub>1.5 block, % (at conc, μM), 3 Hz</th><th class="colsep0 rowsep0" align="center" char=".">peak Na<sub>v</sub>1.1, % block at 10 μM, 25 Hz</th><th class="colsep0 rowsep0" align="center" char=".">h</th><th class="colsep0 rowsep0" align="center" char=".">r</th><th class="colsep0 rowsep0" align="center">d</th><th class="colsep0 rowsep0" align="center" char=".">isolated heart (1 μM) ΔAPD<sub>90</sub>, %</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4</b><a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">4-CF<sub>3</sub>O</td><td class="colsep0 rowsep0" align="center">0.88</td><td class="colsep0 rowsep0" align="center">24 (3)</td><td class="colsep0 rowsep0" align="char" char=".">53</td><td class="colsep0 rowsep0" align="char" char=".">395</td><td class="colsep0 rowsep0" align="char" char=".">200</td><td class="colsep0 rowsep0" align="center">354</td><td class="colsep0 rowsep0" align="char" char=".">–62</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>20</b><a class="ref internalNav" href="#t3fn1" aria-label="a">a</a>,<a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">4-CF<sub>3</sub></td><td class="colsep0 rowsep0" align="center">1.08</td><td class="colsep0 rowsep0" align="center">27 (3)</td><td class="colsep0 rowsep0" align="char" char=".">60</td><td class="colsep0 rowsep0" align="char" char=".">348</td><td class="colsep0 rowsep0" align="char" char=".">211</td><td class="colsep0 rowsep0" align="center">371</td><td class="colsep0 rowsep0" align="char" char=".">–62</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="9" align="left">     </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>21</b><a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">3-CF<sub>3</sub>O</td><td class="colsep0 rowsep0" align="center">2.03</td><td class="colsep0 rowsep0" align="center">3 (3)</td><td class="colsep0 rowsep0" align="char" char=".">18</td><td class="colsep0 rowsep0" align="char" char=".">297</td><td class="colsep0 rowsep0" align="char" char=".">294</td><td class="colsep0 rowsep0" align="center">43</td><td class="colsep0 rowsep0" align="char" char=".">–29</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>22</b><a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">2-CF<sub>3</sub>O</td><td class="colsep0 rowsep0" align="center">(26)</td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>23</b><a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">3-CF<sub>3</sub></td><td class="colsep0 rowsep0" align="center">3.03</td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>24</b><a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">4-Cl</td><td class="colsep0 rowsep0" align="center">1.62</td><td class="colsep0 rowsep0" align="center">17 (3)</td><td class="colsep0 rowsep0" align="char" char=".">31</td><td class="colsep0 rowsep0" align="char" char=".">194</td><td class="colsep0 rowsep0" align="char" char=".">96</td><td class="colsep0 rowsep0" align="center">63</td><td class="colsep0 rowsep0" align="char" char=".">–68</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>25</b><a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">4-MeO</td><td class="colsep0 rowsep0" align="center">(13)</td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>26</b><a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="center">(18)</td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>27</b><a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">4-CHF<sub>2</sub>O</td><td class="colsep0 rowsep0" align="center">(13)</td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>28</b><a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">4-CHF<sub>2</sub></td><td class="colsep0 rowsep0" align="center">(17)</td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>29</b><a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">4-MeSO<sub>2</sub></td><td class="colsep0 rowsep0" align="center">(3)</td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>30</b><a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">4-Cl,3-F</td><td class="colsep0 rowsep0" align="center">1.61</td><td class="colsep0 rowsep0" align="center">8 (1)</td><td class="colsep0 rowsep0" align="char" char=".">23</td><td class="colsep0 rowsep0" align="char" char=".">330</td><td class="colsep0 rowsep0" align="char" char=".">98</td><td class="colsep0 rowsep0" align="center">115</td><td class="colsep0 rowsep0" align="char" char=".">–58</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>31</b><a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">4-CF<sub>3</sub>O,2-F</td><td class="colsep0 rowsep0" align="center">1.28</td><td class="colsep0 rowsep0" align="center">37 (3)</td><td class="colsep0 rowsep0" align="char" char=".">35</td><td class="colsep0 rowsep0" align="char" char=".">241</td><td class="colsep0 rowsep0" align="char" char=".">308</td><td class="colsep0 rowsep0" align="center">156</td><td class="colsep0 rowsep0" align="char" char=".">–39</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>32</b><a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">4-CF<sub>3</sub>O,3-Cl</td><td class="colsep0 rowsep0" align="center">0.77</td><td class="colsep0 rowsep0" align="center">15 (3)</td><td class="colsep0 rowsep0" align="char" char=".">33</td><td class="colsep0 rowsep0" align="char" char=".">393</td><td class="colsep0 rowsep0" align="char" char=".">338</td><td class="colsep0 rowsep0" align="center">NT<a class="ref internalNav" href="#t3fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="char" char=".">–23</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>33</b><a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">4-CF<sub>3</sub>O,2-MeCONH</td><td class="colsep0 rowsep0" align="center">(4)</td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="char" char="."> </td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>a</sup><p class="last">Prepared by route 1, <a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>.</p></div><div class="footnote" id="t3fn2"><sup>b</sup><p class="last">Prepared by route 2, <a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>.</p></div><div class="footnote" id="t3fn3"><sup>c</sup><p class="last">NT = not tested.</p></div></div></div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Sodium Channel Blocking Properties of 3,4-Dihydrobenzo[<i>f</i>][1,4]oxazepin-5(2<i>H</i>)-one Compounds<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-19/acs.jmedchem.6b00939/20161007/images/medium/jm-2016-00939m_0016.gif" alt="" id="fx4" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-19/acs.jmedchem.6b00939/20161007/images/medium/jm-2016-00939m_0017.gif" alt="" id="fx5" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>Table a</sup><p class="last">All compounds in this table were prepared by route 1, <a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>.</p></div><div class="footnote" id="t4fn2"><sup>Table b</sup><p class="last">NT = not tested.</p></div></div><div></div></div><figure id="fig3" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-19/acs.jmedchem.6b00939/20161007/images/medium/jm-2016-00939m_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-19/acs.jmedchem.6b00939/20161007/images/large/jm-2016-00939m_0004.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Single crystal X-ray of <b>4</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-19/acs.jmedchem.6b00939/20161007/images/large/jm-2016-00939m_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00939&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">A homology model of Na<sub>v</sub>1.5 was built based on the crystal structure of a bacterial voltage-gated sodium channel, NavAb (3RVY, see <a href="/doi/suppl/10.1021/acs.jmedchem.6b00939/suppl_file/jm6b00939_si_001.pdf" class="ext-link">Supporting Information</a>).<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> The model was manipulated into several states, including the closed, open, and inactivated states. The closed state differs from the open and inactivated states by a translational motion of the S4 helices in response to voltage changes. The shift in the S4 helices alters the position of the S4–S5 linkers, which constrain the extent of the pore aperture opening formed by the S6 helices.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> The open and inactivated states differ by a conformational change in the inactivation gate connecting domains III and IV. In the inactivated state, the inactivation gate closes over the channel opening, directing the residues I1485, F1486, and M1487 into the hydrophobic pore.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> Various compounds described here were docked into the three states of the channel, and a consensus binding mode emerged for compounds docked to the open and inactivated states. This binding mode, as illustrated in <a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a> for compound <b>4</b>, suggests compounds rest in the lidocaine pocket, with the biphenyl motif forming stacking interactions with F1760 and Y1767 on the S6 helix of domain IV. In support of this binding pose, <b>4</b> lost late <i>I</i><sub>Na</sub> inhibition with the mutants F1760A or Y1767A in a similar manner to <b>1</b>. The trifluoromethoxy group of compound <b>4</b> is positioned toward the hydrophobic opening of the channel, interacting primarily with I1466 on the S6 helix of domain III and I1768 on the S6 helix of domain IV. An interaction with F1486 of the inactivation gate may also be possible in the inactivated state. The more polar end of the molecule is directed toward the selectivity filter, defined by the residues D372, E898, K1419, and A1711.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a></div><figure id="fig4" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-19/acs.jmedchem.6b00939/20161007/images/medium/jm-2016-00939m_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-19/acs.jmedchem.6b00939/20161007/images/large/jm-2016-00939m_0005.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Homology model of compound <b>4</b> bound to the inactivated state of Na<sub>v</sub>1.5. Protein surface is colored by residue type: green is hydrophobic, cyan is polar, blue is positively charged. The compound is suggested to bind with its biphenyl motif sandwiched between F1760 and Y1767, which define the lidocaine pocket. Its hydrophobic end (trifluoromethoxy) is directed toward the inactivation gate, while its polar end (pyrimidine) is directed toward the selectivity filter. Inset shows the full length model. Domain I is blue, domain II is green, domain III is yellow, and domain IV is pink. The inactivation gate linking domains III and IV is orange. The C-terminus is red. Compound <b>4</b> is seen to bind in the channel pore.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-19/acs.jmedchem.6b00939/20161007/images/large/jm-2016-00939m_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00939&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Next, we evaluated the antiarrhythmic and anti-ischemic effects of <b>4</b> versus <b>1</b> in isolated heart, in vivo ischemia model (rabbit ΔS–T), and ischemia induced ventricular arrhythmia model. Late <i>I</i><sub>Na</sub> was induced in ex vivo isolated rabbit hearts through the addition of toxin ATX-II that prolongs the MAPD<sub>90</sub> by approximately 100 ms (ms, <a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>). Late <i>I</i><sub>Na</sub> inhibitors <b>4</b> or <b>1</b> reverse the prolongation of MAPD<sub>90</sub> in the isolated heart but to a different degree and potency. Compound <b>4</b> reverses the ATX-II effect by 100% with an IC<sub>50</sub> of 700 nM, while <b>1</b> provides only a partial reversal by 60% with an IC<sub>50</sub> of 16 μM. Compound <b>4</b> is 22 times more potent in reversal of late <i>I</i><sub>Na</sub> effects than <b>1</b>. It is noteworthy that neither <b>4</b> or <b>1</b> have L-type calcium channel activity at the concentrations tested as this would also shorten the MAPD<sub>90</sub>. The prolongation of MAPD<sub>90</sub> by late <i>I</i><sub>Na</sub> translates into a longer QT interval in vivo. In these isolated heart ex vivo studies, the effect of <b>4</b> is much more pronounced on the QT interval with complete reversal of ATX-II induced prolongation as compared to a partial reversal observed with <b>1</b> (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>). Patients with long QT-3 have a persistent current late in the action potential duration due to mutations in their sodium channel that lead to improper inactivation of the channel. Both <b>1</b> and <b>4</b> have been shown to shorten the long QT interval in LQT-3 patients that is consistent with late <i>I</i><sub>Na</sub> inhibition.<a onclick="showRef(event, 'ref24 ref25'); return false;" href="javascript:void(0);" class="ref ref24 ref25">(24, 25)</a> The ATX-II isolated heart model is an ex vivo LQT3 model. Compound <b>1</b> has been shown in chronic angina patients to increase their treadmill exercise times before angina pain develops that correlates with changes in their S–T segment during exercise.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> Preclinically, <b>1</b> inhibits the S–T segment elevation with an EC<sub>50</sub> of 8 μM in a rabbit model of ischemia where the LAD artery of a rabbit heart is occluded for 15 min and <b>1</b> was infused prior to ischemia (<a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>). Compound <b>4</b> inhibits S–T segment elevation with an EC<sub>50</sub> of 190 nM, and it nearly abolishes S–T segment elevation at 500 nM (93% inhibition). Compound <b>1</b> only inhibits 60% of S–T segment elevation at 12 μM. Compound <b>20</b> inhibits S–T elevation with an EC<sub>50</sub> of 300 nM, slightly inferior to <b>4</b>. The favorable activity of <b>4</b> in the rabbit S–T assay is even more than expected based on cellular late <i>I</i><sub>Na</sub> inhibition (IC<sub>50</sub> = 600 nM, −120 mV, manual patch HEK-293). Compound <b>4</b> has increased late <i>I</i><sub>Na</sub> potency, as the resting membrane voltage decreases to −80 mV with an improvement in IC<sub>50</sub> to 100 nM. This enhanced voltage dependent block (VDB) of <b>4</b> for late <i>I</i><sub>Na</sub> current is consistent with ischemic states where resting membrane potentials are as low as −75 mV. Previously, Pierre Fabre researchers found their lead late <i>I</i><sub>Na</sub> inhibitors that performed well in advanced ischemia models had a high degree of VDB.<a onclick="showRef(event, 'ref26 ref27'); return false;" href="javascript:void(0);" class="ref ref26 ref27">(26, 27)</a> While the VDB IC<sub>50</sub> is more in line with the rabbit S–T EC<sub>50</sub>, we did check all off target cardiac ion channels that would affect efficacy and a full selectivity panel of receptors where <b>4</b> was completely clean of effects at 1 μM (see Supporting Information, <a href="/doi/suppl/10.1021/acs.jmedchem.6b00939/suppl_file/jm6b00939_si_001.pdf" class="ext-link">Table 1</a>). The improved efficacy (93%) and potency (42 times) of <b>4</b> relative to <b>1</b> in the rabbit S–T model prompted our decision to advance <b>4</b> to development. We wanted to evaluate additional indications for <b>4</b> and turned to an ischemia induced ventricular arrhythmia model (<a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a>). In the VT–VF model, we constrict the left circumflex artery in the rabbit for 30 min to induce the control animals to have episodes of VT and VF. Both the class Ic peak sodium current inhibitor flecainide and class 1b mexiletine increase ventricular tachycardia/fibrillation (VT–VF) and subsequent death due to their pro-arrhythmic properties (<a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a> and Supporting Information, <a href="/doi/suppl/10.1021/acs.jmedchem.6b00939/suppl_file/jm6b00939_si_001.pdf" class="ext-link">Figure 2</a>).<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> Compound <b>4</b> (class Ib) completely inhibits VT–VF and death at 2.5 μM with an EC<sub>50</sub> of approximately 1.7 μM. Previously, we found that <b>1</b> was only partially protective in a chemically induced Torsades des Pointes (TdP) assay with 40% of the animals having Tdp at 14 μM.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> Compound <b>4</b> was also evaluated in the chemically induced TdP assay, and it was again completely protective at 2.5 μM (see supplement). Overall, compound <b>4</b> had marked improvement in potency and efficacy relative to <b>1</b> in animal models of ischemia and arrhythmia consistent with advancement as a second-generation late <i>I</i><sub>Na</sub> inhibitor, so we further characterized its ion channel and PK properties.</div><figure id="fig5" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-19/acs.jmedchem.6b00939/20161007/images/medium/jm-2016-00939m_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-19/acs.jmedchem.6b00939/20161007/images/large/jm-2016-00939m_0006.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. LQT-3 model <b>4</b> (orange) vs <b>1</b> (red), ex vivo isolated heart IC<sub>50</sub> (rabbit).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-19/acs.jmedchem.6b00939/20161007/images/large/jm-2016-00939m_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00939&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig6" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-19/acs.jmedchem.6b00939/20161007/images/medium/jm-2016-00939m_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-19/acs.jmedchem.6b00939/20161007/images/large/jm-2016-00939m_0007.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Anti-ischemic effect of <b>1</b> versus <b>4</b> versus <b>20</b> in left anterior descending (LAD) coronary occlusion model (15 min, rabbit).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-19/acs.jmedchem.6b00939/20161007/images/large/jm-2016-00939m_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00939&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig7" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-19/acs.jmedchem.6b00939/20161007/images/medium/jm-2016-00939m_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-19/acs.jmedchem.6b00939/20161007/images/large/jm-2016-00939m_0008.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. <b>4</b> suppresses ischemia induced VT–VF arrhythmias recorded during 30 min of LCX ligation in anesthetized rabbits. Flecainide (class 1c antiarrhythmic) and mexiletine (class 1b antiarrhythmic, Supporting Information, <a href="/doi/suppl/10.1021/acs.jmedchem.6b00939/suppl_file/jm6b00939_si_001.pdf" class="ext-link">Figure 2</a>) induce VT–VF and mortality at clinical exposures.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-19/acs.jmedchem.6b00939/20161007/images/large/jm-2016-00939m_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00939&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Our initial triazolopyridine lead <b>2</b> has an IC<sub>50</sub> of 400 nM against the brain sodium isoforms Na<sub>v</sub>1.1, 1.2, 1.3 with a stimulating frequency of 10 Hz, while <b>4</b> has an IC<sub>50</sub> of 96, 60, and 16 μM, respectively (<a class="ref internalNav" href="#tbl4a" aria-label="Table 5">Table 5</a>).<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> This enhanced selectivity is thought to be important to avoid off-target CNS effects observed with <b>2</b> that resulted in a narrow therapeutic index. It is also important to avoid hitting the muscular isoforms Na<sub>v</sub>1.4 and 1.6 to avoid tremors in the peripheral nervous system where <b>4</b> has low activity as well. The Na<sub>v</sub>1.7 and 1.8 are targets for pain indications in the periphery where the high frequency (25 Hz) inhibition by <b>4</b> may actually prove beneficial in diabetic neuropathy, a common co-morbidity of ischemic patients. It is noteworthy that <b>1</b> has demonstrated efficacy in preclinical models of pain.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> Compound <b>4</b> has use dependent block with increased activity for late <i>I</i><sub>Na</sub> inhibition with an IC<sub>50</sub> less than 100 nM for 3 Hz stimulation (180 beats per minute). The off-target activity for <b>4</b> does increase at the high frequency of 25 Hz, but it is still above 3 μM for the brain isoforms. Ultimately, <b>4</b> was found to be well tolerated in vivo as far as a CNS effects with single ascending dose studies in rat and dog supporting adverse events occurring above 10 μM. Compound <b>4</b> was found to be approximately 10 times more potent than <b>1</b> for late <i>I</i><sub>Na</sub> inhibition in cells (<a class="ref internalNav" href="#tbl5" aria-label="Table 6">Table 6</a>) while maintaining a good separation from peak sodium inhibition. Compound <b>1</b> has only a 2 fold separation of late <i>I</i><sub>Na</sub> inhibition from hERG inhibition, but <b>4</b> has a 10-fold separation. The late <i>I</i><sub>Na</sub> inhibiting effects of <b>1</b> on MAPD<sub>90</sub> in isolated hearts are likely compromised by its hERG inhibition that works against it. This may be the reason for the partial efficacy observed with <b>1</b> in the isolated heart assay. Both <b>4</b> and <b>1</b> have low activity at the brain isoform Na<sub>v</sub>1.1 at 10 μM with 10 Hz stimulation.</div><div class="NLM_table-wrap" id="tbl4a"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Sodium Channel Blocking Properties of 3,4-Dihydrobenzo[<i>f</i>][1,4]oxazepin-5(2<i>H</i>)-one <b>4</b> (Manual Patch Clamp)</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-19/acs.jmedchem.6b00939/20161007/images/medium/jm-2016-00939m_0018.gif" alt="" id="GRAPHIC-d7e2915-autogenerated" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center" char=".">IC<sub>50</sub> (μM) stimulating frequency (Hz)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">Na<sup>+</sup> channel isoform</th><th class="colsep0 rowsep0" align="center" char=".">10 Hz</th><th class="colsep0 rowsep0" align="center" char=".">25 Hz</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Na<sub>v</sub>1.1</td><td class="colsep0 rowsep0" align="char" char=".">∼96</td><td class="colsep0 rowsep0" align="char" char=".">3.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Na<sub>v</sub>1.2</td><td class="colsep0 rowsep0" align="char" char=".">∼60</td><td class="colsep0 rowsep0" align="char" char=".">10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Na<sub>v</sub>1.3</td><td class="colsep0 rowsep0" align="char" char=".">∼16</td><td class="colsep0 rowsep0" align="char" char=".">3.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Na<sub>v</sub>1.4</td><td class="colsep0 rowsep0" align="char" char=".">∼13</td><td class="colsep0 rowsep0" align="char" char=".">3.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Na<sub>v</sub>1.6</td><td class="colsep0 rowsep0" align="char" char=".">∼28</td><td class="colsep0 rowsep0" align="char" char=".">4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Na<sub>v</sub>1.7</td><td class="colsep0 rowsep0" align="char" char=".">5</td><td class="colsep0 rowsep0" align="char" char=".">1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Na<sub>v</sub>1.8</td><td class="colsep0 rowsep0" align="char" char=".">∼18.8</td><td class="colsep0 rowsep0" align="char" char=".">1.5</td></tr></tbody></table></div></div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. Sodium Channel Blocking Properties of 3,4-Dihydrobenzo[<i>f</i>][1,4]oxazepin-5(2<i>H</i>)-one <b>4</b> versus <b>1</b> (Manual Patch Clamp)</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"><b>4</b></th><th class="colsep0 rowsep0" align="center"><b>1</b></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">late <i>I</i><sub>Na</sub> IC<sub>50</sub> (μM) ATX II</td><td class="colsep0 rowsep0" align="left">0.62 (10-fold)</td><td class="colsep0 rowsep0" align="left">6.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">peak <i>I</i><sub>Na</sub> IC<sub>50</sub> (μM) (peak/late)</td><td class="colsep0 rowsep0" align="left">51 (82-fold)</td><td class="colsep0 rowsep0" align="left">428 (62-fold)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">hERG IC<sub>50</sub> (μM) (hERG/late)</td><td class="colsep0 rowsep0" align="left">6.0 (10-fold)</td><td class="colsep0 rowsep0" align="left">12 (2-fold)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">peak Na<sub>v</sub>1.1 @ 10 μM (10 Hz)</td><td class="colsep0 rowsep0" align="left">no effect</td><td class="colsep0 rowsep0" align="left">no effect</td></tr></tbody></table></div></div><div class="NLM_p">We evaluated the pharmacokinetics of <b>4</b> across species with a good correlation between in vitro and in vivo clearance in rat and dog but a slightly lower clearance (3×) observed in vivo in the cynomolgus monkey (<a class="ref internalNav" href="#tbl6" aria-label="Table 7">Table 7</a>). The volume steady state (<i>V</i><sub>ss</sub>) across species was in an acceptable range where allometric scaling projected a human volume of 1.5 L/kg. The half-life of <b>4</b> varied from 5 h in the cyno to 27.9 h in dog. Compound <b>4</b> had good oral bioavailability across species consistent with excellent permeability (heterogeneous human epithelial colorectal adenocarcinoma, CACO-2 A → B/B → A 34.6/29 × 10<sup>–6</sup> cm/s) and low first-pass metabolism. The low clearance in pooled human hepatocytes using tritiated <b>4</b> was consistent with once a day dosing. The subsequent maintenance doses of <b>4</b> used in phase II trials were 3 and 6 mg per day.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> We do not anticipate drug–drug interactions with <b>4</b> as there were no significant inhibitory activity observed against the major cytochrome P450s (>10 μM, Cyp 3A4, 2D6, 2C8, 1A, 2C9, 2C19, 2B6). We did measure the levels of <b>4</b> in the brain in the rat after oral dosing, and the total brain to plasma ratios were approximately 3:1. Fortunately, <b>4</b> was found to be well tolerated in vivo in the rat as far as a CNS effects due to the decreased activity at the brain isoforms as mentioned above.</div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 7. Preclinical PK Properties across Species for <b>4</b></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center">parameter</th><th class="colsep0 rowsep0" align="center" char=".">SD rat</th><th class="colsep0 rowsep0" align="center" char=".">beagle dog</th><th class="colsep0 rowsep0" align="center" char=".">cyno monkey</th><th class="colsep0 rowsep0" align="center" char=".">human</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">hepatocytes <sup>3</sup>H-<b>4</b></td><td class="colsep0 rowsep0" align="left">Cl<sub>int</sub> (L/h/kg)</td><td class="colsep0 rowsep0" align="char" char=".">0.16</td><td class="colsep0 rowsep0" align="char" char=".">0.06</td><td class="colsep0 rowsep0" align="char" char=".">0.36</td><td class="colsep0 rowsep0" align="char" char="."><0.015</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="6" align="left">     </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">IV</td><td class="colsep0 rowsep0" align="left">Cl (L/h/kg)</td><td class="colsep0 rowsep0" align="char" char=".">0.14</td><td class="colsep0 rowsep0" align="char" char=".">0.042</td><td class="colsep0 rowsep0" align="char" char=".">0.11</td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><i>V</i><sub>ss</sub> (L/kg)</td><td class="colsep0 rowsep0" align="char" char=".">2.5</td><td class="colsep0 rowsep0" align="char" char=".">1.6</td><td class="colsep0 rowsep0" align="char" char=".">1.5</td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><i>T</i><sub>1/2</sub> (h)</td><td class="colsep0 rowsep0" align="char" char=".">13</td><td class="colsep0 rowsep0" align="char" char=".">27.9</td><td class="colsep0 rowsep0" align="char" char=".">5.0</td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="6" align="left">     </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PO</td><td class="colsep0 rowsep0" align="left">%<i>F</i></td><td class="colsep0 rowsep0" align="char" char=".">91</td><td class="colsep0 rowsep0" align="char" char=".">100</td><td class="colsep0 rowsep0" align="char" char=".">39</td><td class="colsep0 rowsep0" align="char" char="."> </td></tr></tbody></table></div></div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i15">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_15825" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_15825" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">We identified <b>4</b> as an appropriate second-generation late <i>I</i><sub>Na</sub> inhibitor with improved potency and efficacy relative to <b>1</b> in cells, ex vivo isolated hearts, and in animal models of ischemia and arrhythmia. Late sodium current is enhanced during ischemia, leading to calcium overload that increases energy demand during ischemia and increases the probability of early after depolarizations and delayed after depolarizations, both triggers for arrhythmias.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> The first-generation late <i>I</i><sub>Na</sub> inhibitor <b>1</b> within its therapeutic range (2–8 μM) does not completely inhibit late <i>I</i><sub>Na</sub> (estimated at 15–30% inhibition based on rabbit S–T), has only a 2-fold selectivity over hERG, has significant β-blocker activity at therapeutic concentrations, requires twice a day dosing at approved doses up to 1000 mg, and has dizziness as a side effect due to CNS effects (6% at 1000 mg). Compound <b>4</b> is estimated to have a 100% coverage of late <i>I</i><sub>Na</sub> inhibition at 1 μM (based on rabbit S–T), has a 10-fold selectivity over hERG, does not inhibit β-receptors at 10 μM, is QD at 3 and 6 mg, and was well tolerated in phase I studies. Compound <b>4</b> is 10 times more potent late <i>I</i><sub>Na</sub> inhibitor than <b>1</b> in cells and 22 times more potent in isolated heart ex vivo assay. Compound <b>4</b> was 42 times more potent than <b>1</b> in reducing ischemic burden in vivo (rabbit S–T segment) with 93% inhibition at 500 nM, while <b>1</b> provided only 60% at 12 μM. In a drug-induced model of <i>TdP</i> ventricular arrhythmia model (supplement), <b>4</b> was completely protective at 2.4 μM, while <b>1</b> provides only 60% reduction at 14 μM. Compound <b>4</b> does not potentiate ischemia-induced arrhythmias (VT–VF) or mortality as was observed with other class 1 antiarrhythmics in the LCX model. Compound <b>4</b> is currently in clinical development for treatment of LQT-3 syndrome, HCM, and VT–VF. Compound <b>4</b> represents a new class of potent late <i>I</i><sub>Na</sub> inhibitors that will be useful in further delineating the role of inhibitors of this current in the treatment of patients with cardiovascular disease.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i16">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_12663" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_12663" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Nuclear magnetic resonance (NMR) spectra were recorded on Varian Mercury Plus 400 MHz and a Varian Unity Plus 500 MHz spectrometers at room temperature, with tetramethylsilane as an internal standard. Chemical shifts (δ) are reported in parts per million (ppm), and signals are reported as s (singlet), d (doublet), t (triplet), q (quartet), m (multiplet), or br s (broad singlet). Purities of the final compounds were determined by HPLC and were greater than 95%. HPLC conditions to assess purity were as follows: Agilent HPLC, Phenomenex Kinetix C18, 4.6 mm × 100 mm (2.6 μm); gradient of 0.1% TFA water (A) and 0.1% TFA acetonitrile (B) start at 98:2 A:B with 8.5 min gradient to 0:100; flow rate, 1.5 mL/min; wavelength, UV 254 nM. The LC-MS spectra were obtained on an Agilent system with the following HPLC conditions: column, Phenomenex Luna C18, 4.6 mm × 75 mm (5 μm), gradient of 0.05% TFA water (A) and 0.04% TFA acetonitrile (B), flow rate, 1.0 mL/min. The preparative HPLC system includes two sets of Gilson 332 pumps, a Gilson 156 UV/vis detector, and a Gilson 215 injector and fraction collector, with Trilution LC software. A Phenomenex Luna 150 mm × 21.2 mm column was used. The mobile phase was a gradient of 0.1% TFA water (A) and 0.1% TFA acetonitrile (B). High-resolution mass spectra were recorded on a Xevo G2 Q–T of mass spectrometer with an ESI source.</div><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> 7-(4-(Trifluoromethoxy)phenyl)-3,4-dihydrobenzo[<i>f</i>][1,4]oxazepin-5(2<i>H</i>)-one (<b>4</b>)</h3><div class="NLM_p">Commercially available 6-bromochroman-4-one (1.0 g, 3 mmol) was dissolved in 10 mL of methanesulfonic acid. The solution was cooled using an ice bath, and sodium azide (0.30 g, 4.5 mmol) was added over a period of 45 min. The mixture was stirred at RT for 16 h. The mixture was neutralized using conc HCl. The resulting solid was filtered and washed with water to afford <b>11</b> as analytically pure sample.</div><div class="NLM_p last">Route 2: To a solution of <b>11</b> (20.0 g, 0.083 mol, 1 equiv) and 2-(chloromethyl)pyrimidine (25.0 g, 0.15 mol, 1.8 equiv) in DMF (150 mL), NaOH solution (20 mL, 10M, 5 equiv) was slowly added at room temperature (slightly exothermic) and stirred at rt for 10 min, followed by heating at 95 °C for 2 h. After cooling the reaction mixture, ethyl acetate (200 mL) was added and the organic layer was separated. The organic layer was washed with water (20 mL), brine, dried over sodium sulfate, and concentrated. The residue was dissolved in 1,4-dioxane (50 mL) and to this 4 N HCl in dioxane (50 mL) and conc HCl (2 mL) was added and stirred at room temperature for 4 h. The resulting precipitate was filtered, washed with ethyl acetate, and dried. Compound <b>13</b> obtained (30 g, 98.0%) was obtained as a light-yellow solid. To the bromide <b>13</b> (15 g, 0.04 mol, 1 equiv), 4-trifluoromethoxyphenylboronic acid (12.5 g, 0.06 mol, 1.5 equiv) and potassium carbonate (22.0 g, 0.16 mol, 4 equiv) in a round-bottom flask, solvent (150 mL, toluene/2-propanol/water, 2/1/1) was added and stirred under nitrogen for 10 min. To the above solution, the palladium catalyst Pd(dppf)Cl<sub>2</sub>·CH<sub>2</sub>Cl<sub>2</sub> (1.0 g, 0.012 mol, 0.02 equiv) was added and heated at 85 °C for 2 h. The reaction mixture was diluted with ethyl acetate (300 mL), and the organic layer was separated, filtered through a plug of Celite and silica gel, and concentrated in vacuo. Flash column purification on silica gel using ethyl acetate/hexane as eluent provided <b>4</b> (13.0 g 78%). This reaction was repeated to afford an additional 13.0 g of <b>4</b>. To a solution of <b>4</b> (26 g) in 1,4-dioxane (25 mL), 4 N HCl/dioxane (25 mL) was added followed by conc. HCl (2 mL) and stirred at room temperature for 4 h. Solvent was distilled off, and dichloromethane was added and distilled off. To the residue, ethyl acetate (150 mL) was added and stirred at room temperature overnight. The precipitate was filtered, washed with ethyl acetate and hexane, and dried under vacuum. Compound <b>4 HCl</b> obtained (24.8 g) was obtained as a white solid. Anal. HPLC 100% (6.78 min). <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 8.72 (d, 2H, <i>J</i> = 5.2 Hz), 8.17 (d, 1H, <i>J</i> = 2.4 Hz), 7.59–7.63 (m, 3H), 7.26 (d, 2H, <i>J</i> = 3.2 Hz), 7.22 (t, 1H, <i>J</i> = 4.8 Hz), 7.10 (d, 1H, <i>J</i> = 8.4 Hz), 5.10 (s, 2H), 4.56 (t, 2H, <i>J</i> = 5.0 Hz), 3.77 (t, 2H, <i>J</i> = 5.0 Hz). LCMS <i>m</i>/<i>z</i> 416.1 (M + H). HRMS-ESI+: [M + H]<sup>+</sup> calcd for C<sub>21</sub>H<sub>16</sub>F<sub>3</sub>N<sub>3</sub>O<sub>3</sub>, 416.1217; found, 416.1215.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> 6-Bromobenzo[<i>d</i>][1,2,3]triazin-4(3<i>H</i>)-one (<b>7</b>)</h3><div class="NLM_p last">To a mixture of commercially available compound <b>6</b> (9.250 g, 43.03 mmol) and sodium nitrite (8.909 g, 129.11 mmol) in 1,4-dioxane (40 mL) was added dropwise 2N aqeuous HCl (80 mL, 160.00 mmol) with vigorous stir over a period of 30 min, during which H<sub>2</sub>O was added twice (40 mL each at 10th and 20th min). After completion of addition, the reaction mixture was stirred overnight then diluted with H<sub>2</sub>O (200 mL), sonicated, filtered, washed with H<sub>2</sub>O (500 mL), and dried to afford the desired product as <b>7</b>. LCMS <i>m</i>/<i>z</i> 226.0 (M + H), 228.0 (M + H + 2). Anal. HPLC > 98%. <sup>1</sup>H NMR (400 MHz; DMSO-<i>d</i><sub>6</sub>) δ 8.30 (d, <i>J</i> = 2.3 Hz, 1H), 8.22 (dd, <i>J</i> = 8.6, 2.0 Hz, 1H), 8.10 (d, <i>J</i> = 9.0 Hz, 1H).</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> 6-(4-(Trifluoromethoxy)phenyl)benzo[<i>d</i>][1,2,3]triazin-4(3<i>H</i>)-one (<b>8</b>)</h3><div class="NLM_p last">To a solution of <b>7</b> (1.130 g, 5.0 mmol) and 4-trifluoromethoxyphenylboronic acid (1.544 g, 7.5 mmol) in DMF (30 mL) was added K<sub>2</sub>CO<sub>3</sub> (2.073 g, 15.0 mmol) and H<sub>2</sub>O (3 mL). The reaction mixture was stirred for 5 min under an atmosphere of dry N<sub>2</sub>. Pd(dppf)Cl<sub>2</sub>·CH<sub>2</sub>Cl<sub>2</sub> (146 mg, 0.20 mmol) was added, and the resulting mixture was heated at 98 °C until <b>7</b> was consumed (LCMS). The reaction mixture was cooled, diluted with EtOAc (70 mL), filtered through a layer of Celite, washed with 20% DMF in EtOAc (100 mL), transferred to a separation funnel, organic phase was washed with 0.5 M K<sub>2</sub>CO<sub>3</sub> (50 mL, 25.0 mmol), 30% aqeuous NH<sub>4</sub>Cl (100 mL)and brine (100 mL), dried, and concentrated. To the crude product was added 10% EtOAc in <i>n</i>-hexane (10 mL), sonicated, filtered, and washed with 10% EtOAc in <i>n</i>-hexane (20 mL) to afford the desired product as <b>8</b>, MS <i>m</i>/<i>z</i> 308.0 (M + H), HPLC purity >97%. <sup>1</sup>H NMR matched the desired product. The combined filtrate was concentrated, subjected to Gilson’s reverse-phase preparative HPLC with a gradient 0.1% TFA containing CH<sub>3</sub>CN/H<sub>2</sub>O (10% to 90%) to afford additional desired product as <b>8</b>. LCMS <i>m</i>/<i>z</i> 308.0 (M + H). Anal. HPLC > 99%. The overall combined yield is 71%. <sup>1</sup>H NMR (400 MHz; DMSO-<i>d</i><sub>6</sub>) δ 8.42 (m, 1H), 8.39 (d, <i>J</i> = 2.3 Hz, 1H), 8.26 (d, <i>J</i> = 8.2 Hz, 1H), 8.00 (m, 2H); 7.52 (d, <i>J</i> = 8.2 Hz, 2H). <sup>19</sup>F NMR (376 MHz; DMSO-<i>d</i><sub>6</sub>) δ −57.2 (s, 3F).</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> 3-((5-Cyclopropyl-1,3,4-oxadiazol-2-yl)methyl)-6-(4-(trifluoromethyl)phenyl)benzo[<i>d</i>][1,2,3]triazin-4(3<i>H</i>)-one (<b>15</b>)</h3><div class="NLM_p last">To a solution of <b>8</b> (2.446 g, 7.96 mmol) and 3-(chloromethyl)-5-cyclopropyl-1,3,4-oxadiazole (1.660 g, 10.47 mmol) in DMF (15 mL) in a Biotage microwave tube (20 mL capacity) was added potassium carbonate (1.881 g, 13.61 mmol) and triethyl amine (2 mL) with stirring. The reaction mixture was stirred at room temperature for 5 min and then subjected to microwave heating at 120 °C until <b>8</b> was consumed in LCMS. The mixture was cooled, diluted with 20% DMF in EtOAc (50 mL), filtered, and washed with 20% DMF in EtOAc (100 mL). The combined filtrate was concentrated in vacuo, dissolved mostly in dichloromethane (20 mL), and filtered, and the filtrate was subjected to Yamazen chromatography over Universal column, eluted with a gradient EtOAc in <i>n</i>-hexane to afford, after drying, <b>15</b>. Anal. HPLC 97% (7.19 min). <b>15</b> was recrystallized from EtOAc/<i>n</i>-hexane and dried to give <b>15</b>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.57–8.44 (m, 2H), 8.36 (d, <i>J</i> = 8.4 Hz, 1H), 8.09 (d, <i>J</i> = 8.1 Hz, 2H), 7.88 (d, <i>J</i> = 8.2 Hz, 2H), 5.82 (s, 2H), 2.20 (ddd, <i>J</i> = 8.4, 4.9, 3.5 Hz, 1H), 1.15–1.02 (m, 2H), 1.02–0.86 (m, 2H). HRMS-ESI+: [M + H]<sup>+</sup> calcd for C<sub>20</sub>H<sub>14</sub>F<sub>3</sub>N<sub>5</sub>O<sub>2</sub>, 414.1172; found, 414.1167.</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> 3-((3-Methyl-1,2,4-oxadiazol-5-yl)methyl)-6-(4-(trifluoromethoxy)phenyl)quinazolin-4(3<i>H</i>)-one (<b>16</b>)</h3><div class="NLM_p last"><b>16</b> was prepared using the procedures disclosed herein above with the appropriate starting materials. LC/MS (<i>m</i>/<i>z</i>): 403.0 (M + H<sup>+</sup>). Anal. HPLC 100% (7.21 min). <sup>1</sup>H NMR (chloroform-<i>d</i>) δ 8.50 (d, <i>J</i> = 2.2 Hz, 1H), 8.24 (s, 1H), 8.01 (dd, <i>J</i> = 8.5, 2.2 Hz, 1H), 7.86 (d, <i>J</i> = 8.5 Hz, 1H), 7.69 (d, <i>J</i> = 8.7 Hz, 2H), 7.33 (dd, <i>J</i> = 8.9, 1.0 Hz, 1H), 5.42 (s, 2H), 2.38 (s, 3H). HRMS-ESI+: [M + H]<sup>+</sup> calcd for C<sub>19</sub>H<sub>13</sub>F<sub>3</sub>N<sub>4</sub>O<sub>3</sub>, 403.1013; found, 403.1010.</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> 2-((3-Methyl-1,2,4-oxadiazol-5-yl)methyl)-7-(4-(trifluoromethoxy)phenyl)phthalazin-1(2<i>H</i>)-one (<b>17</b>)</h3><div class="NLM_p">A mixture of 7-bromophthalazinone (1.09g, 4.84 mmol), 4-trifluoromethoxyphenyl boronic acid (1.20 g, 5.81 mmol), Pd(dppf)Cl<sub>2</sub>·CH<sub>2</sub>Cl<sub>2</sub> (177 mg, 0.242 mmol), and potassium carbonate (1.34 g, 9.68 mmol) in degassed toluene (4 mL), degassed water (2 mL), and degassed 2-propanol (2 mL) was heated at 90 °C for 12 h. The layers were separated, the organic layer was concentrated, and the residue was purified by trituration with hexanes/ethyl acetate to provide 7-(4-(trifluoromethoxy)phenyl)phthalazin-1(2<i>H</i>)-one as a white powder. LCMS <i>m</i>/<i>z</i> C<sub>15</sub>H<sub>9</sub>F<sub>3</sub>N<sub>2</sub>O<sub>2.</sub> 307.2 (M + 1).</div><div class="NLM_p last">To a mixture of 7-(4-(trifluoromethoxy)phenyl)phthalazin-1(2<i>H</i>)-one (50 mg, 0.163 mmol), 5-(chloromethyl)-3-methyl-1,2,4-oxadiazole (47.5 mg, 0.359 mmol), and potassium carbonate (68 mg, 9.68 mmol) was added DMF (1 mL), and the reaction was heated to 80 °C overnight. The reaction was diluted with EtOAC and water, the layers were separated, and the organic layer was concentrated to an oil. The residue was purified by flash chromatography (<i>R</i><sub>f</sub> = 0.32, 1:1 hexanes/ethyl acetate) to afford 2-((3-methyl-1,2,4-oxadiazol-5-yl)methyl)-7-(4-(trifluoromethoxy)phenyl)phthalazin-1(2<i>H</i>)-one <b>17</b> as a white solid. C<sub>19</sub>H<sub>13</sub>F<sub>3</sub>N<sub>4</sub>O<sub>3.</sub> LCMS <i>m</i>/<i>z</i> 403.1 (M + 1). Anal. HPLC 99.6% (7.18 min). <sup>1</sup>H NMR (DMSO) δ 8.58 (s, 1H), 8.48 (d, <i>J</i> = 2.0 Hz, 1H), 8.34 (dd, <i>J</i> = 2.0, 8.4 Hz, 1H), 8.12 (d, <i>J</i> = 8.4 Hz, 1H), 7.98–8.02 (m, 2H), 7.54 (d, <i>J</i> = 8.0 Hz, 1H), 5.67 (s, 2H), 2.31 (s, 1H). HRMS-ESI+: [M + H]<sup>+</sup> calcd for C<sub>19</sub>H<sub>13</sub>F<sub>3</sub>N<sub>4</sub>O<sub>3</sub>, 403.1013; found, 403.1011.</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> 2-(Pyrimidin-2-ylmethyl)-7-(4-(trifluoromethyl)phenyl)-3,4-dihydroisoquinolin-1(2<i>H</i>)-one (<b>18</b>)</h3><div class="NLM_p last">Compound <b>18</b> was prepared using the procedures disclosed in the above scheme using the appropriate starting materials. Anal. HPLC 99.3% (6.84 min). <sup>1</sup>H NMR (CD<sub>3</sub>OD) δ 8.72 (d, 2H, <i>J</i> = 4.8 Hz), 8.22 (d, 1H, <i>J</i> = 2.0 Hz), 7.77–7.81 (m, 3H), 7.72 (d, 2H, <i>J</i> = 8.0 Hz), 7.39 (d, 1H, <i>J</i> = 8.0 Hz), 7.34 (t, 1H, <i>J</i> = 5.0 Hz), 5.02 (s, 2H), 3.81 (t, 2H, <i>J</i> = 6.4 Hz), 3.14 (t, 2H, <i>J</i> = 6.4 Hz). MS <i>m</i>/<i>z</i> 384.1 (M + H). HRMS-ESI+: [M + H]<sup>+</sup> calcd for C<sub>21</sub>H<sub>16</sub>F<sub>3</sub>N<sub>3</sub>O, 384.1318; found, 384.1316.</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> 2-(Pyrimidin-2-ylmethyl)-7-(4-(trifluoromethoxy)phenyl)-3,4-dihydroisoquinolin-1(2<i>H</i>)-one (<b>19</b>)</h3><div class="NLM_p last">Compound <b>19</b> was prepared using the procedures disclosed in the above scheme using the appropriate starting materials. Anal. HPLC 100% (6.96 min). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 8.75 (d, 2H, <i>J</i> = 5.2 Hz), 8.17 (d, 1H, <i>J</i> = 2.4 Hz), 7.78 (m,3H) 7.35–7.45 (m,4H), 4.93 (s, 1H), 3.74–3.78 (t, 2H),3.07–3.10 (t, 2H). LCMS <i>m</i>/<i>z</i> 400.1 (M + H).</div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> 7-(4-(Trifluoromethyl)phenyl)-3,4-dihydrobenzo[<i>f</i>][1,4]oxazepin-5(2<i>H</i>)-one (<b>20</b>)</h3><div class="NLM_p">Route 1: 7-Bromo-3,4-dihydrobenzo[<i>f</i>][1,4]oxazepin-5(2<i>H</i>)-one (2.0 g), 4-trifluoromethoxyphenylboronic acid (2.2 g), and potassium carbonate (2.0 g) were combined in a mixture of toluene (20 mL), 2-propanol (10 mL), and water (10 mL), and the resulting suspension was degassed with nitrogen. Palladium catalyst Pd(dppf)Cl<sub>2</sub>·CH<sub>2</sub>Cl<sub>2</sub> was added (0.42 g), and the reaction was heated overnight at 85 °C. After cooling, the aqueous layer was discarded and the organic layer was diluted 2-fold with ethyl acetate, dried over MgSO<sub>4</sub>, and concentrated. Recrystallization was conducted by dissolving in a minimum necessary amount of dichloromethane and triturating with excess hexane, resulting in 7-(4-(trifluoromethyl)phenyl)-3,4-dihydrobenzo[<i>f</i>][1,4]oxazepin-5(2<i>H</i>)-one as a gray solid (1.43 g). <sup>1</sup>H NMR: 8.42 (t, 1H), 8.12 (d, 1H), 7.86–7.76 (m, 5H), 7.13 (d, 1H), 4.38 (t, 2H), 3.37 (quartet, 2H). <b>20</b> was made via alkylation with 2-(chloromethyl)pyrimidine using the conditions described above for making <b>13</b>. Anal. HPLC 100% (6.78 min).</div><div class="NLM_p last">Route 2: To the bromide <b>13</b> (28.0 g, 0.083 mol, 1 equiv), 4-trifluoromethylphenylboronic acid (24.0 g, 0.125 mol, 1.5 equiv), and potassium carbonate (45.0 g, 0.332 mol, 4 equiv) in a round-bottom flask, solvent (200 mL, toluene/2-propanol/water, 2/1/1) was added and stirred under nitrogen for 10 min. To the above solution, the palladium catalyst Pd(dppf)Cl<sub>2</sub>·CH<sub>2</sub>Cl<sub>2</sub> (1.4 g, 0.00166 mol, 0.02 equiv) was added and heated at 85 °C for 3 h. The reaction mixture was diluted with ethyl acetate (200 mL), separated the organic layer, washed with water, and brine. The organic layer was filtered through a plug of Celite and concentrated. Column purification on silica gel using ethyl acetate/hexane (70/30) as eluent provided the product <b>20</b> (28.9 g; 87%). <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 8.80 (d, 2H, <i>J</i> = 5.2 Hz), 8.19 (d, 1H, <i>J</i> = 2.8 Hz), 7.66–7.71 (m, 5H), 7.33 (t, 1H, <i>J</i> = 5.0 Hz), 7.13 (d, 1H, <i>J</i> = 8.4 Hz), 5.14 (s, 2H), 4.59 (t, 2H, <i>J</i> = 4.8 Hz), 3.81 (t, 2H, <i>J</i> = 5.0 Hz). LCMS <i>m</i>/<i>z</i> 400.1 (M + H). HRMS-ESI+: [M + H]<sup>+</sup> calcd for C<sub>21</sub>H<sub>16</sub>F<sub>3</sub>N<sub>3</sub>O<sub>2</sub>, 400.1267; found, 400.1267.</div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> 7-(3-(Trifluoromethoxy)phenyl)-3,4-dihydrobenzo[<i>f</i>][1,4]oxazepin-5(2<i>H</i>)-one (<b>21</b>)</h3><div class="NLM_p last">Compound <b>21</b> was prepared according to <b>4</b> disclosed herein using the appropriate starting materials. Anal. HPLC 100% (6.86 min). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.77 (d, <i>J</i> = 4.8 Hz, 2H), 8.01 (d, <i>J</i> = 2.5 Hz, 1H), 7.81 (dd, <i>J</i> = 8.8, 2.4 Hz, 1H)7.77–7.65 (m, 1H), 7.66–7.53 (m, 2H), 7.43 (t, <i>J</i> = 4.9 Hz, 1H), 7.36 (d, <i>J</i> = 8.2 Hz, 1H), 7.17 (d, <i>J</i> = 8.5 Hz, 1H), 5.00 (s, 2H), 4.55 (t, <i>J</i> = 4.8 Hz, 2H), 3.79 (t, <i>J</i> = 4.8 Hz, 2H). HRMS-ESI+: [M + H]<i>+</i> calcd for C<sub>21</sub>H<sub>16</sub>F<sub>3</sub>N<sub>3</sub>O<sub>3</sub>, 416.1216; found, 416.1213.</div></div><div id="sec4_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> Automated Ion Channel Assays</h3><div class="NLM_p">The late sodium current (late <i>I</i><sub>Na</sub>) and peak sodium current (peak <i>I</i><sub>Na</sub>) assays were performed at room temperature on the QPatch automated electrophysiology platform (Sophion Bioscience, Copenhagen, Denmark), which used the whole cell patch clamp technique to measure currents through the cell membrane. Series resistance compensation was set to 100%, and series resistance and whole-cell compensation were performed automatically and currents were digitized at 25 kHz.</div><div id="sec4_11_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> Cardiac hNa<sub>V</sub>1.5 Assays</h4><div class="NLM_p last">HEK293 cells stably expressing the human Na<sub>v</sub>1.5voltage-gated sodium channel (Millipore, Billerica, MA) were used to measure the block of <i>I</i><sub>Na</sub> at resting membrane potential of −120 mV. For the late <i>I</i><sub>Na</sub> assay, a voltage step from the resting membrane potential to −20 mV for 220 ms was performed at a stimulating frequency of 0.1 Hz. To improve assay signal-to-noise, late <i>I</i><sub>Na</sub> was enhanced using continuous application of tefluthrin (TEF, 10 μM) in the extracellular and intracellular solutions. Late <i>I</i><sub>Na</sub> was measured as the magnitude of <i>I</i><sub>Na</sub> during the end phase of the voltage step (210–220 ms). The extracellular solution was (in mM): 140 NaCl, 4 KCl, 1.8 CaCl<sub>2</sub>, 0.75 MgCl<sub>2</sub>, and 5 HEPES with pH adjusted to 7.4 using NaOH. The intracellular solution was (in mM): 120 CsF, 20 CsCl, 5 EGTA, 5 HEPES, and pH adjusted to 7.4 with CsOH. For the peak <i>I</i><sub>Na</sub> assay, a voltage step from the resting membrane potential to −20 mV for 20 ms was performed at a stimulating frequency of 0.1 Hz. This protocol was performed in control solution and after the superfusion of compound containing solution. The extracellular solution was (in mM): 40 NaCl, 100 choline Cl, 4 KCl, 1.8 CaCl<sub>2</sub>, 0.75 MgCl<sub>2</sub> and 5 HEPES with pH adjusted to 7.4 using NaOH. The intracellular solution was (in mM): 120 CsF, 20 CsCl, 5 EGTA, 5 HEPES, and pH adjusted to 7.4 with CsOH.</div></div><div id="sec4_11_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> hERG Assay</h4><div class="NLM_p last">CHO–hERG DUO cells stably expressing the human ERG (<i>Ether-à-go-go</i> gene) K<sub>V</sub>11.1 voltage-gated potassium channel were obtained from Sophion. Inhibition of peak tail current was measured from a holding potential of −80 mV. The voltage protocol consisted of two contiguous steps: first a step to +20 mV for 4.8 s followed by step to −40 mV for 5 s with a sweep frequency of 0.0667 Hz. Peak tail current IK was measured at the start of the step to −40 mV. This protocol was performed in control solution and after the superfusion of compound containing solution. Then 1 μM Cisapride solution was added near the end to define the baseline. The external recording solution was (in mM): 140 NaCl, 4 KCl, 1.8 CaCl<sub>2</sub>, 1 MaCl<sub>2</sub>, 10 HEPES, and 10 glucose. The internal recording solution was (in mM): 120 KCl, 31.25/10 KOH/EGTA, 10 HEPES, 5.374 CaCl<sub>2</sub>, 1.75 MgCl<sub>2</sub>, 4 Na<sub>2</sub>-ATP.</div></div></div><div id="sec4_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> Manual Ion Channel Assays for Non-Cardiac Na<sub>V</sub>1.X Channels</h3><div class="NLM_p last">Assays were performed at room temperature using a manual patch clamp in the whole-cell configuration using a MultiClamp 700B amplifier, Digidata 1400 digitizer, and pClamp 10 software (Molecular Devices, Sunnyvale, CA, USA). Series resistance was compensated 90% to ensure that the command potential was reached within microseconds with a voltage error <2 mV. Leak currents were subtracted by using an online P/4 procedure. Currents were low-pass Bessel filtered at 4 kHz and digitized at 50 kHz. The bath solution contained (mM): 140 NaCl, 4 KCl, 1.8 CaCl<sub>2</sub>, 1 MgCl<sub>2</sub>, 10 dextrose, and 10 HEPES, with a pH of 7.35. The pipet solution consisted of (mM) 10 NaF, 110 CsF, 20 CsCl, 2 EGTA, and 10 HEPES, with a pH of 7.35. Inhibition was assessed using a train of 50 square voltage steps (P<sub>1</sub> to P<sub>50</sub>) from a holding potential of −120 mV to a test potential of 0 mV (20 ms) at a frequency of either 10 Hz. The ratio P50/P1 obtained in the presence of drug was normalized to the ratio obtained in the absence of drug (Control) to calculate the degree of inhibition.</div></div><div id="sec4_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> Isolated Rabbit Heart Assay</h3><div class="NLM_p last">Animal use was approved by the Institutional Animal Care and Use Committee of Gilead Sciences (Fremont, CA). New Zealand White female rabbits, weighing 2.5–3.5 kg, were sedated then anesthetized using IM and IV injections, respectively, of xylazine and ketamine. The heart was excised and placed in a modified Krebs–Heinsleit (K–H) solution (pH 7.4, gassed with 95% O<sub>2</sub> and 5% CO<sub>2</sub>). The K–H solution contained (in mM): 118 NaCl, 2.8 KCl, 1.2 KH<sub>2</sub>PO<sub>4</sub>, 2.5 CaCl<sub>2</sub>, 0.5 MgSO<sub>4</sub>, 2.0 sodium pyruvate, 5.5 glucose, 0.57 Na<sub>2</sub>EDTA, and 25 NaHCO<sub>3</sub>. The aorta was cannulated and the heart was perfused by the method of Langendorff with K–H solution warmed to 36.5 °C. To ensure capture during pacing, the right atrial wall was partially removed and complete atrioventricular block was induced by thermoablation of the atrioventricular nodal area. A bipolar Teflon-coated electrode was placed on the right ventricular septum to pace the heart. Electrical stimuli, 2 ms in width and 3-fold threshold amplitude, were delivered to the pacing electrode at a frequency of 1 Hz using EP-4 stimulator (EP MedSystems, ST. JUDE MEDICAL). After initiation of ventricular pacing, a 30–50 min period was allowed for equilibration of heart rhythm. Pressure-contact Ag-AgCl MAP electrodes were placed on the epicardial ventricular free wall below the level of the atrial–ventricular valve at the base of the left ventricle. Electrical signals were amplified, filtered, and digitized in real time using a BIOPAC Systems MP 150 signal processor and displayed on a computer screen by AcqKnowledge 4.2 for MP150 software (BIOPAC Systems Inc.). The duration of the monophasic action potential at 90% repolarization (MAPD<sub>90</sub>) was used to monitor left ventricular repolarization. MAPD<sub>90</sub> was first prolonged by the perfusion of the heart with ATX-II to activate late <i>I</i><sub>Na</sub>. The degree of MAPD<sub>90</sub> shortening back to baseline was measured at steady-state following compound perfusion.</div></div><div id="sec4_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> Ischemia-Induced ECG S–T Segment Elevation by LAD Ligation in Rabbits</h3><div class="NLM_p">Female New Zealand rabbits (3.0–4.0 kg) were purchased from Western Oregon Rabbitry. Animals were housed on a 12 h light and dark cycle and received standard laboratory chow and water. All experiments were performed in accordance with the Guide for the Care and Use of Laboratory Animals published by The National Research Council and with the experimental protocol approved by the Institutional Animal Care Committee of Gilead Sciences, Inc.</div><div class="NLM_p">Rabbits were anesthetized with ketamine (35 mg/kg) and xylazine (5 mg/kg) intramuscular injection (IM). A tracheotomy was performed, and the trachea was intubated with an endotracheal tube. The animal was ventilated with room air supplemented with oxygen using a pressure control animal ventilator (Kent Scientific Corp., Torrington, CT) at a respiratory rate of 40 strokes/min and peak inspiration pressure of 10 mmH<sub>2</sub>O, which was adjusted to keep blood gases and pH within the physiological range (iSTAT clinic analyzer, Heska Corp.; Waukesha, WI). The left femoral artery was cannulated for the measurement of blood pressure (BP). Blood samples were also withdrawn from femoral artery. The right external jugular vein was cannulated for drug/vehicle administration. Needle electrodes were inserted subcutaneously into the limbs for recording of the surface electrocardiogram (ECG). The heart was exposed via an incision in the fourth intercostal space (fourth and/or fifth ribs were cut for a clear surgical vision). The chest was opened and a pericardial cradle was formed using four retractors. A coronary artery occluder, comprised of a snare made of 5 cm PE-10 tubing with a 6–0 Prolene polypropylene suture in it, was placed loosely around the left anterior descending artery (LAD) at its origin. Two unipolar electrodes, made with Teflon coated silver wire attached to a small patch of filter paper, were attached on the surface of the ischemic and normal regions of the left ventricle to record epicardial electrocardiogram. Reference electrodes were placed in the open incision of the neck. The body temperature of the animal was monitored via a rectal thermometer and maintained at 37–40 °C by adjusting the surface temperature of the surgical table. Regional ischemia (15 min) was induced by ligating the LAD, followed by 15 min of reperfusion caused by releasing the ligation. BP and ECG were monitored and recorded continuously using a computer data acquisition system (PowerLab, AD Instruments; Mountain View, CA). S–T segment height in both epicardial and surface ECG, and PR, QRS, and QT interval in surface ECG was analyzed using an ECG analysis module (AD Instruments, Mountain View, CA).</div><div class="NLM_p">The heart was excised at the end of the experiment, and the LAD was religated. The ischemic area was visualized by perfusing the heart with 1% Evans blue in saline and calculated as a percentage of total ventricular weight. Rabbits with ischemic area less than 10% or larger than 25% were excluded from the analysis.</div><div id="sec5" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> Experimental Protocol</h4><div class="NLM_p">Animals were randomly assigned to vehicle, GS-compound groups. After 30 min of dosing, the heart was subjected to 15 min of ischemia followed by 15 min of reperfusion.</div><div class="NLM_p">Blood samples were collected at 1, 5, 10, 30, and 60 min after drug administration for determination of plasma concentrations of the compound. Plasma concentrations of GS compound were determined using a high performance liquid chromatograph–tandem mass spectrometric (LC/MS/MS).</div><div class="NLM_p">The <b>20</b> dose-dependently prevented the ischemia-induced S–T elevation. The area under curve (AUC) for the S–T segment height was reduced (vs control) by 38% and 88% at 0.28 and 0.52 μM plasma concentration of <b>20</b>. At the plasma concentration levels studied, <b>20</b> had no significant effect on blood pressure (BP), heart rate (HR), and ECG intervals prior to the ischemia.</div><div class="NLM_p last">Similarly, <b>4</b> dose-dependently prevented the ischemia-induced ST elevation. The area under curve (AUC) for the S–T segment height was reduced (vs control) by 55% and 93% at 0.25 and 0.5 μM, respectively, and plasma concentration of compound of <b>4</b>. At the plasma concentration levels studied, compound <b>4</b> had no significant effect on blood pressure (BP), heart rate (HR), and ECG intervals prior to the ischemia.</div></div></div><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> Ischemia-Induced Arrhythmia by LCX Ligation in Rabbits</h3><div class="NLM_p">Female New Zealand rabbits (3.0–4.0 kg) were purchased from Western Oregon Rabbit Company. Animals were housed on a 12 h light and dark cycle and received standard laboratory chow and water ad libitum. All experiments were performed in accordance with the Guide for the Care and Use of Laboratory Animals published by National Research Council and with the experimental protocol approved by the Institutional Animal Care Committee of Gilead Sciences, Inc. Rabbits were anesthetized with sodium pentobarbital given as an intravenous injection of 30 mg/kg followed by IV infusion at 15 mg/kg/h. A tracheotomy was performed, and the trachea was intubated with an endotracheal tube. The animal was ventilated with room air supplemented with oxygen using a pressure control animal ventilator (Kent Scientific Corp., Torrington, CT) at a respiratory rate of 40 strokes/min and peak inspiration pressure of 10 mmH<sub>2</sub>O, which was adjusted to keep blood gases and pH within the physiological range (iSTAT clinic analyzer; Heska Corp., Waukesha, WI). The left femoral artery was cannulated for the measurement of blood pressure (BP). Blood samples were also withdrawn from femoral artery. The right external jugular vein was cannulated for drug/vehicle administration. Needle electrodes were inserted subcutaneously into the limbs for recording of the surface electrocardiogram (ECG). The heart was exposed via an incision at the fourth intercostal space (fourth and/or fifth ribs were cut for a clear surgical vision). The chest was opened, and a pericardial cradle was formed using four retractors. A coronary artery occluder, comprised of a snare made of 5 cm PE-10 tubing with a 6–0 prolene polypropylene suture in it, was placed loosely around the LCX 2–3 mm from its origin. The body temperature of the rabbit was monitored via a rectal thermometer and maintained between 37 and 40 °C by adjusting the surface temperature of the surgical table. Regional ischemia (30 min) was induced by ligating the LCX. BP and ECG were monitored and recorded continuously using a computerized data acquisition system (PowerLab; AD Instruments, Mountain View, CA). Incidences of ventricular tachycardia (VT) and ventricular fibrillation (VF) were examined during the ischemia period.</div><div class="NLM_p">The heart was excised at the end of the experiment. The ischemic area was visualized by perfusing the heart with 1% Evans Blue in saline and calculated as a percentage of the total ventricular weight. Hearts with ischemic area less than 25% or larger than 50% were excluded from the analysis.</div><div id="sec5_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> Experimental Protocol</h4><div class="NLM_p last">Animals were randomly assigned to vehicle or GS compound groups. At 30 min after the dose of GS compounds, the heart was subjected to 30 min of ischemia. Blood samples were collected at 1, 5, 10, 30, and 60 min after drug administration for determination of plasma concentrations of the compound. Plasma concentrations of GS compound were determined using a high performance liquid chromatograph–tandem mass spectrometry (LC/MS/MS).</div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i36"><a href="/doi/suppl/10.1021/acs.jmedchem.6b00939">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_57480" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_57480" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.6b00939" class="ext-link">10.1021/acs.jmedchem.6b00939</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Experimental for compounds <b>22</b>–<b>40</b>, additional pharmacological data for <b>4</b> including ion channel panel, in vitro selectivity panel results, methoxyamine–clofilium induced VT–VF model with <b>4</b>, mexilitine data in a LCX ligation model of VT–VF, details of homology model including sequence analysis of sodium channel isoforms (<a href="/doi/suppl/10.1021/acs.jmedchem.6b00939/suppl_file/jm6b00939_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.6b00939/suppl_file/jm6b00939_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b00939/suppl_file/jm6b00939_si_001.pdf">jm6b00939_si_001.pdf (792.21 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b00939/suppl_file/jm6b00939_si_002.csv">jm6b00939_si_002.csv (5.43 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.6b00939" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_03626" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_03626" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jeff A. Zablocki</span> - <span class="hlFld-Affiliation affiliation">†Medicinal Chemistry, ‡Drug Metabolism, §Drug Safety Evaluation, ∥Formulation and
Process Development, and ⊥Structural Chemistry, Gilead
Sciences Inc., 333 Lakeside
Drive, Foster City, California 94404, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Biology, Gilead Sciences Inc., 7601 Dumbarton Circle, Fremont, California 94555, United States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#b2f8d7d4d49ce8d3d0deddd1d9dbf2f5dbded7d3d69cd1dddf"><span class="__cf_email__" data-cfemail="f8b29d9e9ed6a2999a94979b9391b8bf91949d999cd69b9795">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Elfatih Elzein</span> - <span class="hlFld-Affiliation affiliation">†Medicinal Chemistry, ‡Drug Metabolism, §Drug Safety Evaluation, ∥Formulation and
Process Development, and ⊥Structural Chemistry, Gilead
Sciences Inc., 333 Lakeside
Drive, Foster City, California 94404, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Biology, Gilead Sciences Inc., 7601 Dumbarton Circle, Fremont, California 94555, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xiaofen Li</span> - <span class="hlFld-Affiliation affiliation">†Medicinal Chemistry, ‡Drug Metabolism, §Drug Safety Evaluation, ∥Formulation and
Process Development, and ⊥Structural Chemistry, Gilead
Sciences Inc., 333 Lakeside
Drive, Foster City, California 94404, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Biology, Gilead Sciences Inc., 7601 Dumbarton Circle, Fremont, California 94555, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dmitry O. Koltun</span> - <span class="hlFld-Affiliation affiliation">†Medicinal Chemistry, ‡Drug Metabolism, §Drug Safety Evaluation, ∥Formulation and
Process Development, and ⊥Structural Chemistry, Gilead
Sciences Inc., 333 Lakeside
Drive, Foster City, California 94404, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Biology, Gilead Sciences Inc., 7601 Dumbarton Circle, Fremont, California 94555, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Eric Q. Parkhill</span> - <span class="hlFld-Affiliation affiliation">†Medicinal Chemistry, ‡Drug Metabolism, §Drug Safety Evaluation, ∥Formulation and
Process Development, and ⊥Structural Chemistry, Gilead
Sciences Inc., 333 Lakeside
Drive, Foster City, California 94404, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Biology, Gilead Sciences Inc., 7601 Dumbarton Circle, Fremont, California 94555, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Tetsuya Kobayashi</span> - <span class="hlFld-Affiliation affiliation">†Medicinal Chemistry, ‡Drug Metabolism, §Drug Safety Evaluation, ∥Formulation and
Process Development, and ⊥Structural Chemistry, Gilead
Sciences Inc., 333 Lakeside
Drive, Foster City, California 94404, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Biology, Gilead Sciences Inc., 7601 Dumbarton Circle, Fremont, California 94555, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ruben Martinez</span> - <span class="hlFld-Affiliation affiliation">†Medicinal Chemistry, ‡Drug Metabolism, §Drug Safety Evaluation, ∥Formulation and
Process Development, and ⊥Structural Chemistry, Gilead
Sciences Inc., 333 Lakeside
Drive, Foster City, California 94404, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Biology, Gilead Sciences Inc., 7601 Dumbarton Circle, Fremont, California 94555, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Britton Corkey</span> - <span class="hlFld-Affiliation affiliation">†Medicinal Chemistry, ‡Drug Metabolism, §Drug Safety Evaluation, ∥Formulation and
Process Development, and ⊥Structural Chemistry, Gilead
Sciences Inc., 333 Lakeside
Drive, Foster City, California 94404, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Biology, Gilead Sciences Inc., 7601 Dumbarton Circle, Fremont, California 94555, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Haibo Jiang</span> - <span class="hlFld-Affiliation affiliation">†Medicinal Chemistry, ‡Drug Metabolism, §Drug Safety Evaluation, ∥Formulation and
Process Development, and ⊥Structural Chemistry, Gilead
Sciences Inc., 333 Lakeside
Drive, Foster City, California 94404, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Biology, Gilead Sciences Inc., 7601 Dumbarton Circle, Fremont, California 94555, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Thao Perry</span> - <span class="hlFld-Affiliation affiliation">†Medicinal Chemistry, ‡Drug Metabolism, §Drug Safety Evaluation, ∥Formulation and
Process Development, and ⊥Structural Chemistry, Gilead
Sciences Inc., 333 Lakeside
Drive, Foster City, California 94404, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Biology, Gilead Sciences Inc., 7601 Dumbarton Circle, Fremont, California 94555, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Rao Kalla</span> - <span class="hlFld-Affiliation affiliation">†Medicinal Chemistry, ‡Drug Metabolism, §Drug Safety Evaluation, ∥Formulation and
Process Development, and ⊥Structural Chemistry, Gilead
Sciences Inc., 333 Lakeside
Drive, Foster City, California 94404, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Biology, Gilead Sciences Inc., 7601 Dumbarton Circle, Fremont, California 94555, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gregory T. Notte</span> - <span class="hlFld-Affiliation affiliation">†Medicinal Chemistry, ‡Drug Metabolism, §Drug Safety Evaluation, ∥Formulation and
Process Development, and ⊥Structural Chemistry, Gilead
Sciences Inc., 333 Lakeside
Drive, Foster City, California 94404, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Biology, Gilead Sciences Inc., 7601 Dumbarton Circle, Fremont, California 94555, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Oliver Saunders</span> - <span class="hlFld-Affiliation affiliation">†Medicinal Chemistry, ‡Drug Metabolism, §Drug Safety Evaluation, ∥Formulation and
Process Development, and ⊥Structural Chemistry, Gilead
Sciences Inc., 333 Lakeside
Drive, Foster City, California 94404, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Biology, Gilead Sciences Inc., 7601 Dumbarton Circle, Fremont, California 94555, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michael Graupe</span> - <span class="hlFld-Affiliation affiliation">†Medicinal Chemistry, ‡Drug Metabolism, §Drug Safety Evaluation, ∥Formulation and
Process Development, and ⊥Structural Chemistry, Gilead
Sciences Inc., 333 Lakeside
Drive, Foster City, California 94404, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Biology, Gilead Sciences Inc., 7601 Dumbarton Circle, Fremont, California 94555, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yafan Lu</span> - <span class="hlFld-Affiliation affiliation">†Medicinal Chemistry, ‡Drug Metabolism, §Drug Safety Evaluation, ∥Formulation and
Process Development, and ⊥Structural Chemistry, Gilead
Sciences Inc., 333 Lakeside
Drive, Foster City, California 94404, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Biology, Gilead Sciences Inc., 7601 Dumbarton Circle, Fremont, California 94555, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Chandru Venkataramani</span> - <span class="hlFld-Affiliation affiliation">†Medicinal Chemistry, ‡Drug Metabolism, §Drug Safety Evaluation, ∥Formulation and
Process Development, and ⊥Structural Chemistry, Gilead
Sciences Inc., 333 Lakeside
Drive, Foster City, California 94404, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Biology, Gilead Sciences Inc., 7601 Dumbarton Circle, Fremont, California 94555, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Juan Guerrero</span> - <span class="hlFld-Affiliation affiliation">†Medicinal Chemistry, ‡Drug Metabolism, §Drug Safety Evaluation, ∥Formulation and
Process Development, and ⊥Structural Chemistry, Gilead
Sciences Inc., 333 Lakeside
Drive, Foster City, California 94404, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Biology, Gilead Sciences Inc., 7601 Dumbarton Circle, Fremont, California 94555, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jason Perry</span> - <span class="hlFld-Affiliation affiliation">†Medicinal Chemistry, ‡Drug Metabolism, §Drug Safety Evaluation, ∥Formulation and
Process Development, and ⊥Structural Chemistry, Gilead
Sciences Inc., 333 Lakeside
Drive, Foster City, California 94404, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Biology, Gilead Sciences Inc., 7601 Dumbarton Circle, Fremont, California 94555, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mark Osier</span> - <span class="hlFld-Affiliation affiliation">†Medicinal Chemistry, ‡Drug Metabolism, §Drug Safety Evaluation, ∥Formulation and
Process Development, and ⊥Structural Chemistry, Gilead
Sciences Inc., 333 Lakeside
Drive, Foster City, California 94404, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Biology, Gilead Sciences Inc., 7601 Dumbarton Circle, Fremont, California 94555, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Robert Strickley</span> - <span class="hlFld-Affiliation affiliation">†Medicinal Chemistry, ‡Drug Metabolism, §Drug Safety Evaluation, ∥Formulation and
Process Development, and ⊥Structural Chemistry, Gilead
Sciences Inc., 333 Lakeside
Drive, Foster City, California 94404, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Biology, Gilead Sciences Inc., 7601 Dumbarton Circle, Fremont, California 94555, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gongxin Liu</span> - <span class="hlFld-Affiliation affiliation">Biology, Gilead Sciences Inc., 7601 Dumbarton Circle, Fremont, California 94555, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Wei-Qun Wang</span> - <span class="hlFld-Affiliation affiliation">Biology, Gilead Sciences Inc., 7601 Dumbarton Circle, Fremont, California 94555, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lufei Hu</span> - <span class="hlFld-Affiliation affiliation">Biology, Gilead Sciences Inc., 7601 Dumbarton Circle, Fremont, California 94555, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xiao-Jun Li</span> - <span class="hlFld-Affiliation affiliation">Biology, Gilead Sciences Inc., 7601 Dumbarton Circle, Fremont, California 94555, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nesrine El-Bizri</span> - <span class="hlFld-Affiliation affiliation">Biology, Gilead Sciences Inc., 7601 Dumbarton Circle, Fremont, California 94555, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ryoko Hirakawa</span> - <span class="hlFld-Affiliation affiliation">Biology, Gilead Sciences Inc., 7601 Dumbarton Circle, Fremont, California 94555, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kris Kahlig</span> - <span class="hlFld-Affiliation affiliation">Biology, Gilead Sciences Inc., 7601 Dumbarton Circle, Fremont, California 94555, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Cheng Xie</span> - <span class="hlFld-Affiliation affiliation">Biology, Gilead Sciences Inc., 7601 Dumbarton Circle, Fremont, California 94555, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Cindy Hong Li</span> - <span class="hlFld-Affiliation affiliation">Biology, Gilead Sciences Inc., 7601 Dumbarton Circle, Fremont, California 94555, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Arvinder K. Dhalla</span> - <span class="hlFld-Affiliation affiliation">Biology, Gilead Sciences Inc., 7601 Dumbarton Circle, Fremont, California 94555, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sridharan Rajamani</span> - <span class="hlFld-Affiliation affiliation">Biology, Gilead Sciences Inc., 7601 Dumbarton Circle, Fremont, California 94555, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nevena Mollova</span> - <span class="hlFld-Affiliation affiliation">†Medicinal Chemistry, ‡Drug Metabolism, §Drug Safety Evaluation, ∥Formulation and
Process Development, and ⊥Structural Chemistry, Gilead
Sciences Inc., 333 Lakeside
Drive, Foster City, California 94404, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Biology, Gilead Sciences Inc., 7601 Dumbarton Circle, Fremont, California 94555, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Daniel Soohoo</span> - <span class="hlFld-Affiliation affiliation">†Medicinal Chemistry, ‡Drug Metabolism, §Drug Safety Evaluation, ∥Formulation and
Process Development, and ⊥Structural Chemistry, Gilead
Sciences Inc., 333 Lakeside
Drive, Foster City, California 94404, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Biology, Gilead Sciences Inc., 7601 Dumbarton Circle, Fremont, California 94555, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Eve-Irene Lepist</span> - <span class="hlFld-Affiliation affiliation">†Medicinal Chemistry, ‡Drug Metabolism, §Drug Safety Evaluation, ∥Formulation and
Process Development, and ⊥Structural Chemistry, Gilead
Sciences Inc., 333 Lakeside
Drive, Foster City, California 94404, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Biology, Gilead Sciences Inc., 7601 Dumbarton Circle, Fremont, California 94555, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Bernard Murray</span> - <span class="hlFld-Affiliation affiliation">†Medicinal Chemistry, ‡Drug Metabolism, §Drug Safety Evaluation, ∥Formulation and
Process Development, and ⊥Structural Chemistry, Gilead
Sciences Inc., 333 Lakeside
Drive, Foster City, California 94404, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Biology, Gilead Sciences Inc., 7601 Dumbarton Circle, Fremont, California 94555, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gerry Rhodes</span> - <span class="hlFld-Affiliation affiliation">†Medicinal Chemistry, ‡Drug Metabolism, §Drug Safety Evaluation, ∥Formulation and
Process Development, and ⊥Structural Chemistry, Gilead
Sciences Inc., 333 Lakeside
Drive, Foster City, California 94404, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Biology, Gilead Sciences Inc., 7601 Dumbarton Circle, Fremont, California 94555, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Luiz Belardinelli</span> - <span class="hlFld-Affiliation affiliation">Biology, Gilead Sciences Inc., 7601 Dumbarton Circle, Fremont, California 94555, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Manoj C. Desai</span> - <span class="hlFld-Affiliation affiliation">†Medicinal Chemistry, ‡Drug Metabolism, §Drug Safety Evaluation, ∥Formulation and
Process Development, and ⊥Structural Chemistry, Gilead
Sciences Inc., 333 Lakeside
Drive, Foster City, California 94404, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Biology, Gilead Sciences Inc., 7601 Dumbarton Circle, Fremont, California 94555, United States</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d7e4515-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i37">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_52717" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_52717" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank John Shryock and Lin Wu for helpful discussions. All authors were fully supported by Gilead Sciences Inc. with no external funding of the research described.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i38" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i38"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i39" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i39"> Abbreviations Used</h2><tr><td class="NLM_term">Å</td><td class="NLM_def"><p class="first last">angstrom</p></td></tr><tr><td class="NLM_term">br s</td><td class="NLM_def"><p class="first last">broad singlet</p></td></tr><tr><td class="NLM_term">CACO-2</td><td class="NLM_def"><p class="first last">heterogeneous human epithelial colorectal adenocarcinoma</p></td></tr><tr><td class="NLM_term">CNS</td><td class="NLM_def"><p class="first last">central nervous system</p></td></tr><tr><td class="NLM_term">Cyp</td><td class="NLM_def"><p class="first last">cytochrome P450</p></td></tr><tr><td class="NLM_term">d</td><td class="NLM_def"><p class="first last">doublet</p></td></tr><tr><td class="NLM_term">hERG</td><td class="NLM_def"><p class="first last">human <i>Ether-à-go-go</i>-related gene</p></td></tr><tr><td class="NLM_term">HCM</td><td class="NLM_def"><p class="first last">hypertrophic cardiomyopathy</p></td></tr><tr><td class="NLM_term">HEK-293</td><td class="NLM_def"><p class="first last">human embryonic kidney cell</p></td></tr><tr><td class="NLM_term">(Hz)</td><td class="NLM_def"><p class="first last">hertz</p></td></tr><tr><td class="NLM_term">IHD</td><td class="NLM_def"><p class="first last">ischemic heart disease</p></td></tr><tr><td class="NLM_term">IC<sub>50</sub></td><td class="NLM_def"><p class="first last">inhibitory concentration<sub>50</sub></p></td></tr><tr><td class="NLM_term">IH assay</td><td class="NLM_def"><p class="first last">isolated heart assay</p></td></tr><tr><td class="NLM_term">late <i>I</i><sub>Na</sub></td><td class="NLM_def"><p class="first last">late sodium current</p></td></tr><tr><td class="NLM_term">LAD</td><td class="NLM_def"><p class="first last">left anteriorior descending</p></td></tr><tr><td class="NLM_term">LQT-3 syndrome</td><td class="NLM_def"><p class="first last">long QT-3 syndrome</p></td></tr><tr><td class="NLM_term">MAPD<sub>90</sub></td><td class="NLM_def"><p class="first last">monophasic action potential duration<sub>90</sub></p></td></tr><tr><td class="NLM_term">MARISA study</td><td class="NLM_def"><p class="first last">Monotherapy Assessment of Ranolazine in Stable Angina Study</p></td></tr><tr><td class="NLM_term">ms</td><td class="NLM_def"><p class="first last">milliseconds</p></td></tr><tr><td class="NLM_term">m</td><td class="NLM_def"><p class="first last">multiplet</p></td></tr><tr><td class="NLM_term">NMR</td><td class="NLM_def"><p class="first last">nuclear magnetic resonance</p></td></tr><tr><td class="NLM_term">peak <i>I</i><sub>Na</sub> current</td><td class="NLM_def"><p class="first last">peak cardiac sodium current</p></td></tr><tr><td class="NLM_term">ppm</td><td class="NLM_def"><p class="first last">parts per million</p></td></tr><tr><td class="NLM_term">q</td><td class="NLM_def"><p class="first last">quartet</p></td></tr><tr><td class="NLM_term">ROS</td><td class="NLM_def"><p class="first last">reactive oxygen species</p></td></tr><tr><td class="NLM_term">ATX-II</td><td class="NLM_def"><p class="first last">sea anemone toxin II</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structure–activity relationship</p></td></tr><tr><td class="NLM_term">rabbit ΔS–T</td><td class="NLM_def"><p class="first last">rabbit change in S–T segment elevation during ischemia</p></td></tr><tr><td class="NLM_term">s</td><td class="NLM_def"><p class="first last">singlet</p></td></tr><tr><td class="NLM_term">SA</td><td class="NLM_def"><p class="first last">sinoatrial</p></td></tr><tr><td class="NLM_term">TdP</td><td class="NLM_def"><p class="first last">Torsades des Pointes</p></td></tr><tr><td class="NLM_term">t</td><td class="NLM_def"><p class="first last">triplet</p></td></tr><tr><td class="NLM_term">US</td><td class="NLM_def"><p class="first last">United States</p></td></tr><tr><td class="NLM_term">VT–VF</td><td class="NLM_def"><p class="first last">ventricular tachycardia–ventricular fibrillation</p></td></tr><tr><td class="NLM_term"><i>V</i><sub>ss</sub></td><td class="NLM_def"><p class="first last">volume steady state</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i40">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_86224" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_86224" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 29 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Fang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaw, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keenan, N. L.</span><span> </span><span class="NLM_article-title">Prevalence of coronary heart disease-United States, 2006–2010</span> <span class="citation_source-journal">MMWR Morb. Mortal. Wkly. Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">1377</span><span class="NLM_x">–</span> <span class="NLM_lpage">1381</span><span class="refDoi"> DOI: 10.15585/mmwr.mm6040a1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00939&amp;key=10.15585%2Fmmwr.mm6040a1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00939&amp;key=21993341" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2011&pages=1377-1381&author=J.+Fangauthor=K.+M.+Shawauthor=N.+L.+Keenan&title=Prevalence+of+coronary+heart+disease-United+States%2C+2006%E2%80%932010&doi=10.15585%2Fmmwr.mm6040a1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.15585%2Fmmwr.mm6040a1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.15585%252Fmmwr.mm6040a1%26sid%3Dliteratum%253Aachs%26aulast%3DFang%26aufirst%3DJ.%26aulast%3DShaw%26aufirst%3DK.%2BM.%26aulast%3DKeenan%26aufirst%3DN.%2BL.%26atitle%3DPrevalence%2520of%2520coronary%2520heart%2520disease-United%2520States%252C%25202006%25E2%2580%25932010%26jtitle%3DMMWR%2520Morb.%2520Mortal.%2520Wkly.%2520Rep.%26date%3D2011%26volume%3D60%26spage%3D1377%26epage%3D1381%26doi%3D10.15585%2Fmmwr.mm6040a1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Kochanek, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minin, A. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kung, H. C.</span><span> </span><span class="NLM_article-title">Deaths: preliminary data for 2010</span> <span class="citation_source-journal">National Vital Statistics Report</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">52</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2012&pages=1-52&author=K.+D.+Kochanekauthor=J.+Xuauthor=S.+L.+Murphyauthor=A.+O.+Mininauthor=H.+C.+Kung&title=Deaths%3A+preliminary+data+for+2010"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKochanek%26aufirst%3DK.%2BD.%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DMurphy%26aufirst%3DS.%2BL.%26aulast%3DMinin%26aufirst%3DA.%2BO.%26aulast%3DKung%26aufirst%3DH.%2BC.%26atitle%3DDeaths%253A%2520preliminary%2520data%2520for%25202010%26jtitle%3DNational%2520Vital%2520Statistics%2520Report%26date%3D2012%26volume%3D60%26spage%3D1%26epage%3D52" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Banon, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Filion, K. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Budlovsky, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franck, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eisenberg, M. J.</span><span> </span><span class="NLM_article-title">The usefulness of ranolazine for the treatment of refractory chronic stable angina pectoris as determined from a systematic review of randomized controlled trials</span> <span class="citation_source-journal">Am. J. Cardiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">113</span><span class="NLM_x">, </span> <span class="NLM_fpage">1075</span><span class="NLM_x">–</span> <span class="NLM_lpage">1082</span><span class="refDoi"> DOI: 10.1016/j.amjcard.2013.11.070</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00939&amp;key=10.1016%2Fj.amjcard.2013.11.070" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=2014&pages=1075-1082&author=D.+Banonauthor=K.+B.+Filionauthor=T.+Budlovskyauthor=C.+Franckauthor=M.+J.+Eisenberg&title=The+usefulness+of+ranolazine+for+the+treatment+of+refractory+chronic+stable+angina+pectoris+as+determined+from+a+systematic+review+of+randomized+controlled+trials&doi=10.1016%2Fj.amjcard.2013.11.070"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2Fj.amjcard.2013.11.070&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.amjcard.2013.11.070%26sid%3Dliteratum%253Aachs%26aulast%3DBanon%26aufirst%3DD.%26aulast%3DFilion%26aufirst%3DK.%2BB.%26aulast%3DBudlovsky%26aufirst%3DT.%26aulast%3DFranck%26aufirst%3DC.%26aulast%3DEisenberg%26aufirst%3DM.%2BJ.%26atitle%3DThe%2520usefulness%2520of%2520ranolazine%2520for%2520the%2520treatment%2520of%2520refractory%2520chronic%2520stable%2520angina%2520pectoris%2520as%2520determined%2520from%2520a%2520systematic%2520review%2520of%2520randomized%2520controlled%2520trials%26jtitle%3DAm.%2520J.%2520Cardiol.%26date%3D2014%26volume%3D113%26spage%3D1075%26epage%3D1082%26doi%3D10.1016%2Fj.amjcard.2013.11.070" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Zaza, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belardinelli, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shryock, J. C.</span><span> </span><span class="NLM_article-title">Pathophysiology and pharmacology of the cardiac ″late sodium current.</span> <span class="citation_source-journal">Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">119</span><span class="NLM_x">, </span> <span class="NLM_fpage">326</span><span class="NLM_x">–</span> <span class="NLM_lpage">339</span><span class="refDoi"> DOI: 10.1016/j.pharmthera.2008.06.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00939&amp;key=10.1016%2Fj.pharmthera.2008.06.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00939&amp;key=18662720" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00939&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVyltbnO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=119&publication_year=2008&pages=326-339&author=A.+Zazaauthor=L.+Belardinelliauthor=J.+C.+Shryock&title=Pathophysiology+and+pharmacology+of+the+cardiac+%E2%80%B3late+sodium+current.&doi=10.1016%2Fj.pharmthera.2008.06.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Pathophysiology and pharmacology of the cardiac "late sodium current"</span></div><div class="casAuthors">Zaza, Antonio; Belardinelli, Luiz; Shryock, John C.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">119</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">326-339</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  The "late sodium current" (I NaL) is a sustained component of the fast Na+ current of cardiac myocytes and neurons.  As recently appreciated, common neurol. and cardiac conditions are assocd. with abnormal I NaL enhancement, which may contribute to the pathogenesis of both elec. and contractile dysfunction.  For this reason, I NaL has become an appealing pharmacol. target, with a potentially broad range of therapeutic indications.  The recent approval by the FDA of an I NaL blocker (ranolazine) for clin. use justifies the increased interest in I NaL as a pathogenic mechanism and the rapid evolution of the information concerning it.  The review focuses on cardiac aspects of I NaL enhancement; it deals with the origin of I NaL, with its pathophysiol. role and with the consequences of its pharmacol. modulation.  Both basic aspects and clin. evidence are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojuv5I4Jg4B7Vg90H21EOLACvtfcHk0ljFmXHOuAty8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVyltbnO&md5=f9fd0198886a5b76684eaa8de51e80e1</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2008.06.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2008.06.001%26sid%3Dliteratum%253Aachs%26aulast%3DZaza%26aufirst%3DA.%26aulast%3DBelardinelli%26aufirst%3DL.%26aulast%3DShryock%26aufirst%3DJ.%2BC.%26atitle%3DPathophysiology%2520and%2520pharmacology%2520of%2520the%2520cardiac%2520%25E2%2580%25B3late%2520sodium%2520current.%26jtitle%3DPharmacol.%2520Ther.%26date%3D2008%26volume%3D119%26spage%3D326%26epage%3D339%26doi%3D10.1016%2Fj.pharmthera.2008.06.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Le Grand, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vie, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Talmant, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coraboeuf, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">John, G. W.</span><span> </span><span class="NLM_article-title">Alleviation of contractile dysfunction in ischemic hearts by slowly inactivating Na+ current blockers</span> <span class="citation_source-journal">Am. J. Physiol.: Heart Circ. Physiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">269</span><span class="NLM_x">, </span> <span class="NLM_fpage">H533</span><span class="NLM_x">–</span> <span class="NLM_lpage">H540</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=269&publication_year=1995&pages=H533-H540&author=B.+Le+Grandauthor=B.+Vieauthor=J.+Talmantauthor=E.+Coraboeufauthor=G.+W.+John&title=Alleviation+of+contractile+dysfunction+in+ischemic+hearts+by+slowly+inactivating+Na%2B+current+blockers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLe%2BGrand%26aufirst%3DB.%26aulast%3DVie%26aufirst%3DB.%26aulast%3DTalmant%26aufirst%3DJ.%26aulast%3DCoraboeuf%26aufirst%3DE.%26aulast%3DJohn%26aufirst%3DG.%2BW.%26atitle%3DAlleviation%2520of%2520contractile%2520dysfunction%2520in%2520ischemic%2520hearts%2520by%2520slowly%2520inactivating%2520Na%252B%2520current%2520blockers%26jtitle%3DAm.%2520J.%2520Physiol.%253A%2520Heart%2520Circ.%2520Physiol.%26date%3D1995%26volume%3D269%26spage%3DH533%26epage%3DH540" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Antzelevitch, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belardinelli, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zygmunt, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burashnikov, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Diego, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fish, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cordeiro, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, G.</span><span> </span><span class="NLM_article-title">Electrophysiological effects of ranolazine, a novel antianginal agent with antiarrhythmic properties</span> <span class="citation_source-journal">Circulation</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">110</span><span class="NLM_x">, </span> <span class="NLM_fpage">904</span><span class="NLM_x">–</span> <span class="NLM_lpage">910</span><span class="refDoi"> DOI: 10.1161/01.CIR.0000139333.83620.5D</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00939&amp;key=10.1161%2F01.CIR.0000139333.83620.5D" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2004&pages=904-910&author=C.+Antzelevitchauthor=L.+Belardinelliauthor=A.+C.+Zygmuntauthor=A.+Burashnikovauthor=J.+M.+Di+Diegoauthor=J.+M.+Fishauthor=J.+M.+Cordeiroauthor=G.+Thomas&title=Electrophysiological+effects+of+ranolazine%2C+a+novel+antianginal+agent+with+antiarrhythmic+properties&doi=10.1161%2F01.CIR.0000139333.83620.5D"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1161%2F01.CIR.0000139333.83620.5D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252F01.CIR.0000139333.83620.5D%26sid%3Dliteratum%253Aachs%26aulast%3DAntzelevitch%26aufirst%3DC.%26aulast%3DBelardinelli%26aufirst%3DL.%26aulast%3DZygmunt%26aufirst%3DA.%2BC.%26aulast%3DBurashnikov%26aufirst%3DA.%26aulast%3DDi%2BDiego%26aufirst%3DJ.%2BM.%26aulast%3DFish%26aufirst%3DJ.%2BM.%26aulast%3DCordeiro%26aufirst%3DJ.%2BM.%26aulast%3DThomas%26aufirst%3DG.%26atitle%3DElectrophysiological%2520effects%2520of%2520ranolazine%252C%2520a%2520novel%2520antianginal%2520agent%2520with%2520antiarrhythmic%2520properties%26jtitle%3DCirculation%26date%3D2004%26volume%3D110%26spage%3D904%26epage%3D910%26doi%3D10.1161%2F01.CIR.0000139333.83620.5D" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Chaitman, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skettino, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, J. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanley, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meluzin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuch, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pepine, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nelson, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hebert, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolff, A. A.</span><span> </span><span class="NLM_article-title">Anti-ischemic effects and long-term survival during ranolazine monotherapy in patients with chronic severe angina</span> <span class="citation_source-journal">J. Am. Coll. Cardiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">1375</span><span class="NLM_x">–</span> <span class="NLM_lpage">1382</span><span class="refDoi"> DOI: 10.1016/j.jacc.2003.11.045</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00939&amp;key=10.1016%2Fj.jacc.2003.11.045" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00939&amp;key=15093870" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00939&amp;key=1%3ACAS%3A528%3ADC%252BD2cXkt1Wksr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2004&pages=1375-1382&author=B.+R.+Chaitmanauthor=S.+L.+Skettinoauthor=J.+O.+Parkerauthor=P.+Hanleyauthor=J.+Meluzinauthor=J.+Kuchauthor=C.+J.+Pepineauthor=W.+Wangauthor=J.+J.+Nelsonauthor=D.+A.+Hebertauthor=A.+A.+Wolff&title=Anti-ischemic+effects+and+long-term+survival+during+ranolazine+monotherapy+in+patients+with+chronic+severe+angina&doi=10.1016%2Fj.jacc.2003.11.045"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Anti-ischemic effects and long-term survival during ranolazine monotherapy in patients with chronic severe angina</span></div><div class="casAuthors">Chaitman, Bernard R.; Skettino, Sandra L.; Parker, John O.; Hanley, Peter; Meluzin, Jaroslav; Kuch, Jerzy; Pepine, Carl J.; Wang, Whedy; Nelson, Jeanenne J.; Hebert, David A.; Wolff, Andrew A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American College of Cardiology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1375-1382</span>CODEN:
                <span class="NLM_cas:coden">JACCDI</span>;
        ISSN:<span class="NLM_cas:issn">0735-1097</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">The primary objective of the Monotherapy Assessment of Ranolazine In Stable Angina (MARISA) trial was to det. the dose-response relationship of ranolazine, a potentially new anti-anginal compd., on symptom-limited exercise duration.  Fatty acids rise precipitously in response to stress, including acute myocardial ischemia.  Ranolazine is believed to partially inhibit fatty acid oxidn., shift metab. toward carbohydrate oxidn., and increase the efficiency of oxygen use.  Patients (n = 191) with angina-limited exercise discontinued anti-anginal medications and were randomized into a double-blind four-period crossover study of sustained-release ranolazine 500, 1,000, or 1,500 mg, or placebo, each administered twice daily for one week.  Exercise testing was performed at the end of each treatment during both trough and peak ranolazine plasma concns.  Exercise duration at trough increased with ranolazine 500, 1,000, and 1,500 mg twice daily by 94, 103, and 116 s, resp., all greater (p < 0.005) than the 70-s increase on placebo.  Dose-related increases in exercise duration at peak and in times to 1 mm ST-segment depression at trough and peak and to angina at trough and peak were also demonstrated (all p < 0.005).  Ranolazine had negligible effects on heart rate and blood pressure.  One year survival rate combining data from the MARISA trial and its open-label follow-on study was 96.3 ± 1.7%.  In chronic angina patients, ranolazine monotherapy was well tolerated and increased exercise performance throughout its dosing interval at all doses studied without clin. meaningful hemodynamic effects.  One-year survival was not lower than expected in this high-risk patient population.  This metabolic approach to treating myocardial ischemia may offer a new therapeutic option for chronic angina patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoug0GtwKfosrVg90H21EOLACvtfcHk0lgynL9tm0nW8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXkt1Wksr4%253D&md5=507feda3da676474b0ea489837bd2a38</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fj.jacc.2003.11.045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jacc.2003.11.045%26sid%3Dliteratum%253Aachs%26aulast%3DChaitman%26aufirst%3DB.%2BR.%26aulast%3DSkettino%26aufirst%3DS.%2BL.%26aulast%3DParker%26aufirst%3DJ.%2BO.%26aulast%3DHanley%26aufirst%3DP.%26aulast%3DMeluzin%26aufirst%3DJ.%26aulast%3DKuch%26aufirst%3DJ.%26aulast%3DPepine%26aufirst%3DC.%2BJ.%26aulast%3DWang%26aufirst%3DW.%26aulast%3DNelson%26aufirst%3DJ.%2BJ.%26aulast%3DHebert%26aufirst%3DD.%2BA.%26aulast%3DWolff%26aufirst%3DA.%2BA.%26atitle%3DAnti-ischemic%2520effects%2520and%2520long-term%2520survival%2520during%2520ranolazine%2520monotherapy%2520in%2520patients%2520with%2520chronic%2520severe%2520angina%26jtitle%3DJ.%2520Am.%2520Coll.%2520Cardiol.%26date%3D2004%26volume%3D43%26spage%3D1375%26epage%3D1382%26doi%3D10.1016%2Fj.jacc.2003.11.045" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Fredj, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sampson, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kass, R. S.</span><span> </span><span class="NLM_article-title">Molecular basis of ranolazine block of LQT-3 mutant sodium channels: evidence for site of action</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">148</span><span class="NLM_x">, </span> <span class="NLM_fpage">16</span><span class="NLM_x">–</span> <span class="NLM_lpage">24</span><span class="refDoi"> DOI: 10.1038/sj.bjp.0706709</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00939&amp;key=10.1038%2Fsj.bjp.0706709" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00939&amp;key=16520744" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00939&amp;key=1%3ACAS%3A528%3ADC%252BD28XjvF2lt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=148&publication_year=2006&pages=16-24&author=S.+Fredjauthor=K.+J.+Sampsonauthor=H.+Liuauthor=R.+S.+Kass&title=Molecular+basis+of+ranolazine+block+of+LQT-3+mutant+sodium+channels%3A+evidence+for+site+of+action&doi=10.1038%2Fsj.bjp.0706709"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular basis of ranolazine block of LQT-3 mutant sodium channels: evidence for site of action</span></div><div class="casAuthors">Fredj, Sandra; Sampson, Kevin J.; Liu, Huajun; Kass, Robert S.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">148</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">16-24</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">We studied the effects of ranolazine, an antianginal agent with promise as an antiarrhythmic drug, on wild-type (WT) and long QT syndrome variant 3 (LQT-3) mutant Na+ channels expressed in human embryonic kidney (HEK) 293 cells and knock-in mouse cardiomyocytes and used site-directed mutagenesis to probe the site of action of the drug.  We find preferential ranolazine block of sustained vs peak Na+ channel current for LQT-3 mutant (ΔKPQ and Y1795C) channels (IC50=15 vs 135 μM) with similar results obtained in HEK 293 cells and knock-in myocytes.  Ranolazine block of both peak and sustained Na+ channel current is significantly reduced by mutation (F1760A) of a single residue previously shown to contribute critically to the binding site for local anesthetic (LA) mols. in the Na+ channel.  Ranolazine significantly decreases action potential duration (APD) at 50 and 90% repolarization by 23±5 and 27±3%, resp., in ΔKPQ mouse ventricular myocytes but has little effect on APD of WT myocytes.  Computational modeling of human cardiac myocyte elec. activity that incorporates our voltage-clamp data predicts marked ranolazine-induced APD shortening in cells expressing LQT-3 mutant channels.  Our results demonstrate for the first time the utility of ranolazine as a blocker of sustained Na+ channel activity induced by inherited mutations that cause human disease and further, that these effects are very likely due to interactions of ranolazine with the receptor site for LA mols. in the sodium channel.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpaWhoeH51HkbVg90H21EOLACvtfcHk0lhj8oE2k0EA9A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XjvF2lt74%253D&md5=1ce122373fe4cc948d6b4361b3f5301c</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0706709&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0706709%26sid%3Dliteratum%253Aachs%26aulast%3DFredj%26aufirst%3DS.%26aulast%3DSampson%26aufirst%3DK.%2BJ.%26aulast%3DLiu%26aufirst%3DH.%26aulast%3DKass%26aufirst%3DR.%2BS.%26atitle%3DMolecular%2520basis%2520of%2520ranolazine%2520block%2520of%2520LQT-3%2520mutant%2520sodium%2520channels%253A%2520evidence%2520for%2520site%2520of%2520action%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2006%26volume%3D148%26spage%3D16%26epage%3D24%26doi%3D10.1038%2Fsj.bjp.0706709" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Catteral, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldin, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waxman, S. G.</span><span> </span><span class="NLM_article-title">International union of pharmacology. XLVII. nomenclature and structure-function relationships of voltage-gated sodium channels</span> <span class="citation_source-journal">Pharmacol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">397</span><span class="NLM_x">–</span> <span class="NLM_lpage">409</span><span class="refDoi"> DOI: 10.1124/pr.57.4.4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00939&amp;key=10.1124%2Fpr.57.4.4" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2005&pages=397-409&author=W.+A.+Catteralauthor=A.+L.+Goldinauthor=S.+G.+Waxman&title=International+union+of+pharmacology.+XLVII.+nomenclature+and+structure-function+relationships+of+voltage-gated+sodium+channels&doi=10.1124%2Fpr.57.4.4"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1124%2Fpr.57.4.4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fpr.57.4.4%26sid%3Dliteratum%253Aachs%26aulast%3DCatteral%26aufirst%3DW.%2BA.%26aulast%3DGoldin%26aufirst%3DA.%2BL.%26aulast%3DWaxman%26aufirst%3DS.%2BG.%26atitle%3DInternational%2520union%2520of%2520pharmacology.%2520XLVII.%2520nomenclature%2520and%2520structure-function%2520relationships%2520of%2520voltage-gated%2520sodium%2520channels%26jtitle%3DPharmacol.%2520Rev.%26date%3D2005%26volume%3D57%26spage%3D397%26epage%3D409%26doi%3D10.1124%2Fpr.57.4.4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Abelman, M.; Elzein, E.; Jiang, R.; Kalla, R.; Kobayashi, T.; Li, X.; Perry, T.</span><span> </span><span class="NLM_article-title">Fused heterocyclic compounds as ion channel modulators</span>. WO2010056527, May 20,<span class="NLM_x"> </span><span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=M.+Abelman&author=E.+Elzein&author=R.+Jiang&author=R.+Kalla&author=T.+Kobayashi&author=X.+Li&author=T.+Perry&title=Fused+heterocyclic+compounds+as+ion+channel+modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAbelman%26aufirst%3DM.%26atitle%3DFused%2520heterocyclic%2520compounds%2520as%2520ion%2520channel%2520modulators%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Koltun, D. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parkhill, E. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elzein, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobayashi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Notte, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalla, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perry, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Avila, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, W. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith-Maxwell, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dhalla, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rajamani, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shryock, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mollova, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stafford, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belardinelli, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zablocki, J. A.</span><span> </span><span class="NLM_article-title">Discovery of triazolopyridine GS-458967, a late sodium current inhibitor (Late INai) of the cardiac NaV 1.5 channel with improved efficacy and potency relative to ranolazine</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">3202</span><span class="NLM_x">–</span> <span class="NLM_lpage">3206</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2016.03.101</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00939&amp;key=10.1016%2Fj.bmcl.2016.03.101" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=3202-3206&author=D.+O.+Koltunauthor=E.+Q.+Parkhillauthor=E.+Elzeinauthor=T.+Kobayashiauthor=G.+Notteauthor=R.+H.+Jiangauthor=R.+Kallaauthor=X.+Liauthor=T.+Perryauthor=B.+Avilaauthor=W.+Q.+Wangauthor=C.+Smith-Maxwellauthor=A.+K.+Dhallaauthor=S.+Rajamaniauthor=J.+Shryockauthor=N.+Mollovaauthor=B.+Staffordauthor=J.+Tangauthor=L.+Belardinelliauthor=J.+A.+Zablocki&title=Discovery+of+triazolopyridine+GS-458967%2C+a+late+sodium+current+inhibitor+%28Late+INai%29+of+the+cardiac+NaV+1.5+channel+with+improved+efficacy+and+potency+relative+to+ranolazine&doi=10.1016%2Fj.bmcl.2016.03.101"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2016.03.101&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2016.03.101%26sid%3Dliteratum%253Aachs%26aulast%3DKoltun%26aufirst%3DD.%2BO.%26aulast%3DParkhill%26aufirst%3DE.%2BQ.%26aulast%3DElzein%26aufirst%3DE.%26aulast%3DKobayashi%26aufirst%3DT.%26aulast%3DNotte%26aufirst%3DG.%26aulast%3DJiang%26aufirst%3DR.%2BH.%26aulast%3DKalla%26aufirst%3DR.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DPerry%26aufirst%3DT.%26aulast%3DAvila%26aufirst%3DB.%26aulast%3DWang%26aufirst%3DW.%2BQ.%26aulast%3DSmith-Maxwell%26aufirst%3DC.%26aulast%3DDhalla%26aufirst%3DA.%2BK.%26aulast%3DRajamani%26aufirst%3DS.%26aulast%3DShryock%26aufirst%3DJ.%26aulast%3DMollova%26aufirst%3DN.%26aulast%3DStafford%26aufirst%3DB.%26aulast%3DTang%26aufirst%3DJ.%26aulast%3DBelardinelli%26aufirst%3DL.%26aulast%3DZablocki%26aufirst%3DJ.%2BA.%26atitle%3DDiscovery%2520of%2520triazolopyridine%2520GS-458967%252C%2520a%2520late%2520sodium%2520current%2520inhibitor%2520%2528Late%2520INai%2529%2520of%2520the%2520cardiac%2520NaV%25201.5%2520channel%2520with%2520improved%2520efficacy%2520and%2520potency%2520relative%2520to%2520ranolazine%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D26%26spage%3D3202%26epage%3D3206%26doi%3D10.1016%2Fj.bmcl.2016.03.101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Kobayashi, T.; Koltun, D.; Notte, G.; Parkhill, E.; Zablocki, J.</span><span> </span><span class="NLM_article-title">Fused heterocyclic compounds as ion channel modulators</span>. WO 2012/003392, January 5,<span class="NLM_x"> </span><span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=T.+Kobayashi&author=D.+Koltun&author=G.+Notte&author=E.+Parkhill&author=J.+Zablocki&title=Fused+heterocyclic+compounds+as+ion+channel+modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DKobayashi%26aufirst%3DT.%26atitle%3DFused%2520heterocyclic%2520compounds%2520as%2520ion%2520channel%2520modulators%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Koltun, D. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parkhill, E. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elzein, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobayashi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perry, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Avila, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, W. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirakawa, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith-Maxwell, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dhalla, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rajamani, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mollova, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stafford, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belardinelli, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zablocki, J. A.</span><span> </span><span class="NLM_article-title">Discovery of triazolopyridinone GS-462808, a late sodium current inhibitor (Late INai) of the cardiac Na<sub>v</sub>1.5 channel with improved efficacy and potency relative to ranolazine</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">3207</span><span class="NLM_x">–</span> <span class="NLM_lpage">3211</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2016.03.096</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00939&amp;key=10.1016%2Fj.bmcl.2016.03.096" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=3207-3211&author=D.+O.+Koltunauthor=E.+Q.+Parkhillauthor=E.+Elzeinauthor=T.+Kobayashiauthor=R.+H.+Jiangauthor=X.+Liauthor=T.+D.+Perryauthor=B.+Avilaauthor=W.+Q.+Wangauthor=R.+Hirakawaauthor=C.+Smith-Maxwellauthor=L.+Wuauthor=A.+D.+Dhallaauthor=S.+Rajamaniauthor=N.+Mollovaauthor=B.+Staffordauthor=J.+Tangauthor=L.+Belardinelliauthor=J.+A.+Zablocki&title=Discovery+of+triazolopyridinone+GS-462808%2C+a+late+sodium+current+inhibitor+%28Late+INai%29+of+the+cardiac+Nav1.5+channel+with+improved+efficacy+and+potency+relative+to+ranolazine&doi=10.1016%2Fj.bmcl.2016.03.096"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2016.03.096&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2016.03.096%26sid%3Dliteratum%253Aachs%26aulast%3DKoltun%26aufirst%3DD.%2BO.%26aulast%3DParkhill%26aufirst%3DE.%2BQ.%26aulast%3DElzein%26aufirst%3DE.%26aulast%3DKobayashi%26aufirst%3DT.%26aulast%3DJiang%26aufirst%3DR.%2BH.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DPerry%26aufirst%3DT.%2BD.%26aulast%3DAvila%26aufirst%3DB.%26aulast%3DWang%26aufirst%3DW.%2BQ.%26aulast%3DHirakawa%26aufirst%3DR.%26aulast%3DSmith-Maxwell%26aufirst%3DC.%26aulast%3DWu%26aufirst%3DL.%26aulast%3DDhalla%26aufirst%3DA.%2BD.%26aulast%3DRajamani%26aufirst%3DS.%26aulast%3DMollova%26aufirst%3DN.%26aulast%3DStafford%26aufirst%3DB.%26aulast%3DTang%26aufirst%3DJ.%26aulast%3DBelardinelli%26aufirst%3DL.%26aulast%3DZablocki%26aufirst%3DJ.%2BA.%26atitle%3DDiscovery%2520of%2520triazolopyridinone%2520GS-462808%252C%2520a%2520late%2520sodium%2520current%2520inhibitor%2520%2528Late%2520INai%2529%2520of%2520the%2520cardiac%2520Nav1.5%2520channel%2520with%2520improved%2520efficacy%2520and%2520potency%2520relative%2520to%2520ranolazine%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D26%26spage%3D3207%26epage%3D3211%26doi%3D10.1016%2Fj.bmcl.2016.03.096" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Belardinelli, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith-Maxwell, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, W. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">El-Bizri, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirakawa, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karpinski, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crumb, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koltun, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zablocki, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dhalla, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rajamani, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shryock, J. C.</span><span> </span><span class="NLM_article-title">A novel, potent, and selective inhibitor of cardiac late sodium current suppresses experimental arrhythmias</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">344</span><span class="NLM_x">, </span> <span class="NLM_fpage">23</span><span class="NLM_x">–</span> <span class="NLM_lpage">32</span><span class="refDoi"> DOI: 10.1124/jpet.112.198887</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00939&amp;key=10.1124%2Fjpet.112.198887" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00939&amp;key=23010360" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00939&amp;key=1%3ACAS%3A528%3ADC%252BC3sXms1Cluw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=344&publication_year=2013&pages=23-32&author=L.+Belardinelliauthor=G.+Liuauthor=C.+Smith-Maxwellauthor=W.+Q.+Wangauthor=N.+El-Bizriauthor=R.+Hirakawaauthor=S.+Karpinskiauthor=C.+H.+Liauthor=L.+Huauthor=X.+J.+Liauthor=W.+Crumbauthor=L.+Wuauthor=D.+Koltunauthor=J.+Zablockiauthor=L.+Yaoauthor=A.+K.+Dhallaauthor=S.+Rajamaniauthor=J.+C.+Shryock&title=A+novel%2C+potent%2C+and+selective+inhibitor+of+cardiac+late+sodium+current+suppresses+experimental+arrhythmias&doi=10.1124%2Fjpet.112.198887"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">A novel, potent, and selective inhibitor of cardiac late sodium current suppresses experimental arrhythmias</span></div><div class="casAuthors">Belardinelli, Luiz; Liu, Gongxin; Smith-Maxwell, Cathy; Wang, Wei-Qun; El-Bizri, Nesrine; Hirakawa, Ryoko; Karpinski, Serge; Li, Cindy Hong; Hu, Lufei; Li, Xiao-Jun; Crumb, William; Wu, Lin; Koltun, Dmitry; Zablocki, Jeff; Yao, Lina; Dhalla, Arvinder K.; Rajamani, Sridharan; Shryock, John C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">344</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">23-32</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Inhibition of cardiac late sodium current (late INa) is a strategy to suppress arrhythmias and sodium-dependent calcium overload assocd. with myocardial ischemia and heart failure.  Current inhibitors of late INa are unselective and can be proarrhythmic.  This study introduces GS967 (6-[4-(trifluoromethoxy)phenyl]-3-(trifluoromethyl)-[1,2,4]triazolo[4,3-a]pyridine), a potent and selective inhibitor of late INa, and demonstrates its effectiveness to suppress ventricular arrhythmias.  The effects of GS967 on rabbit ventricular myocyte ion channel currents and action potentials were detd.  Anti-arrhythmic actions of GS967 were characterized in ex vivo and in vivo rabbit models of reduced repolarization reserve and ischemia.  GS967 inhibited Anemonia sulcata toxin II (ATX-II)-induced late INa in ventricular myocytes and isolated hearts with IC50 values of 0.13 and 0.21 μM, resp.  Redn. of peak INa by GS967 was minimal at a holding potential of -120 mV but increased at -80 mV.  GS967 did not prolong action potential duration or the QRS interval.  GS967 prevented and reversed proarrhythmic effects (after-depolarizations and torsades de pointes) of the late INa enhancer ATX-II and the IKr inhibitor E-4031 in isolated ventricular myocytes and hearts.  GS967 significantly attenuated the proarrhythmic effects of methoxamine + clofilium and suppressed ischemia-induced arrhythmias.  GS967 was more potent and effective to reduce late INa and arrhythmias than either flecainide or ranolazine.  Results of all studies and assays of binding and activity of GS967 at numerous receptors, transporters, and enzymes indicated that GS967 selectively inhibited late INa.  In summary, GS967 selectively suppressed late INa and prevented and/or reduced the incidence of exptl. induced arrhythmias in rabbit myocytes and hearts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYy-fqILCzlrVg90H21EOLACvtfcHk0lgpOw0t3yOmAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXms1Cluw%253D%253D&md5=40b1168a154190ef13ca312e473be7e2</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1124%2Fjpet.112.198887&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.112.198887%26sid%3Dliteratum%253Aachs%26aulast%3DBelardinelli%26aufirst%3DL.%26aulast%3DLiu%26aufirst%3DG.%26aulast%3DSmith-Maxwell%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DW.%2BQ.%26aulast%3DEl-Bizri%26aufirst%3DN.%26aulast%3DHirakawa%26aufirst%3DR.%26aulast%3DKarpinski%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DC.%2BH.%26aulast%3DHu%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DX.%2BJ.%26aulast%3DCrumb%26aufirst%3DW.%26aulast%3DWu%26aufirst%3DL.%26aulast%3DKoltun%26aufirst%3DD.%26aulast%3DZablocki%26aufirst%3DJ.%26aulast%3DYao%26aufirst%3DL.%26aulast%3DDhalla%26aufirst%3DA.%2BK.%26aulast%3DRajamani%26aufirst%3DS.%26aulast%3DShryock%26aufirst%3DJ.%2BC.%26atitle%3DA%2520novel%252C%2520potent%252C%2520and%2520selective%2520inhibitor%2520of%2520cardiac%2520late%2520sodium%2520current%2520suppresses%2520experimental%2520arrhythmias%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2013%26volume%3D344%26spage%3D23%26epage%3D32%26doi%3D10.1124%2Fjpet.112.198887" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Corkey, B. K.; Elzein, E.; Jiang, R. H.; Kalla, R. V.; Koltun, D.; Li, X.; Martinez, R.; Parkhill, E. Q.; Perry, T.; Zablocki, J.; Venkataramani, C.; Graupe, M.; Guerrero, J.</span><span> </span><span class="NLM_article-title">Fused benzoxazepinones as ion channel modulators</span>. WO 2013/006485, January 10,<span class="NLM_x"> </span><span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=B.+K.+Corkey&author=E.+Elzein&author=R.+H.+Jiang&author=R.+V.+Kalla&author=D.+Koltun&author=X.+Li&author=R.+Martinez&author=E.+Q.+Parkhill&author=T.+Perry&author=J.+Zablocki&author=C.+Venkataramani&author=M.+Graupe&author=J.+Guerrero&title=Fused+benzoxazepinones+as+ion+channel+modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCorkey%26aufirst%3DB.%2BK.%26atitle%3DFused%2520benzoxazepinones%2520as%2520ion%2520channel%2520modulators%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Corkey, B. K.; Elzein, E.; Jiang, R. H.; Kalla, R. V.; Koltun, D.; Li, X.; Martinez, R.; Parkhill, E. Q.; Perry, T.; Zablocki, J.; Venkataramani, C.; Graupe, M.; Guerrero, J.</span><span> </span><span class="NLM_article-title">Fused heterocyclic compounds as sodium channel modulators</span>. WO 2012/154760, November 15,<span class="NLM_x"> </span><span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=B.+K.+Corkey&author=E.+Elzein&author=R.+H.+Jiang&author=R.+V.+Kalla&author=D.+Koltun&author=X.+Li&author=R.+Martinez&author=E.+Q.+Parkhill&author=T.+Perry&author=J.+Zablocki&author=C.+Venkataramani&author=M.+Graupe&author=J.+Guerrero&title=Fused+heterocyclic+compounds+as+sodium+channel+modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCorkey%26aufirst%3DB.%2BK.%26atitle%3DFused%2520heterocyclic%2520compounds%2520as%2520sodium%2520channel%2520modulators%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Smart, B. E.</span><span> </span><span class="NLM_article-title">Fluorine substituent effects (on bioactivity)</span> <span class="citation_source-journal">J. Fluorine Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">109</span><span class="NLM_x">, </span> <span class="NLM_fpage">3</span><span class="NLM_x">–</span> <span class="NLM_lpage">11</span><span class="refDoi"> DOI: 10.1016/S0022-1139(01)00375-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00939&amp;key=10.1016%2FS0022-1139%2801%2900375-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00939&amp;key=1%3ACAS%3A528%3ADC%252BD3MXksFKltbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2001&pages=3-11&author=B.+E.+Smart&title=Fluorine+substituent+effects+%28on+bioactivity%29&doi=10.1016%2FS0022-1139%2801%2900375-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Fluorine substituent effects (on bioactivity)</span></div><div class="casAuthors">Smart, B. E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Fluorine Chemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">3-11</span>CODEN:
                <span class="NLM_cas:coden">JFLCAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-1139</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science S.A.</span>)
        </div><div class="casAbstract">A review, with 32 refs.,.  The characteristic effects of F and fluoroalkyl substituents on the physicochem. properties of mols. that are important to biol. activity of fluorinated compds. are highlighted.  The influence of fluorination on acidity, H-bonding, and lipophilicity that affect compd. absorption and distribution is described.  The current perspectives on F steric interactions and the controversial role of H-bonding involving the C-F bond are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr6E1WbRFxuJ7Vg90H21EOLACvtfcHk0lgpOw0t3yOmAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXksFKltbY%253D&md5=bd8cda675e305cd19c4a4eb8db59e107</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2FS0022-1139%2801%2900375-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0022-1139%252801%252900375-X%26sid%3Dliteratum%253Aachs%26aulast%3DSmart%26aufirst%3DB.%2BE.%26atitle%3DFluorine%2520substituent%2520effects%2520%2528on%2520bioactivity%2529%26jtitle%3DJ.%2520Fluorine%2520Chem.%26date%3D2001%26volume%3D109%26spage%3D3%26epage%3D11%26doi%3D10.1016%2FS0022-1139%2801%2900375-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Muller, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faeh, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diederich, F.</span><span> </span><span class="NLM_article-title">Fluorine in pharmaceuticals: looking beyond intuition</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">317</span><span class="NLM_x">, </span> <span class="NLM_fpage">1881</span><span class="NLM_x">–</span> <span class="NLM_lpage">1886</span><span class="refDoi"> DOI: 10.1126/science.1131943</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00939&amp;key=10.1126%2Fscience.1131943" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00939&amp;key=17901324" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00939&amp;key=1%3ACAS%3A280%3ADC%252BD2srnvVOnuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=317&publication_year=2007&pages=1881-1886&author=K.+Mullerauthor=C.+Faehauthor=F.+Diederich&title=Fluorine+in+pharmaceuticals%3A+looking+beyond+intuition&doi=10.1126%2Fscience.1131943"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Fluorine in pharmaceuticals: looking beyond intuition</span></div><div class="casAuthors">Muller Klaus; Faeh Christoph; Diederich Francois</div><div class="citationInfo"><span class="NLM_cas:title">Science (New York, N.Y.)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">317</span>
        (<span class="NLM_cas:issue">5846</span>),
    <span class="NLM_cas:pages">1881-6</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Fluorine substituents have become a widespread and important drug component, their introduction facilitated by the development of safe and selective fluorinating agents.  Organofluorine affects nearly all physical and adsorption, distribution, metabolism, and excretion properties of a lead compound.  Its inductive effects are relatively well understood, enhancing bioavailability, for example, by reducing the basicity of neighboring amines.  In contrast, exploration of the specific influence of carbon-fluorine single bonds on docking interactions, whether through direct contact with the protein or through stereoelectronic effects on molecular conformation of the drug, has only recently begun.  Here, we review experimental progress in this vein and add complementary analysis based on comprehensive searches in the Cambridge Structural Database and the Protein Data Bank.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQekuTGhVzexmgRQsDqrjW_fW6udTcc2ea2OOfDHvk6MLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2srnvVOnuw%253D%253D&md5=f624ab3733f7fc9d4b1711f2f3566ca2</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1126%2Fscience.1131943&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1131943%26sid%3Dliteratum%253Aachs%26aulast%3DMuller%26aufirst%3DK.%26aulast%3DFaeh%26aufirst%3DC.%26aulast%3DDiederich%26aufirst%3DF.%26atitle%3DFluorine%2520in%2520pharmaceuticals%253A%2520looking%2520beyond%2520intuition%26jtitle%3DScience%26date%3D2007%26volume%3D317%26spage%3D1881%26epage%3D1886%26doi%3D10.1126%2Fscience.1131943" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Muller, K.</span><span> </span><span class="NLM_article-title">Simple vector considerations to assess the polarity of partially fluorinated alkyl and alkoxy groups</span> <span class="citation_source-journal">Chimia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">356</span><span class="NLM_x">–</span> <span class="NLM_lpage">362</span><span class="refDoi"> DOI: 10.2533/chimia.2014.356</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00939&amp;key=10.2533%2Fchimia.2014.356" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00939&amp;key=25198745" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00939&amp;key=1%3ACAS%3A528%3ADC%252BC2cXht1emsLrI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2014&pages=356-362&author=K.+Muller&title=Simple+vector+considerations+to+assess+the+polarity+of+partially+fluorinated+alkyl+and+alkoxy+groups&doi=10.2533%2Fchimia.2014.356"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Simple vector considerations to assess the polarity of partially fluorinated alkyl and alkoxy groups</span></div><div class="casAuthors">Muller, Klaus</div><div class="citationInfo"><span class="NLM_cas:title">Chimia</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">356-362</span>CODEN:
                <span class="NLM_cas:coden">CHIMAD</span>;
        ISSN:<span class="NLM_cas:issn">0009-4293</span>.
    
            (<span class="NLM_cas:orgname">Swiss Chemical Society</span>)
        </div><div class="casAbstract">A review.  While H/F exchange at aryl groups or introduction of CF3 units have dominated medicinal chem. for decades, the use of partially fluorinated alkyl and alkoxy groups has come into focus more recently.  A simple bond vector anal. scheme, based on the assumption of context-independent bond polarities as well as idealized configurational and conformational geometries, is applied to small alkyl and alkoxy groups with prototypic fluorination patterns for qual. assessments of relative polarities as well as polarity modulation by conformational change.  Combined with a const. vol. increase for each hydrogen/fluorine exchange these polarity ests. can be translated into expected lipophilicity shifts (ΔlogP), using a simple parameterization scheme derived from exptl. logP values.  While terminal monofluoro- and gem-difluoromethyl groups in small aliph. units are correctly predicted to show lower lipophilicity compared to their tri- or non-fluorinated congeners, vicinal difluoro and bis-vicinal trifluoro patterns are identified to exhibit significantly lower lipophilicities than their resp. geminal di- and trifluoro substituted counterparts.  The trifluoromethoxy group is diagnosed as an intrinsically lipophilic unit compared to the parent methoxy group.  The difluoromethoxy group is of particular interest as it can easily interconvert between a highly lipophilic and a polar conformation, thus enabling this unit to adjust to polarity changes of the mol. environment.  For di- and trifluoroalkoxy groups, again the vic-difluoro and bis-vic-trifluoro substitution patterns stand out as most promising to keep lipophilicity low.  The 1,3-difluoro pattern next to an ether moiety shows an interesting conformational dependence of polarity, similar to the difluoromethoxy group.  While very qual. in nature, the simple bond vector anal. promises to be a useful tool for the identification of lipophilicity-lowering fluorinated alkyl or alkoxy groups and particularly those groups that display marked conformation-dependent lipophilicity and thus potentially serve as 'environmental adaptors'.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr6yZ2IogEjkrVg90H21EOLACvtfcHk0ljkop2Q06G7bg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXht1emsLrI&md5=073bd4a2d1d9dcc5f1540296263dda62</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.2533%2Fchimia.2014.356&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2533%252Fchimia.2014.356%26sid%3Dliteratum%253Aachs%26aulast%3DMuller%26aufirst%3DK.%26atitle%3DSimple%2520vector%2520considerations%2520to%2520assess%2520the%2520polarity%2520of%2520partially%2520fluorinated%2520alkyl%2520and%2520alkoxy%2520groups%26jtitle%3DChimia%26date%3D2014%26volume%3D68%26spage%3D356%26epage%3D362%26doi%3D10.2533%2Fchimia.2014.356" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Payandeh, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scheuer, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Catterall, W. A.</span><span> </span><span class="NLM_article-title">The crystal structure of a voltage-gated sodium channel</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">475</span><span class="NLM_x">, </span> <span class="NLM_fpage">353</span><span class="NLM_x">–</span> <span class="NLM_lpage">358</span><span class="refDoi"> DOI: 10.1038/nature10238</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00939&amp;key=10.1038%2Fnature10238" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00939&amp;key=21743477" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00939&amp;key=1%3ACAS%3A528%3ADC%252BC3MXos1OmsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=475&publication_year=2011&pages=353-358&author=J.+Payandehauthor=T.+Scheuerauthor=N.+Zhengauthor=W.+A.+Catterall&title=The+crystal+structure+of+a+voltage-gated+sodium+channel&doi=10.1038%2Fnature10238"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">The crystal structure of a voltage-gated sodium channel</span></div><div class="casAuthors">Payandeh, Jian; Scheuer, Todd; Zheng, Ning; Catterall, William A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">475</span>
        (<span class="NLM_cas:issue">7356</span>),
    <span class="NLM_cas:pages">353-358</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Voltage-gated sodium (NaV) channels initiate elec. signalling in excitable cells and are the mol. targets for drugs and disease mutations, but the structural basis for their voltage-dependent activation, ion selectivity and drug block is unknown.  Here, we report the crystal structure of a voltage-gated Na+ channel from Arcobacter butzleri (NavAb) captured in a closed-pore conformation with four activated voltage sensors at 2.7 Å resoln.  The arginine gating charges make multiple hydrophilic interactions within the voltage sensor, including unanticipated hydrogen bonds to the protein backbone.  Comparisons to previous open-pore potassium channel structures indicate that the voltage-sensor domains and the S4-S5 linkers dilate the central pore by pivoting together around a hinge at the base of the pore module.  The NavAb selectivity filter is short, ∼4.6 Å wide, and water filled, with four acidic side chains surrounding the narrowest part of the ion conduction pathway.  This unique structure presents a high-field-strength anionic coordination site, which confers Na+ selectivity through partial dehydration via direct interaction with glutamate side chains.  Fenestrations in the sides of the pore module are unexpectedly penetrated by fatty acyl chains that extend into the central cavity, and these portals are large enough for the entry of small, hydrophobic pore-blocking drugs.  This structure provides the template for understanding elec. signalling in excitable cells and the actions of drugs used for pain, epilepsy and cardiac arrhythmia at the at. level.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWTPZUI8wqg7Vg90H21EOLACvtfcHk0ljkop2Q06G7bg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXos1OmsLs%253D&md5=b24b729f516809e422a526b9b7727ee7</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1038%2Fnature10238&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature10238%26sid%3Dliteratum%253Aachs%26aulast%3DPayandeh%26aufirst%3DJ.%26aulast%3DScheuer%26aufirst%3DT.%26aulast%3DZheng%26aufirst%3DN.%26aulast%3DCatterall%26aufirst%3DW.%2BA.%26atitle%3DThe%2520crystal%2520structure%2520of%2520a%2520voltage-gated%2520sodium%2520channel%26jtitle%3DNature%26date%3D2011%26volume%3D475%26spage%3D353%26epage%3D358%26doi%3D10.1038%2Fnature10238" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Jensen, M.Ø.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jogini, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borhani, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leffler, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dror, R. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaw, D. E.</span><span> </span><span class="NLM_article-title">Mechanism of voltage gating in potassium channels</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">336</span><span class="NLM_x">, </span> <span class="NLM_fpage">229</span><span class="NLM_x">–</span> <span class="NLM_lpage">233</span><span class="refDoi"> DOI: 10.1126/science.1216533</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00939&amp;key=10.1126%2Fscience.1216533" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00939&amp;key=22499946" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00939&amp;key=1%3ACAS%3A528%3ADC%252BC38Xlt1ehsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=336&publication_year=2012&pages=229-233&author=M.%C3%98.+Jensenauthor=V.+Joginiauthor=D.+W.+Borhaniauthor=A.+E.+Lefflerauthor=R.+O.+Drorauthor=D.+E.+Shaw&title=Mechanism+of+voltage+gating+in+potassium+channels&doi=10.1126%2Fscience.1216533"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanism of voltage gating in potassium channels</span></div><div class="casAuthors">Jensen, Morten O.; Jogini, Vishwanath; Borhani, David W.; Leffler, Abba E.; Dror, Ron O.; Shaw, David E.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">336</span>
        (<span class="NLM_cas:issue">6078</span>),
    <span class="NLM_cas:pages">229-233</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">The mechanism of ion channel voltage gating, i.e., how channels open and close in response to voltage changes, has been debated since Hodgkin and Huxley's seminal discovery that the crux of nerve conduction is ion flow across cellular membranes.  Here, using all-atom mol. dynamics simulations, the authors show how a voltage-gated K+ channel (KV) switches between activated and deactivated states.  On deactivation, pore hydrophobic collapse rapidly halts ion flow.  Subsequent voltage-sensing domain (VSD) relaxation, including inward, 15-Å S4-helix motion, completes the transition.  On activation, outward S4 motion tightens the VSD-pore linker, perturbing linker-S6-helix packing.  Fluctuations allow water, then K+ ions, to reenter the pore; linker-S6 repacking stabilizes the open pore.  The authors propose a mechanistic model for the Na+/K+/Ca2+ voltage-gated ion channel superfamily that reconciles apparently conflicting exptl. data.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTW9w1jb4_Q7Vg90H21EOLACvtfcHk0ljkop2Q06G7bg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xlt1ehsrc%253D&md5=41e537127531e9d78853ac2dcc5e2019</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1126%2Fscience.1216533&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1216533%26sid%3Dliteratum%253Aachs%26aulast%3DJensen%26aufirst%3DM.%25C3%2598.%26aulast%3DJogini%26aufirst%3DV.%26aulast%3DBorhani%26aufirst%3DD.%2BW.%26aulast%3DLeffler%26aufirst%3DA.%2BE.%26aulast%3DDror%26aufirst%3DR.%2BO.%26aulast%3DShaw%26aufirst%3DD.%2BE.%26atitle%3DMechanism%2520of%2520voltage%2520gating%2520in%2520potassium%2520channels%26jtitle%3DScience%26date%3D2012%26volume%3D336%26spage%3D229%26epage%3D233%26doi%3D10.1126%2Fscience.1216533" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Rohl, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boeckman, F. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scheuer, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Catterall, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klevit, R. E.</span><span> </span><span class="NLM_article-title">Solution structure of the sodium channel inactivation gate</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">855</span><span class="NLM_x">–</span> <span class="NLM_lpage">861</span><span class="refDoi"> DOI: 10.1021/bi9823380</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi9823380" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00939&amp;key=1%3ACAS%3A528%3ADyaK1cXotVOmtrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1999&pages=855-861&author=C.+A.+Rohlauthor=F.+A.+Boeckmanauthor=C.+Bakerauthor=T.+Scheuerauthor=W.+A.+Catterallauthor=R.+E.+Klevit&title=Solution+structure+of+the+sodium+channel+inactivation+gate&doi=10.1021%2Fbi9823380"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Solution Structure of the Sodium Channel Inactivation Gate</span></div><div class="casAuthors">Rohl, Carol A.; Boeckman, Faye A.; Baker, Carl; Scheuer, Todd; Catterall, William A.; Klevit, Rachel E.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">855-861</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The sodium channel initiates action potentials by opening in response to membrane depolarization.  Fast channel inactivation, which is required for proper physiol. function, is mediated by a cytoplasmic loop proposed to occlude the ion pore via a hinged lid mechanism with the triad IFM serving as a hydrophobic "latch".  The NMR soln. structure of the isolated inactivation gate reveals a stably folded core comprised of an α-helix capped by an N-terminal turn, supporting a model in which the tightly folded core contg. the latch motif pivots on a more flexible hinge region to occlude the pore during inactivation.  The structure, in combination with substituted cysteine mutagenesis expts., indicates that the IFM triad and adjacent Thr are essential components of the latch and suggests differing roles for the residues of the IFMT motif in fast inactivation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrss-kaPoPG07Vg90H21EOLACvtfcHk0lismmSv5APc9w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXotVOmtrs%253D&md5=313a8eb96c8bdbaa81c5cf6209901c37</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fbi9823380&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi9823380%26sid%3Dliteratum%253Aachs%26aulast%3DRohl%26aufirst%3DC.%2BA.%26aulast%3DBoeckman%26aufirst%3DF.%2BA.%26aulast%3DBaker%26aufirst%3DC.%26aulast%3DScheuer%26aufirst%3DT.%26aulast%3DCatterall%26aufirst%3DW.%2BA.%26aulast%3DKlevit%26aufirst%3DR.%2BE.%26atitle%3DSolution%2520structure%2520of%2520the%2520sodium%2520channel%2520inactivation%2520gate%26jtitle%3DBiochemistry%26date%3D1999%26volume%3D38%26spage%3D855%26epage%3D861%26doi%3D10.1021%2Fbi9823380" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Heinemann, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terlau, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stühmer, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imoto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Numa, S.</span><span> </span><span class="NLM_article-title">Calcium channel characteristics conferred on the sodium channel by single mutations</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">356</span><span class="NLM_x">, </span> <span class="NLM_fpage">441</span><span class="NLM_x">–</span> <span class="NLM_lpage">443</span><span class="refDoi"> DOI: 10.1038/356441a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00939&amp;key=10.1038%2F356441a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00939&amp;key=1313551" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00939&amp;key=1%3ACAS%3A528%3ADyaK38XktVartbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=356&publication_year=1992&pages=441-443&author=S.+H.+Heinemannauthor=H.+Terlauauthor=W.+St%C3%BChmerauthor=K.+Imotoauthor=S.+Numa&title=Calcium+channel+characteristics+conferred+on+the+sodium+channel+by+single+mutations&doi=10.1038%2F356441a0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Calcium channel characteristics conferred on the sodium channel by single mutations</span></div><div class="casAuthors">Heinemann, Stefan H.; Terlau, Heinrich; Stuehmer, Walter; Imoto, Keiji; Numa, Shosaku</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">356</span>
        (<span class="NLM_cas:issue">6368</span>),
    <span class="NLM_cas:pages">441-3</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    </div><div class="casAbstract">The sodium channel, one of the family of structurally homologous voltage-gated ion channels, differs from other members, such as the calcium and the potassium channels, in its high selectivity for Na+.  This selectivity presumably reflects a distinct structure of its ion-conducting pore.  Two clusters of predominantly neg. charged amino-acid residues, located at equiv. positions in the four internal repeats of the sodium channel, were recently identified as the main determinants of sensitivity to the blockers tetrodotoxin and saxitoxin.  All site-directed mutations reducing net neg. charge at these positions also caused a marked decrease in single-channel conductance.  Thus these two amino acid clusters probably form part of the extracellular mouth and/or the pore wall of the sodium channel.  Here the effects on ion selectivity of replacing lysine at position 1,422 in repeat III and/or alanine at position 1,714 in repeat IV of rat sodium channel II, each located in one of the two clusters, by glutamic acid, which occurs at the equiv. positions in calcium channels, are reported.  These amino-acid substitutions, unlike other substitutions in the adjacent regions, alter ion-selection properties of the sodium channel to resemble those of calcium channels.  This result indicates that lysine 1,422 and alanine 1,714 are crit. in detg. the ion selectivity of the sodium channel, suggesting that these residues constitute part of the selectivity filter of the channel.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpaUozzNzBhobVg90H21EOLACvtfcHk0lismmSv5APc9w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38XktVartbc%253D&md5=69e3fab07a67600cf48ba960a1b23125</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1038%2F356441a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F356441a0%26sid%3Dliteratum%253Aachs%26aulast%3DHeinemann%26aufirst%3DS.%2BH.%26aulast%3DTerlau%26aufirst%3DH.%26aulast%3DSt%25C3%25BChmer%26aufirst%3DW.%26aulast%3DImoto%26aufirst%3DK.%26aulast%3DNuma%26aufirst%3DS.%26atitle%3DCalcium%2520channel%2520characteristics%2520conferred%2520on%2520the%2520sodium%2520channel%2520by%2520single%2520mutations%26jtitle%3DNature%26date%3D1992%26volume%3D356%26spage%3D441%26epage%3D443%26doi%3D10.1038%2F356441a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Moss, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zareba, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwarz, K. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosero, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McNitt, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robinson, J. L.</span><span> </span><span class="NLM_article-title">Ranolazine shortens repolarization in patients with sustained inward sodium current due to type-3 Long-QT syndrome</span> <span class="citation_source-journal">J. Cardiovasc. Electrophysiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">1289</span><span class="NLM_x">–</span> <span class="NLM_lpage">1293</span><span class="refDoi"> DOI: 10.1111/j.1540-8167.2008.01246.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00939&amp;key=10.1111%2Fj.1540-8167.2008.01246.x" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2008&pages=1289-1293&author=A.+J.+Mossauthor=W.+Zarebaauthor=K.+Q.+Schwarzauthor=S.+Roseroauthor=S.+McNittauthor=J.+L.+Robinson&title=Ranolazine+shortens+repolarization+in+patients+with+sustained+inward+sodium+current+due+to+type-3+Long-QT+syndrome&doi=10.1111%2Fj.1540-8167.2008.01246.x"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1111%2Fj.1540-8167.2008.01246.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1540-8167.2008.01246.x%26sid%3Dliteratum%253Aachs%26aulast%3DMoss%26aufirst%3DA.%2BJ.%26aulast%3DZareba%26aufirst%3DW.%26aulast%3DSchwarz%26aufirst%3DK.%2BQ.%26aulast%3DRosero%26aufirst%3DS.%26aulast%3DMcNitt%26aufirst%3DS.%26aulast%3DRobinson%26aufirst%3DJ.%2BL.%26atitle%3DRanolazine%2520shortens%2520repolarization%2520in%2520patients%2520with%2520sustained%2520inward%2520sodium%2520current%2520due%2520to%2520type-3%2520Long-QT%2520syndrome%26jtitle%3DJ.%2520Cardiovasc.%2520Electrophysiol.%26date%3D2008%26volume%3D19%26spage%3D1289%26epage%3D1293%26doi%3D10.1111%2Fj.1540-8167.2008.01246.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Zareba, W.; Rosero, S.; Zeng, D.; Moss, A. J.; Couderc, J.-P.; Layug, B.; Belardinelli, L.</span><span> </span><span class="NLM_article-title">Sustained QTc shortening by GS-6615 in patients with LQT3</span>. Heart Rhythm Society 35th Annual Meeting May 7–10, 2014, San Francisco,<span class="NLM_x"> </span><span class="NLM_year">2014</span><span class="NLM_x">; </span> <span class="NLM_fpage">Abstract AB-34-05</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&pages=Abstract+AB-34-05&author=W.+Zareba&author=S.+Rosero&author=D.+Zeng&author=A.+J.+Moss&author=J.-P.+Couderc&author=B.+Layug&author=L.+Belardinelli&title=Sustained+QTc+shortening+by+GS-6615+in+patients+with+LQT3"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DZareba%26aufirst%3DW.%26atitle%3DSustained%2520QTc%2520shortening%2520by%2520GS-6615%2520in%2520patients%2520with%2520LQT3%26jtitle%3DHeart%2520Rhythm%2520Society%252035th%2520Annual%2520Meeting%2520May%25207%25E2%2580%259310%252C%25202014%252C%2520San%2520Francisco%26date%3D2014%26spage%3DAbstract%2520AB-34-05" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Le Grand, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pignier, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Létienne, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cuisiat, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rolland, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mas, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vacher, B.</span><span> </span><span class="NLM_article-title">Sodium late current blockers in ischemia reperfusion: is the bullet magic?</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">3856</span><span class="NLM_x">–</span> <span class="NLM_lpage">3866</span><span class="refDoi"> DOI: 10.1021/jm800100z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm800100z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00939&amp;key=1%3ACAS%3A528%3ADC%252BD1cXmslamtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=3856-3866&author=B.+Le+Grandauthor=C.+Pignierauthor=R.+L%C3%A9tienneauthor=F.+Cuisiatauthor=F.+Rollandauthor=A.+Masauthor=B.+Vacher&title=Sodium+late+current+blockers+in+ischemia+reperfusion%3A+is+the+bullet+magic%3F&doi=10.1021%2Fjm800100z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Sodium Late Current Blockers in Ischemia Reperfusion: Is the Bullet Magic?</span></div><div class="casAuthors">Le Grand, Bruno; Pignier, Christophe; Letienne, Robert; Cuisiat, Florence; Rolland, Francoise; Mas, Agnes; Vacher, Bernard</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">3856-3866</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We describe the discovery of the first selective, potent, and voltage-dependent inhibitor of the late current mediated by the cardiac sodium channel NaV1.5.  The compd. 3,4-dihydro-N-[(2S)-3-[(2-methoxyphenyl)thio]-2-methylpropyl]-2H-(3R)-1,5-benzoxathiepin-3-amine (I)(F 15845), was identified from a novel family of 3-amino-1,5-benzoxathiepine derivs.  The late sodium current inhibition and antiischemic effects of I were studied in various models in vitro and in vivo.  In a rabbit model of ischemia-reperfusion, I exhibited more potent antiischemic effects than ref. compds. KC 12291, ranolazine, and ivabradine.  Thus, after a single administration, I almost abolished ST segment elevation in response to a transient coronary occlusion.  Further, the antiischemic activity of I is maintained over a wide range of doses and is not assocd. with any hemodynamic changes, contrary to conventional antiischemic agents.  The unique pharmacol. profile of I opens new and promising opportunities for the treatment of ischemic heart diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqalBdranKqqbVg90H21EOLACvtfcHk0lgttX7vXe2fjg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXmslamtL0%253D&md5=6436bf6c98d7cfce8eec3feaf2dfa9f2</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fjm800100z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800100z%26sid%3Dliteratum%253Aachs%26aulast%3DLe%2BGrand%26aufirst%3DB.%26aulast%3DPignier%26aufirst%3DC.%26aulast%3DL%25C3%25A9tienne%26aufirst%3DR.%26aulast%3DCuisiat%26aufirst%3DF.%26aulast%3DRolland%26aufirst%3DF.%26aulast%3DMas%26aufirst%3DA.%26aulast%3DVacher%26aufirst%3DB.%26atitle%3DSodium%2520late%2520current%2520blockers%2520in%2520ischemia%2520reperfusion%253A%2520is%2520the%2520bullet%2520magic%253F%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D3856%26epage%3D3866%26doi%3D10.1021%2Fjm800100z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Le Grand, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pignier, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Létienne, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colpaert, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cuisiat, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rolland, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mas, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borras, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vacher, B.</span><span> </span><span class="NLM_article-title">Na+ currents in cardioprotection: better to be late</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">4149</span><span class="NLM_x">–</span> <span class="NLM_lpage">4160</span><span class="refDoi"> DOI: 10.1021/jm900296e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm900296e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00939&amp;key=1%3ACAS%3A528%3ADC%252BD1MXntVGjsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=4149-4160&author=B.+Le+Grandauthor=C.+Pignierauthor=R.+L%C3%A9tienneauthor=F.+Colpaertauthor=F.+Cuisiatauthor=F.+Rollandauthor=A.+Masauthor=M.+Borrasauthor=B.+Vacher&title=Na%2B+currents+in+cardioprotection%3A+better+to+be+late&doi=10.1021%2Fjm900296e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Na+ Currents in Cardioprotection</span></div><div class="casAuthors">Le Grand, Bruno; Pignier, Christophe; Letienne, Robert; Colpaert, Francis; Cuisiat, Florence; Rolland, Francoise; Mas, Agnes; Borras, Maud; Vacher, Bernard</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">4149-4160</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We report the discovery of a selective, potent inhibitor of the late current mediated by the cardiac isoform of the sodium channel (NaV1.5).  The compd., 3,4-dihydro-N-[(2S)-3-[(2-hydroxy-3-methylphenyl)thio]-2-methylpropyl]-2H-(3R)-1,5-benzoxathiepin-3-amine (F15741), blocks the late component of the Na+ currents and greatly reduces veratridine- or ischemia-induced contracture in isolated tissue and whole heart.  The cardioprotective action of F15741 was further established in a model of myocardial infarction in the pig in which F15741 prevents ischemia-reperfusion damage after 60 min of coronary occlusion and 48 h reperfusion.  Under these exptl. conditions, only F15741 and cariporide reduce infarct size.  Remarkably, myocardial protection afforded by F15741 occurs in the absence of hemodynamic effects.  These data expand the therapeutic potential of late INa blockers and suggest that 2d could be useful in pathologies for which pharmacol. treatments are not yet available.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWdnKNuOcBorVg90H21EOLACvtfcHk0lgttX7vXe2fjg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXntVGjsrw%253D&md5=8e1e7b4c97f9ec034397a86d483f92a4</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fjm900296e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900296e%26sid%3Dliteratum%253Aachs%26aulast%3DLe%2BGrand%26aufirst%3DB.%26aulast%3DPignier%26aufirst%3DC.%26aulast%3DL%25C3%25A9tienne%26aufirst%3DR.%26aulast%3DColpaert%26aufirst%3DF.%26aulast%3DCuisiat%26aufirst%3DF.%26aulast%3DRolland%26aufirst%3DF.%26aulast%3DMas%26aufirst%3DA.%26aulast%3DBorras%26aufirst%3DM.%26aulast%3DVacher%26aufirst%3DB.%26atitle%3DNa%252B%2520currents%2520in%2520cardioprotection%253A%2520better%2520to%2520be%2520late%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D4149%26epage%3D4160%26doi%3D10.1021%2Fjm900296e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Echt, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liebson, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitchell, L. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peters, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Obias-Manno, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barker, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arensberg, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedman, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greene, H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huther, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richardson, D.</span><span> </span><span class="NLM_article-title">W Mortality and morbidity in patients receiving encainide, flecainide, or placebo — the Cardiac Arrhythmia Suppression Trial</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">324</span><span class="NLM_x">, </span> <span class="NLM_fpage">781</span><span class="NLM_x">–</span> <span class="NLM_lpage">788</span><span class="refDoi"> DOI: 10.1056/NEJM199103213241201</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00939&amp;key=10.1056%2FNEJM199103213241201" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00939&amp;key=1900101" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00939&amp;key=1%3ACAS%3A280%3ADyaK3M7kvVKluw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=324&publication_year=1991&pages=781-788&author=D.+S.+Echtauthor=P.+R.+Liebsonauthor=L.+B.+Mitchellauthor=R.+W.+Petersauthor=D.+Obias-Mannoauthor=A.+H.+Barkerauthor=D.+Arensbergauthor=A.+Bakerauthor=R.+Friedmanauthor=H.+L.+Greeneauthor=M.+L.+Hutherauthor=D.+Richardson&title=W+Mortality+and+morbidity+in+patients+receiving+encainide%2C+flecainide%2C+or+placebo+%E2%80%94+the+Cardiac+Arrhythmia+Suppression+Trial&doi=10.1056%2FNEJM199103213241201"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial</span></div><div class="casAuthors">Echt D S; Liebson P R; Mitchell L B; Peters R W; Obias-Manno D; Barker A H; Arensberg D; Baker A; Friedman L; Greene H L; et al</div><div class="citationInfo"><span class="NLM_cas:title">The New England journal of medicine</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">324</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">781-8</span>
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    </div><div class="casAbstract">BACKGROUND AND METHODS:  In the Cardiac Arrhythmia Suppression Trial, designed to test the hypothesis that suppression of ventricular ectopy after a myocardial infarction reduces the incidence of sudden death, patients in whom ventricular ectopy could be suppressed with encainide, flecainide, or moricizine were randomly assigned to receive either active drug or placebo.  The use of encainide and flecainide was discontinued because of excess mortality.  We examined the mortality and morbidity after randomization to encainide or flecainide or their respective placebo.  RESULTS:  Of 1498 patients, 857 were assigned to receive encainide or its placebo (432 to active drug and 425 to placebo) and 641 were assigned to receive flecainide or its placebo (323 to active drug and 318 to placebo).  After a mean follow-up of 10 months, 89 patients had died: 59 of arrhythmia (43 receiving drug vs. 16 receiving placebo; P = 0.0004), 22 of nonarrhythmic cardiac causes (17 receiving drug vs. 5 receiving placebo; P = 0.01), and 8 of noncardiac causes (3 receiving drug vs. 5 receiving placebo).  Almost all cardiac deaths not due to arrhythmia were attributed to acute myocardial infarction with shock (11 patients receiving drug and 3 receiving placebo) or to chronic congestive heart failure (4 receiving drug and 2 receiving placebo).  There were no differences between the patients receiving active drug and those receiving placebo in the incidence of nonlethal disqualifying ventricular tachycardia, proarrhythmia, syncope, need for a permanent pacemaker, congestive heart failure, recurrent myocardial infarction, angina, or need for coronary-artery bypass grafting or angioplasty.  CONCLUSIONS:  There was an excess of deaths due to arrhythmia and deaths due to shock after acute recurrent myocardial infarction in patients treated with encainide or flecainide.  Nonlethal events, however, were equally distributed between the active-drug and placebo groups.  The mechanisms underlying the excess mortality during treatment with encainide or flecainide remain unknown.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTwCM0PKDJ7n2gRQsDqrjW_fW6udTcc2eZDKvr_GO1Hqbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK3M7kvVKluw%253D%253D&md5=c6bfa1e251d3306b843a03933e450939</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1056%2FNEJM199103213241201&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJM199103213241201%26sid%3Dliteratum%253Aachs%26aulast%3DEcht%26aufirst%3DD.%2BS.%26aulast%3DLiebson%26aufirst%3DP.%2BR.%26aulast%3DMitchell%26aufirst%3DL.%2BB.%26aulast%3DPeters%26aufirst%3DR.%2BW.%26aulast%3DObias-Manno%26aufirst%3DD.%26aulast%3DBarker%26aufirst%3DA.%2BH.%26aulast%3DArensberg%26aufirst%3DD.%26aulast%3DBaker%26aufirst%3DA.%26aulast%3DFriedman%26aufirst%3DR.%26aulast%3DGreene%26aufirst%3DH.%2BL.%26aulast%3DHuther%26aufirst%3DM.%2BL.%26aulast%3DRichardson%26aufirst%3DD.%26atitle%3DW%2520Mortality%2520and%2520morbidity%2520in%2520patients%2520receiving%2520encainide%252C%2520flecainide%252C%2520or%2520placebo%2520%25E2%2580%2594%2520the%2520Cardiac%2520Arrhythmia%2520Suppression%2520Trial%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D1991%26volume%3D324%26spage%3D781%26epage%3D788%26doi%3D10.1056%2FNEJM199103213241201" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Diamond, I.; Belardinelli, L.; Shryock, J.; Rajamani, S.</span><span> </span><span class="NLM_article-title">Use of ranolazine for treating pain</span>. WO 2009/100380 Aug 13,<span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=I.+Diamond&author=L.+Belardinelli&author=J.+Shryock&author=S.+Rajamani&title=Use+of+ranolazine+for+treating+pain"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DDiamond%26aufirst%3DI.%26atitle%3DUse%2520of%2520ranolazine%2520for%2520treating%2520pain%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 21 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Yan-Song Ye, Shu-Zong Du, Na-Na Jiang, Hong-Xi Xu, Jian Yang, Wen-Wei Fu, Yin Nian, <span class="NLM_string-name hlFld-ContribAuthor">Gang Xu</span>. </span><span class="cited-content_cbyCitation_article-title">Novel Meroterpenoids from Hypericum patulum: Highly Potent Late Nav1.5 Sodium Current Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2020,</strong> <em>22 </em>
                                    (16)
                                     , 6339-6343. <a href="https://doi.org/10.1021/acs.orglett.0c02170" title="DOI URL">https://doi.org/10.1021/acs.orglett.0c02170</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.0c02170&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.0c02170%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DNovel%252BMeroterpenoids%252Bfrom%252BHypericum%252Bpatulum%25253A%252BHighly%252BPotent%252BLate%252BNav1.5%252BSodium%252BCurrent%252BInhibitors%26aulast%3DYe%26aufirst%3DYan-Song%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D30062020%26date%3D04082020%26volume%3D22%26issue%3D16%26spage%3D6339%26epage%3D6343" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Dean G. Brown, <span class="NLM_string-name hlFld-ContribAuthor">Jonas Boström</span>. </span><span class="cited-content_cbyCitation_article-title">Where Do Recent Small Molecule Clinical Development Candidates Come From?. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (21)
                                     , 9442-9468. <a href="https://doi.org/10.1021/acs.jmedchem.8b00675" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00675</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00675&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b00675%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DWhere%252BDo%252BRecent%252BSmall%252BMolecule%252BClinical%252BDevelopment%252BCandidates%252BCome%252BFrom%25253F%26aulast%3DBrown%26aufirst%3DDean%2BG.%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D27042018%26date%3D09072018%26date%3D19062018%26volume%3D61%26issue%3D21%26spage%3D9442%26epage%3D9468" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shaoyi  Sun</span>, <span class="hlFld-ContribAuthor ">Qi  Jia</span>, <span class="hlFld-ContribAuthor ">Alla Y.  Zenova</span>, <span class="hlFld-ContribAuthor ">Sophia  Lin</span>, <span class="hlFld-ContribAuthor ">Angela  Hussainkhel</span>, <span class="hlFld-ContribAuthor ">Janette  Mezeyova</span>, <span class="hlFld-ContribAuthor ">Elaine  Chang</span>, <span class="hlFld-ContribAuthor ">Samuel J.  Goodchild</span>, <span class="hlFld-ContribAuthor ">Zhiwei  Xie</span>, <span class="hlFld-ContribAuthor ">Andrea  Lindgren</span>, <span class="hlFld-ContribAuthor ">Gina  de Boer</span>, <span class="hlFld-ContribAuthor ">Rainbow  Kwan</span>, <span class="hlFld-ContribAuthor ">Kuldip  Khakh</span>, <span class="hlFld-ContribAuthor ">Luis  Sojo</span>, <span class="hlFld-ContribAuthor ">Paul  Bichler</span>, <span class="hlFld-ContribAuthor ">J.P.  Johnson</span>, <span class="hlFld-ContribAuthor ">James R.  Empfield</span>, <span class="hlFld-ContribAuthor ">Charles J.  Cohen</span>, <span class="hlFld-ContribAuthor ">Christoph M.  Dehnhardt</span>, <span class="hlFld-ContribAuthor ">Richard  Dean</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of aryl sulfonamides as novel and potent inhibitors of NaV1.5. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2021,</strong> <em>45 </em>, 128133. <a href="https://doi.org/10.1016/j.bmcl.2021.128133" title="DOI URL">https://doi.org/10.1016/j.bmcl.2021.128133</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2021.128133&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2021.128133%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DIdentification%252Bof%252Baryl%252Bsulfonamides%252Bas%252Bnovel%252Band%252Bpotent%252Binhibitors%252Bof%252BNaV1.5%26aulast%3DSun%26aufirst%3DShaoyi%26date%3D2021%26volume%3D45%26spage%3D128133" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rochelle  McGrory</span>, <span class="hlFld-ContribAuthor ">Réka J.  Faggyas</span>, <span class="hlFld-ContribAuthor ">Andrew  Sutherland</span>. </span><span class="cited-content_cbyCitation_article-title">One-pot synthesis of
              N
              -substituted benzannulated triazoles
              via
              stable arene diazonium salts. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2021,</strong> <em>19 </em>
                                    (27)
                                     , 6127-6140. <a href="https://doi.org/10.1039/D1OB00968K" title="DOI URL">https://doi.org/10.1039/D1OB00968K</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D1OB00968K&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD1OB00968K%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DOne-pot%252Bsynthesis%252Bof%252BN%252B-substituted%252Bbenzannulated%252Btriazoles%252Bvia%252Bstable%252Barene%252Bdiazonium%252Bsalts%26aulast%3DMcGrory%26aufirst%3DRochelle%26date%3D2021%26date%3D2021%26volume%3D19%26issue%3D27%26spage%3D6127%26epage%3D6140" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Daniela  Ponce-Balbuena</span>, <span class="hlFld-ContribAuthor ">Isabelle  Deschênes</span>. </span><span class="cited-content_cbyCitation_article-title">Long QT syndrome – Bench to bedside. </span><span class="cited-content_cbyCitation_journal-name">Heart Rhythm O2</span><span> <strong>2021,</strong> <em>2 </em>
                                    (1)
                                     , 89-106. <a href="https://doi.org/10.1016/j.hroo.2021.01.006" title="DOI URL">https://doi.org/10.1016/j.hroo.2021.01.006</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.hroo.2021.01.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.hroo.2021.01.006%26sid%3Dliteratum%253Aachs%26jtitle%3DHeart%2520Rhythm%2520O2%26atitle%3DLong%252BQT%252Bsyndrome%252B%2525E2%252580%252593%252BBench%252Bto%252Bbedside%26aulast%3DPonce-Balbuena%26aufirst%3DDaniela%26date%3D2021%26volume%3D2%26issue%3D1%26spage%3D89%26epage%3D106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wesley L.  McKeithan</span>, <span class="hlFld-ContribAuthor ">Dries A.M.  Feyen</span>, <span class="hlFld-ContribAuthor ">Arne A.N.  Bruyneel</span>, <span class="hlFld-ContribAuthor ">Karl J.  Okolotowicz</span>, <span class="hlFld-ContribAuthor ">Daniel A.  Ryan</span>, <span class="hlFld-ContribAuthor ">Kevin J.  Sampson</span>, <span class="hlFld-ContribAuthor ">Franck  Potet</span>, <span class="hlFld-ContribAuthor ">Alex  Savchenko</span>, <span class="hlFld-ContribAuthor ">Jorge  Gómez-Galeno</span>, <span class="hlFld-ContribAuthor ">Michelle  Vu</span>, <span class="hlFld-ContribAuthor ">Ricardo  Serrano</span>, <span class="hlFld-ContribAuthor ">Alfred L.  George</span>, <span class="hlFld-ContribAuthor ">Robert S.  Kass</span>, <span class="hlFld-ContribAuthor ">John R.  Cashman</span>, <span class="hlFld-ContribAuthor ">Mark  Mercola</span>. </span><span class="cited-content_cbyCitation_article-title">Reengineering an Antiarrhythmic Drug Using Patient hiPSC Cardiomyocytes to Improve Therapeutic Potential and Reduce Toxicity. </span><span class="cited-content_cbyCitation_journal-name">Cell Stem Cell</span><span> <strong>2020,</strong> <em>27 </em>
                                    (5)
                                     , 813-821.e6. <a href="https://doi.org/10.1016/j.stem.2020.08.003" title="DOI URL">https://doi.org/10.1016/j.stem.2020.08.003</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.stem.2020.08.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.stem.2020.08.003%26sid%3Dliteratum%253Aachs%26jtitle%3DCell%2520Stem%2520Cell%26atitle%3DReengineering%252Ban%252BAntiarrhythmic%252BDrug%252BUsing%252BPatient%252BhiPSC%252BCardiomyocytes%252Bto%252BImprove%252BTherapeutic%252BPotential%252Band%252BReduce%252BToxicity%26aulast%3DMcKeithan%26aufirst%3DWesley%2BL.%26date%3D2020%26volume%3D27%26issue%3D5%26spage%3D813%26epage%3D821.e6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rachel E.  Caves</span>, <span class="hlFld-ContribAuthor ">Alexander  Carpenter</span>, <span class="hlFld-ContribAuthor ">Stéphanie C.  Choisy</span>, <span class="hlFld-ContribAuthor ">Ben  Clennell</span>, <span class="hlFld-ContribAuthor ">Hongwei  Cheng</span>, <span class="hlFld-ContribAuthor ">Cameron  McNiff</span>, <span class="hlFld-ContribAuthor ">Brendan  Mann</span>, <span class="hlFld-ContribAuthor ">James T.  Milnes</span>, <span class="hlFld-ContribAuthor ">Jules C.  Hancox</span>, <span class="hlFld-ContribAuthor ">Andrew F.  James</span>. </span><span class="cited-content_cbyCitation_article-title">Inhibition of voltage-gated Na+ currents by eleclazine in rat atrial and ventricular myocytes. </span><span class="cited-content_cbyCitation_journal-name">Heart Rhythm O2</span><span> <strong>2020,</strong> <em>1 </em>
                                    (3)
                                     , 206-214. <a href="https://doi.org/10.1016/j.hroo.2020.05.006" title="DOI URL">https://doi.org/10.1016/j.hroo.2020.05.006</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.hroo.2020.05.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.hroo.2020.05.006%26sid%3Dliteratum%253Aachs%26jtitle%3DHeart%2520Rhythm%2520O2%26atitle%3DInhibition%252Bof%252Bvoltage-gated%252BNa%25252B%252Bcurrents%252Bby%252Beleclazine%252Bin%252Brat%252Batrial%252Band%252Bventricular%252Bmyocytes%26aulast%3DCaves%26aufirst%3DRachel%2BE.%26date%3D2020%26volume%3D1%26issue%3D3%26spage%3D206%26epage%3D214" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Balázs  Horváth</span>, <span class="hlFld-ContribAuthor ">Tamás  Hézső</span>, <span class="hlFld-ContribAuthor ">Dénes  Kiss</span>, <span class="hlFld-ContribAuthor ">Kornél  Kistamás</span>, <span class="hlFld-ContribAuthor ">János  Magyar</span>, <span class="hlFld-ContribAuthor ">Péter P.  Nánási</span>, <span class="hlFld-ContribAuthor ">Tamás  Bányász</span>. </span><span class="cited-content_cbyCitation_article-title">Late Sodium Current Inhibitors as Potential Antiarrhythmic Agents. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Pharmacology</span><span> <strong>2020,</strong> <em>11 </em><a href="https://doi.org/10.3389/fphar.2020.00413" title="DOI URL">https://doi.org/10.3389/fphar.2020.00413</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fphar.2020.00413&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffphar.2020.00413%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Pharmacology%26atitle%3DLate%252BSodium%252BCurrent%252BInhibitors%252Bas%252BPotential%252BAntiarrhythmic%252BAgents%26aulast%3DHorv%25C3%25A1th%26aufirst%3DBal%25C3%25A1zs%26date%3D2020%26date%3D2020%26volume%3D11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xuexin  Jin</span>, <span class="hlFld-ContribAuthor ">Yuan  Jiang</span>, <span class="hlFld-ContribAuthor ">Genlong  Xue</span>, <span class="hlFld-ContribAuthor ">Yin  Yuan</span>, <span class="hlFld-ContribAuthor ">Haixia  Zhu</span>, <span class="hlFld-ContribAuthor ">Linfeng  Zhan</span>, <span class="hlFld-ContribAuthor ">Yuting  Zhuang</span>, <span class="hlFld-ContribAuthor ">Qihe  Huang</span>, <span class="hlFld-ContribAuthor ">Ling  Shi</span>, <span class="hlFld-ContribAuthor ">Yue  Zhao</span>, <span class="hlFld-ContribAuthor ">Penghui  Li</span>, <span class="hlFld-ContribAuthor ">Yilin  Sun</span>, <span class="hlFld-ContribAuthor ">Wanzhen  Su</span>, <span class="hlFld-ContribAuthor ">Yang  Zhang</span>, <span class="hlFld-ContribAuthor ">Baofeng  Yang</span>, <span class="hlFld-ContribAuthor ">Yanjie  Lu</span>, <span class="hlFld-ContribAuthor ">Zhiguo  Wang</span>, <span class="hlFld-ContribAuthor ">Zhenwei  Pan</span>. </span><span class="cited-content_cbyCitation_article-title">Increase of late sodium current contributes to enhanced susceptibility to atrial fibrillation in diabetic mice. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Pharmacology</span><span> <strong>2019,</strong> <em>857 </em>, 172444. <a href="https://doi.org/10.1016/j.ejphar.2019.172444" title="DOI URL">https://doi.org/10.1016/j.ejphar.2019.172444</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejphar.2019.172444&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejphar.2019.172444%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Pharmacology%26atitle%3DIncrease%252Bof%252Blate%252Bsodium%252Bcurrent%252Bcontributes%252Bto%252Benhanced%252Bsusceptibility%252Bto%252Batrial%252Bfibrillation%252Bin%252Bdiabetic%252Bmice%26aulast%3DJin%26aufirst%3DXuexin%26date%3D2019%26volume%3D857%26spage%3D172444" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Daniel T.  Hoagland</span>, <span class="hlFld-ContribAuthor ">Webster  Santos</span>, <span class="hlFld-ContribAuthor ">Steven  Poelzing</span>, <span class="hlFld-ContribAuthor ">Robert G.  Gourdie</span>. </span><span class="cited-content_cbyCitation_article-title">The role of the gap junction perinexus in cardiac conduction: Potential as a novel anti-arrhythmic drug target. </span><span class="cited-content_cbyCitation_journal-name">Progress in Biophysics and Molecular Biology</span><span> <strong>2019,</strong> <em>144 </em>, 41-50. <a href="https://doi.org/10.1016/j.pbiomolbio.2018.08.003" title="DOI URL">https://doi.org/10.1016/j.pbiomolbio.2018.08.003</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.pbiomolbio.2018.08.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.pbiomolbio.2018.08.003%26sid%3Dliteratum%253Aachs%26jtitle%3DProgress%2520in%2520Biophysics%2520and%2520Molecular%2520Biology%26atitle%3DThe%252Brole%252Bof%252Bthe%252Bgap%252Bjunction%252Bperinexus%252Bin%252Bcardiac%252Bconduction%25253A%252BPotential%252Bas%252Ba%252Bnovel%252Banti-arrhythmic%252Bdrug%252Btarget%26aulast%3DHoagland%26aufirst%3DDaniel%2BT.%26date%3D2019%26volume%3D144%26spage%3D41%26epage%3D50" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anton A.  Guryev</span>, <span class="hlFld-ContribAuthor ">Friedrich  Hahn</span>, <span class="hlFld-ContribAuthor ">Manfred  Marschall</span>, <span class="hlFld-ContribAuthor ">Svetlana B.  Tsogoeva</span>. </span><span class="cited-content_cbyCitation_article-title">Visible‐Light‐Driven C−H Oxidation of Cyclic Tertiary Amines: Access to Synthetic
              Strychnos
              Alkaloids with Antiviral Activity. </span><span class="cited-content_cbyCitation_journal-name">Chemistry – A European Journal</span><span> <strong>2019,</strong> <em>25 </em>
                                    (16)
                                     , 4062-4066. <a href="https://doi.org/10.1002/chem.201900078" title="DOI URL">https://doi.org/10.1002/chem.201900078</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/chem.201900078&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fchem.201900078%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520%25E2%2580%2593%2520A%2520European%2520Journal%26atitle%3DVisible%2525E2%252580%252590Light%2525E2%252580%252590Driven%252BC%2525E2%252588%252592H%252BOxidation%252Bof%252BCyclic%252BTertiary%252BAmines%25253A%252BAccess%252Bto%252BSynthetic%252BStrychnos%252BAlkaloids%252Bwith%252BAntiviral%252BActivity%26aulast%3DGuryev%26aufirst%3DAnton%2BA.%26date%3D2019%26date%3D2019%26volume%3D25%26issue%3D16%26spage%3D4062%26epage%3D4066" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Timothy C.  Wong</span>, <span class="hlFld-ContribAuthor ">Matthew  Martinez</span>. </span><span class="cited-content_cbyCitation_article-title">Novel Pharmacotherapy for Hypertrophic Cardiomyopathy. </span><span class="cited-content_cbyCitation_journal-name">Cardiology Clinics</span><span> <strong>2019,</strong> <em>37 </em>
                                    (1)
                                     , 113-117. <a href="https://doi.org/10.1016/j.ccl.2018.08.008" title="DOI URL">https://doi.org/10.1016/j.ccl.2018.08.008</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ccl.2018.08.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ccl.2018.08.008%26sid%3Dliteratum%253Aachs%26jtitle%3DCardiology%2520Clinics%26atitle%3DNovel%252BPharmacotherapy%252Bfor%252BHypertrophic%252BCardiomyopathy%26aulast%3DWong%26aufirst%3DTimothy%2BC.%26date%3D2019%26volume%3D37%26issue%3D1%26spage%3D113%26epage%3D117" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dmitry O.  Koltun</span>, <span class="hlFld-ContribAuthor ">Eric Q.  Parkhill</span>, <span class="hlFld-ContribAuthor ">Rao  Kalla</span>, <span class="hlFld-ContribAuthor ">Thao D.  Perry</span>, <span class="hlFld-ContribAuthor ">Elfatih  Elzein</span>, <span class="hlFld-ContribAuthor ">Xiaofen  Li</span>, <span class="hlFld-ContribAuthor ">Scott P.  Simonovich</span>, <span class="hlFld-ContribAuthor ">Christopher  Ziebenhaus</span>, <span class="hlFld-ContribAuthor ">Timothy R.  Hansen</span>, <span class="hlFld-ContribAuthor ">Bruno  Marchand</span>, <span class="hlFld-ContribAuthor ">WaiLok K.  Hung</span>, <span class="hlFld-ContribAuthor ">Leanna  Lagpacan</span>, <span class="hlFld-ContribAuthor ">Magdeleine  Hung</span>, <span class="hlFld-ContribAuthor ">Ron G.  Aoyama</span>, <span class="hlFld-ContribAuthor ">Bernard P.  Murray</span>, <span class="hlFld-ContribAuthor ">Jason K.  Perry</span>, <span class="hlFld-ContribAuthor ">John R.  Somoza</span>, <span class="hlFld-ContribAuthor ">Armando G.  Villaseñor</span>, <span class="hlFld-ContribAuthor ">Nikos  Pagratis</span>, <span class="hlFld-ContribAuthor ">Jeff A.  Zablocki</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of potent and selective inhibitors of calmodulin-dependent kinase II (CaMKII). </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2018,</strong> <em>28 </em>
                                    (3)
                                     , 541-546. <a href="https://doi.org/10.1016/j.bmcl.2017.10.040" title="DOI URL">https://doi.org/10.1016/j.bmcl.2017.10.040</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2017.10.040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2017.10.040%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252Bpotent%252Band%252Bselective%252Binhibitors%252Bof%252Bcalmodulin-dependent%252Bkinase%252BII%252B%252528CaMKII%252529%26aulast%3DKoltun%26aufirst%3DDmitry%2BO.%26date%3D2018%26volume%3D28%26issue%3D3%26spage%3D541%26epage%3D546" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nesrine  El-Bizri</span>, <span class="hlFld-ContribAuthor ">Cheng  Xie</span>, <span class="hlFld-ContribAuthor ">Lynda  Liu</span>, <span class="hlFld-ContribAuthor ">James  Limberis</span>, <span class="hlFld-ContribAuthor ">Michael  Krause</span>, <span class="hlFld-ContribAuthor ">Ryoko  Hirakawa</span>, <span class="hlFld-ContribAuthor ">Steven  Nguyen</span>, <span class="hlFld-ContribAuthor ">Dennis R.  Tabuena</span>, <span class="hlFld-ContribAuthor ">Luiz  Belardinelli</span>, <span class="hlFld-ContribAuthor ">Kristopher M.  Kahlig</span>. </span><span class="cited-content_cbyCitation_article-title">Eleclazine exhibits enhanced selectivity for long QT syndrome type 3–associated late Na + current. </span><span class="cited-content_cbyCitation_journal-name">Heart Rhythm</span><span> <strong>2018,</strong> <em>15 </em>
                                    (2)
                                     , 277-286. <a href="https://doi.org/10.1016/j.hrthm.2017.09.028" title="DOI URL">https://doi.org/10.1016/j.hrthm.2017.09.028</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.hrthm.2017.09.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.hrthm.2017.09.028%26sid%3Dliteratum%253Aachs%26jtitle%3DHeart%2520Rhythm%26atitle%3DEleclazine%252Bexhibits%252Benhanced%252Bselectivity%252Bfor%252Blong%252BQT%252Bsyndrome%252Btype%252B3%2525E2%252580%252593associated%252Blate%252BNa%252B%25252B%252Bcurrent%26aulast%3DEl-Bizri%26aufirst%3DNesrine%26date%3D2018%26volume%3D15%26issue%3D2%26spage%3D277%26epage%3D286" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Olga  Bakulina</span>, <span class="hlFld-ContribAuthor ">Maria  Chizhova</span>, <span class="hlFld-ContribAuthor ">Dmitry  Dar'in</span>, <span class="hlFld-ContribAuthor ">Mikhail  Krasavin</span>. </span><span class="cited-content_cbyCitation_article-title">A General Way to Construct Arene-Fused Seven-Membered Nitrogen Heterocycles. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Organic Chemistry</span><span> <strong>2018,</strong> <em>2018 </em>
                                    (3)
                                     , 362-371. <a href="https://doi.org/10.1002/ejoc.201701642" title="DOI URL">https://doi.org/10.1002/ejoc.201701642</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ejoc.201701642&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fejoc.201701642%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DA%252BGeneral%252BWay%252Bto%252BConstruct%252BArene-Fused%252BSeven-Membered%252BNitrogen%252BHeterocycles%26aulast%3DBakulina%26aufirst%3DOlga%26date%3D2018%26date%3D2018%26volume%3D2018%26issue%3D3%26spage%3D362%26epage%3D371" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Andrés Ricardo  Pérez-Riera</span>, <span class="hlFld-ContribAuthor ">Raimundo  Barbosa-Barros</span>, <span class="hlFld-ContribAuthor ">Rodrigo  Daminello Raimundo</span>, <span class="hlFld-ContribAuthor ">Marianne Penachini  da Costa de Rezende Barbosa</span>, <span class="hlFld-ContribAuthor ">Isabel Cristina  Esposito Sorpreso</span>, <span class="hlFld-ContribAuthor ">Luiz Carlos  de Abreu</span>. </span><span class="cited-content_cbyCitation_article-title">The congenital long QT syndrome Type 3: An update. </span><span class="cited-content_cbyCitation_journal-name">Indian Pacing and Electrophysiology Journal</span><span> <strong>2018,</strong> <em>18 </em>
                                    (1)
                                     , 25-35. <a href="https://doi.org/10.1016/j.ipej.2017.10.011" title="DOI URL">https://doi.org/10.1016/j.ipej.2017.10.011</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ipej.2017.10.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ipej.2017.10.011%26sid%3Dliteratum%253Aachs%26jtitle%3DIndian%2520Pacing%2520and%2520Electrophysiology%2520Journal%26atitle%3DThe%252Bcongenital%252Blong%252BQT%252Bsyndrome%252BType%252B3%25253A%252BAn%252Bupdate%26aulast%3DP%25C3%25A9rez-Riera%26aufirst%3DAndr%25C3%25A9s%2BRicardo%26date%3D2018%26volume%3D18%26issue%3D1%26spage%3D25%26epage%3D35" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiao-Hong  Wei</span>, <span class="hlFld-ContribAuthor ">Shan-Dong  Yu</span>, <span class="hlFld-ContribAuthor ">Lu  Ren</span>, <span class="hlFld-ContribAuthor ">Si-Hui  Huang</span>, <span class="hlFld-ContribAuthor ">Qiao-Mei  Yang</span>, <span class="hlFld-ContribAuthor ">Ping  Wang</span>, <span class="hlFld-ContribAuthor ">Yan-Peng  Chu</span>, <span class="hlFld-ContribAuthor ">Wei  Yang</span>, <span class="hlFld-ContribAuthor ">Yan-Sheng  Ding</span>, <span class="hlFld-ContribAuthor ">Yong  Huo</span>, <span class="hlFld-ContribAuthor ">Lin  Wu</span>. </span><span class="cited-content_cbyCitation_article-title">Inhibition of late sodium current suppresses calcium-related ventricular arrhythmias by reducing the phosphorylation of CaMK-II and sodium channel expressions. </span><span class="cited-content_cbyCitation_journal-name">Scientific Reports</span><span> <strong>2017,</strong> <em>7 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41598-017-01056-0" title="DOI URL">https://doi.org/10.1038/s41598-017-01056-0</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41598-017-01056-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41598-017-01056-0%26sid%3Dliteratum%253Aachs%26jtitle%3DScientific%2520Reports%26atitle%3DInhibition%252Bof%252Blate%252Bsodium%252Bcurrent%252Bsuppresses%252Bcalcium-related%252Bventricular%252Barrhythmias%252Bby%252Breducing%252Bthe%252Bphosphorylation%252Bof%252BCaMK-II%252Band%252Bsodium%252Bchannel%252Bexpressions%26aulast%3DWei%26aufirst%3DXiao-Hong%26date%3D2017%26date%3D2017%26volume%3D7%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jordi  Heijman</span>, <span class="hlFld-ContribAuthor ">Shokoufeh  Ghezelbash</span>, <span class="hlFld-ContribAuthor ">Dobromir  Dobrev</span>. </span><span class="cited-content_cbyCitation_article-title">Investigational antiarrhythmic agents: promising drugs in early clinical development. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Investigational Drugs</span><span> <strong>2017,</strong> <em>26 </em>
                                    (8)
                                     , 897-907. <a href="https://doi.org/10.1080/13543784.2017.1353601" title="DOI URL">https://doi.org/10.1080/13543784.2017.1353601</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/13543784.2017.1353601&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F13543784.2017.1353601%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Investigational%2520Drugs%26atitle%3DInvestigational%252Bantiarrhythmic%252Bagents%25253A%252Bpromising%252Bdrugs%252Bin%252Bearly%252Bclinical%252Bdevelopment%26aulast%3DHeijman%26aufirst%3DJordi%26date%3D2017%26date%3D2017%26volume%3D26%26issue%3D8%26spage%3D897%26epage%3D907" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Philipp  Bengel</span>, <span class="hlFld-ContribAuthor ">Shakil  Ahmad</span>, <span class="hlFld-ContribAuthor ">Samuel  Sossalla</span>. </span><span class="cited-content_cbyCitation_article-title">Inhibition of Late Sodium Current as an Innovative Antiarrhythmic Strategy. </span><span class="cited-content_cbyCitation_journal-name">Current Heart Failure Reports</span><span> <strong>2017,</strong> <em>14 </em>
                                    (3)
                                     , 179-186. <a href="https://doi.org/10.1007/s11897-017-0333-0" title="DOI URL">https://doi.org/10.1007/s11897-017-0333-0</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11897-017-0333-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11897-017-0333-0%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Heart%2520Failure%2520Reports%26atitle%3DInhibition%252Bof%252BLate%252BSodium%252BCurrent%252Bas%252Ban%252BInnovative%252BAntiarrhythmic%252BStrategy%26aulast%3DBengel%26aufirst%3DPhilipp%26date%3D2017%26date%3D2017%26volume%3D14%26issue%3D3%26spage%3D179%26epage%3D186" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">A. John  Camm</span>. </span><span class="cited-content_cbyCitation_article-title">Hopes and disappointments with antiarrhythmic drugs. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Cardiology</span><span> <strong>2017,</strong> <em>237 </em>, 71-74. <a href="https://doi.org/10.1016/j.ijcard.2017.03.056" title="DOI URL">https://doi.org/10.1016/j.ijcard.2017.03.056</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ijcard.2017.03.056&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ijcard.2017.03.056%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Cardiology%26atitle%3DHopes%252Band%252Bdisappointments%252Bwith%252Bantiarrhythmic%252Bdrugs%26aulast%3DCamm%26aufirst%3DA.%2BJohn%26date%3D2017%26volume%3D237%26spage%3D71%26epage%3D74" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Adam G.  Meyer</span>, <span class="hlFld-ContribAuthor ">Alex C.  Bissember</span>, <span class="hlFld-ContribAuthor ">Christopher  Hyland</span>, <span class="hlFld-ContribAuthor ">Jason A.  Smith</span>, <span class="hlFld-ContribAuthor ">Charlotte C.  Williams</span>, <span class="hlFld-ContribAuthor ">Farzad  Zamani</span>, <span class="hlFld-ContribAuthor ">Steven-Alan G.  Abel</span>. </span><span class="cited-content_cbyCitation_article-title">Seven-Membered Rings. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 579-633. <a href="https://doi.org/10.1016/B978-0-08-102310-5.00016-3" title="DOI URL">https://doi.org/10.1016/B978-0-08-102310-5.00016-3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-08-102310-5.00016-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-08-102310-5.00016-3%26sid%3Dliteratum%253Aachs%26atitle%3DSeven-Membered%252BRings%26aulast%3DMeyer%26aufirst%3DAdam%2BG.%26date%3D2017%26spage%3D579%26epage%3D633%26pub%3DElsevier%26date%3D2017%26volume%3D29" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-19/acs.jmedchem.6b00939/20161007/images/medium/jm-2016-00939m_0019.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-19/acs.jmedchem.6b00939/20161007/images/large/jm-2016-00939m_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00939&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-19/acs.jmedchem.6b00939/20161007/images/medium/jm-2016-00939m_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-19/acs.jmedchem.6b00939/20161007/images/large/jm-2016-00939m_0002.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Gilead late sodium channel current (late <i>I</i><sub>Na</sub>) inhibitors progressed from <b>1</b> to a modified screening hit <b>2</b> with a narrow CNS margin, then to <b>3</b> with a wider CNS margin but a metabolic liability, followed by the development candidate <b>4</b> that meets all criteria.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-19/acs.jmedchem.6b00939/20161007/images/large/jm-2016-00939m_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00939&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-19/acs.jmedchem.6b00939/20161007/images/medium/jm-2016-00939m_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-19/acs.jmedchem.6b00939/20161007/images/large/jm-2016-00939m_0003.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Late sodium current (Late <i>I</i><sub>Na</sub>) in a control experiment (a) or enhanced with aid of 1 nM (b) or 3 nM (c) ATX-II.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-19/acs.jmedchem.6b00939/20161007/images/large/jm-2016-00939m_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00939&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-19/acs.jmedchem.6b00939/20161007/images/medium/jm-2016-00939m_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-19/acs.jmedchem.6b00939/20161007/images/large/jm-2016-00939m_0009.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Preparation of Benzotriazinone <b>15</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-19/acs.jmedchem.6b00939/20161007/images/large/jm-2016-00939m_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00939&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) NaN<sub>3</sub>, 2N aq HCl; (b) 4-CF<sub>3</sub>OC<sub>6</sub>H<sub>4</sub>B(OH)<sub>2</sub>, Pd(dppf)Cl<sub>2</sub>·CH<sub>2</sub>Cl<sub>2</sub>, K<sub>2</sub>CO<sub>3</sub>, toluene/<i>i</i>-PrOH/H<sub>2</sub>O; (c) 3-(chloromethyl)-5-cyclopropyl-1,3,4-oxadiazole, DMF, K<sub>2</sub>CO<sub>3</sub>, Et<sub>3</sub>N.</p></p></figure><figure data-id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-19/acs.jmedchem.6b00939/20161007/images/medium/jm-2016-00939m_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-19/acs.jmedchem.6b00939/20161007/images/large/jm-2016-00939m_0010.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Preparation of Quinazolin-4(3<i>H</i>)-one and Phthalazin-1(2<i>H</i>)-one Derivatives<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-19/acs.jmedchem.6b00939/20161007/images/large/jm-2016-00939m_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00939&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) R<sup>1</sup>PhB(OH)<sub>2</sub>, Pd(dppf)Cl<sub>2</sub>·CH<sub>2</sub>Cl<sub>2</sub>, NaHCO<sub>3</sub>, DMF; (b) R<sup>2</sup>-X, X = Cl or Br, NaH, DMF, 80 °C, 24 h.</p></p></figure><figure data-id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-19/acs.jmedchem.6b00939/20161007/images/medium/jm-2016-00939m_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-19/acs.jmedchem.6b00939/20161007/images/large/jm-2016-00939m_0011.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Preparation of Lactam Core Derivatives<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-19/acs.jmedchem.6b00939/20161007/images/large/jm-2016-00939m_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00939&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) NaN<sub>3</sub>, MeSO<sub>3</sub>H, 0 °C; (b) R<sup>1</sup>PhB(OH)<sub>2</sub>, Pd(dppf)Cl<sub>2</sub>·CH<sub>2</sub>Cl<sub>2</sub>, NaHCO<sub>3</sub>, DMF; (c) R<sup>2</sup>-X, X = Cl or Br, NaH, DMF, 80 °C, 24 h.</p></p></figure><figure data-id="sch4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-19/acs.jmedchem.6b00939/20161007/images/medium/jm-2016-00939m_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-19/acs.jmedchem.6b00939/20161007/images/large/jm-2016-00939m_0012.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Preparation of 3,4-Dihydrobenzo[<i>f</i>][1,4]oxazepin-5(2<i>H</i>)-one Derivatives<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-19/acs.jmedchem.6b00939/20161007/images/large/jm-2016-00939m_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00939&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) NaN<sub>3</sub>, MeSO<sub>3</sub>H, 0 °C; (b) R<sup>1</sup>PhB(OH)<sub>2</sub>, Pd(dppf)Cl<sub>2</sub>·CH<sub>2</sub>Cl<sub>2</sub>, NaHCO<sub>3</sub>, DMF; (c) R<sup>2</sup>-X, X = Cl or Br, NaH, DMF, 80 °C, 24 h.</p></p></figure><figure data-id="fig3" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-19/acs.jmedchem.6b00939/20161007/images/medium/jm-2016-00939m_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-19/acs.jmedchem.6b00939/20161007/images/large/jm-2016-00939m_0004.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Single crystal X-ray of <b>4</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-19/acs.jmedchem.6b00939/20161007/images/large/jm-2016-00939m_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00939&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-19/acs.jmedchem.6b00939/20161007/images/medium/jm-2016-00939m_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-19/acs.jmedchem.6b00939/20161007/images/large/jm-2016-00939m_0005.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Homology model of compound <b>4</b> bound to the inactivated state of Na<sub>v</sub>1.5. Protein surface is colored by residue type: green is hydrophobic, cyan is polar, blue is positively charged. The compound is suggested to bind with its biphenyl motif sandwiched between F1760 and Y1767, which define the lidocaine pocket. Its hydrophobic end (trifluoromethoxy) is directed toward the inactivation gate, while its polar end (pyrimidine) is directed toward the selectivity filter. Inset shows the full length model. Domain I is blue, domain II is green, domain III is yellow, and domain IV is pink. The inactivation gate linking domains III and IV is orange. The C-terminus is red. Compound <b>4</b> is seen to bind in the channel pore.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-19/acs.jmedchem.6b00939/20161007/images/large/jm-2016-00939m_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00939&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-19/acs.jmedchem.6b00939/20161007/images/medium/jm-2016-00939m_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-19/acs.jmedchem.6b00939/20161007/images/large/jm-2016-00939m_0006.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. LQT-3 model <b>4</b> (orange) vs <b>1</b> (red), ex vivo isolated heart IC<sub>50</sub> (rabbit).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-19/acs.jmedchem.6b00939/20161007/images/large/jm-2016-00939m_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00939&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-19/acs.jmedchem.6b00939/20161007/images/medium/jm-2016-00939m_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-19/acs.jmedchem.6b00939/20161007/images/large/jm-2016-00939m_0007.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Anti-ischemic effect of <b>1</b> versus <b>4</b> versus <b>20</b> in left anterior descending (LAD) coronary occlusion model (15 min, rabbit).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-19/acs.jmedchem.6b00939/20161007/images/large/jm-2016-00939m_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00939&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-19/acs.jmedchem.6b00939/20161007/images/medium/jm-2016-00939m_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-19/acs.jmedchem.6b00939/20161007/images/large/jm-2016-00939m_0008.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. <b>4</b> suppresses ischemia induced VT–VF arrhythmias recorded during 30 min of LCX ligation in anesthetized rabbits. Flecainide (class 1c antiarrhythmic) and mexiletine (class 1b antiarrhythmic, Supporting Information, <a href="/doi/suppl/10.1021/acs.jmedchem.6b00939/suppl_file/jm6b00939_si_001.pdf" class="ext-link">Figure 2</a>) induce VT–VF and mortality at clinical exposures.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-19/acs.jmedchem.6b00939/20161007/images/large/jm-2016-00939m_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00939&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i40">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_12210" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_12210" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 29 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Fang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaw, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keenan, N. L.</span><span> </span><span class="NLM_article-title">Prevalence of coronary heart disease-United States, 2006–2010</span> <span class="citation_source-journal">MMWR Morb. Mortal. Wkly. Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">1377</span><span class="NLM_x">–</span> <span class="NLM_lpage">1381</span><span class="refDoi"> DOI: 10.15585/mmwr.mm6040a1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00939&amp;key=10.15585%2Fmmwr.mm6040a1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00939&amp;key=21993341" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2011&pages=1377-1381&author=J.+Fangauthor=K.+M.+Shawauthor=N.+L.+Keenan&title=Prevalence+of+coronary+heart+disease-United+States%2C+2006%E2%80%932010&doi=10.15585%2Fmmwr.mm6040a1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.15585%2Fmmwr.mm6040a1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.15585%252Fmmwr.mm6040a1%26sid%3Dliteratum%253Aachs%26aulast%3DFang%26aufirst%3DJ.%26aulast%3DShaw%26aufirst%3DK.%2BM.%26aulast%3DKeenan%26aufirst%3DN.%2BL.%26atitle%3DPrevalence%2520of%2520coronary%2520heart%2520disease-United%2520States%252C%25202006%25E2%2580%25932010%26jtitle%3DMMWR%2520Morb.%2520Mortal.%2520Wkly.%2520Rep.%26date%3D2011%26volume%3D60%26spage%3D1377%26epage%3D1381%26doi%3D10.15585%2Fmmwr.mm6040a1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Kochanek, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minin, A. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kung, H. C.</span><span> </span><span class="NLM_article-title">Deaths: preliminary data for 2010</span> <span class="citation_source-journal">National Vital Statistics Report</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">52</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2012&pages=1-52&author=K.+D.+Kochanekauthor=J.+Xuauthor=S.+L.+Murphyauthor=A.+O.+Mininauthor=H.+C.+Kung&title=Deaths%3A+preliminary+data+for+2010"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKochanek%26aufirst%3DK.%2BD.%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DMurphy%26aufirst%3DS.%2BL.%26aulast%3DMinin%26aufirst%3DA.%2BO.%26aulast%3DKung%26aufirst%3DH.%2BC.%26atitle%3DDeaths%253A%2520preliminary%2520data%2520for%25202010%26jtitle%3DNational%2520Vital%2520Statistics%2520Report%26date%3D2012%26volume%3D60%26spage%3D1%26epage%3D52" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Banon, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Filion, K. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Budlovsky, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franck, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eisenberg, M. J.</span><span> </span><span class="NLM_article-title">The usefulness of ranolazine for the treatment of refractory chronic stable angina pectoris as determined from a systematic review of randomized controlled trials</span> <span class="citation_source-journal">Am. J. Cardiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">113</span><span class="NLM_x">, </span> <span class="NLM_fpage">1075</span><span class="NLM_x">–</span> <span class="NLM_lpage">1082</span><span class="refDoi"> DOI: 10.1016/j.amjcard.2013.11.070</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00939&amp;key=10.1016%2Fj.amjcard.2013.11.070" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=2014&pages=1075-1082&author=D.+Banonauthor=K.+B.+Filionauthor=T.+Budlovskyauthor=C.+Franckauthor=M.+J.+Eisenberg&title=The+usefulness+of+ranolazine+for+the+treatment+of+refractory+chronic+stable+angina+pectoris+as+determined+from+a+systematic+review+of+randomized+controlled+trials&doi=10.1016%2Fj.amjcard.2013.11.070"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2Fj.amjcard.2013.11.070&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.amjcard.2013.11.070%26sid%3Dliteratum%253Aachs%26aulast%3DBanon%26aufirst%3DD.%26aulast%3DFilion%26aufirst%3DK.%2BB.%26aulast%3DBudlovsky%26aufirst%3DT.%26aulast%3DFranck%26aufirst%3DC.%26aulast%3DEisenberg%26aufirst%3DM.%2BJ.%26atitle%3DThe%2520usefulness%2520of%2520ranolazine%2520for%2520the%2520treatment%2520of%2520refractory%2520chronic%2520stable%2520angina%2520pectoris%2520as%2520determined%2520from%2520a%2520systematic%2520review%2520of%2520randomized%2520controlled%2520trials%26jtitle%3DAm.%2520J.%2520Cardiol.%26date%3D2014%26volume%3D113%26spage%3D1075%26epage%3D1082%26doi%3D10.1016%2Fj.amjcard.2013.11.070" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Zaza, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belardinelli, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shryock, J. C.</span><span> </span><span class="NLM_article-title">Pathophysiology and pharmacology of the cardiac ″late sodium current.</span> <span class="citation_source-journal">Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">119</span><span class="NLM_x">, </span> <span class="NLM_fpage">326</span><span class="NLM_x">–</span> <span class="NLM_lpage">339</span><span class="refDoi"> DOI: 10.1016/j.pharmthera.2008.06.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00939&amp;key=10.1016%2Fj.pharmthera.2008.06.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00939&amp;key=18662720" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00939&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVyltbnO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=119&publication_year=2008&pages=326-339&author=A.+Zazaauthor=L.+Belardinelliauthor=J.+C.+Shryock&title=Pathophysiology+and+pharmacology+of+the+cardiac+%E2%80%B3late+sodium+current.&doi=10.1016%2Fj.pharmthera.2008.06.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Pathophysiology and pharmacology of the cardiac "late sodium current"</span></div><div class="casAuthors">Zaza, Antonio; Belardinelli, Luiz; Shryock, John C.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">119</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">326-339</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  The "late sodium current" (I NaL) is a sustained component of the fast Na+ current of cardiac myocytes and neurons.  As recently appreciated, common neurol. and cardiac conditions are assocd. with abnormal I NaL enhancement, which may contribute to the pathogenesis of both elec. and contractile dysfunction.  For this reason, I NaL has become an appealing pharmacol. target, with a potentially broad range of therapeutic indications.  The recent approval by the FDA of an I NaL blocker (ranolazine) for clin. use justifies the increased interest in I NaL as a pathogenic mechanism and the rapid evolution of the information concerning it.  The review focuses on cardiac aspects of I NaL enhancement; it deals with the origin of I NaL, with its pathophysiol. role and with the consequences of its pharmacol. modulation.  Both basic aspects and clin. evidence are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojuv5I4Jg4B7Vg90H21EOLACvtfcHk0lh5pd3KTlFRAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVyltbnO&md5=f9fd0198886a5b76684eaa8de51e80e1</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2008.06.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2008.06.001%26sid%3Dliteratum%253Aachs%26aulast%3DZaza%26aufirst%3DA.%26aulast%3DBelardinelli%26aufirst%3DL.%26aulast%3DShryock%26aufirst%3DJ.%2BC.%26atitle%3DPathophysiology%2520and%2520pharmacology%2520of%2520the%2520cardiac%2520%25E2%2580%25B3late%2520sodium%2520current.%26jtitle%3DPharmacol.%2520Ther.%26date%3D2008%26volume%3D119%26spage%3D326%26epage%3D339%26doi%3D10.1016%2Fj.pharmthera.2008.06.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Le Grand, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vie, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Talmant, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coraboeuf, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">John, G. W.</span><span> </span><span class="NLM_article-title">Alleviation of contractile dysfunction in ischemic hearts by slowly inactivating Na+ current blockers</span> <span class="citation_source-journal">Am. J. Physiol.: Heart Circ. Physiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">269</span><span class="NLM_x">, </span> <span class="NLM_fpage">H533</span><span class="NLM_x">–</span> <span class="NLM_lpage">H540</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=269&publication_year=1995&pages=H533-H540&author=B.+Le+Grandauthor=B.+Vieauthor=J.+Talmantauthor=E.+Coraboeufauthor=G.+W.+John&title=Alleviation+of+contractile+dysfunction+in+ischemic+hearts+by+slowly+inactivating+Na%2B+current+blockers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLe%2BGrand%26aufirst%3DB.%26aulast%3DVie%26aufirst%3DB.%26aulast%3DTalmant%26aufirst%3DJ.%26aulast%3DCoraboeuf%26aufirst%3DE.%26aulast%3DJohn%26aufirst%3DG.%2BW.%26atitle%3DAlleviation%2520of%2520contractile%2520dysfunction%2520in%2520ischemic%2520hearts%2520by%2520slowly%2520inactivating%2520Na%252B%2520current%2520blockers%26jtitle%3DAm.%2520J.%2520Physiol.%253A%2520Heart%2520Circ.%2520Physiol.%26date%3D1995%26volume%3D269%26spage%3DH533%26epage%3DH540" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Antzelevitch, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belardinelli, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zygmunt, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burashnikov, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Diego, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fish, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cordeiro, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, G.</span><span> </span><span class="NLM_article-title">Electrophysiological effects of ranolazine, a novel antianginal agent with antiarrhythmic properties</span> <span class="citation_source-journal">Circulation</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">110</span><span class="NLM_x">, </span> <span class="NLM_fpage">904</span><span class="NLM_x">–</span> <span class="NLM_lpage">910</span><span class="refDoi"> DOI: 10.1161/01.CIR.0000139333.83620.5D</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00939&amp;key=10.1161%2F01.CIR.0000139333.83620.5D" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2004&pages=904-910&author=C.+Antzelevitchauthor=L.+Belardinelliauthor=A.+C.+Zygmuntauthor=A.+Burashnikovauthor=J.+M.+Di+Diegoauthor=J.+M.+Fishauthor=J.+M.+Cordeiroauthor=G.+Thomas&title=Electrophysiological+effects+of+ranolazine%2C+a+novel+antianginal+agent+with+antiarrhythmic+properties&doi=10.1161%2F01.CIR.0000139333.83620.5D"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1161%2F01.CIR.0000139333.83620.5D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252F01.CIR.0000139333.83620.5D%26sid%3Dliteratum%253Aachs%26aulast%3DAntzelevitch%26aufirst%3DC.%26aulast%3DBelardinelli%26aufirst%3DL.%26aulast%3DZygmunt%26aufirst%3DA.%2BC.%26aulast%3DBurashnikov%26aufirst%3DA.%26aulast%3DDi%2BDiego%26aufirst%3DJ.%2BM.%26aulast%3DFish%26aufirst%3DJ.%2BM.%26aulast%3DCordeiro%26aufirst%3DJ.%2BM.%26aulast%3DThomas%26aufirst%3DG.%26atitle%3DElectrophysiological%2520effects%2520of%2520ranolazine%252C%2520a%2520novel%2520antianginal%2520agent%2520with%2520antiarrhythmic%2520properties%26jtitle%3DCirculation%26date%3D2004%26volume%3D110%26spage%3D904%26epage%3D910%26doi%3D10.1161%2F01.CIR.0000139333.83620.5D" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Chaitman, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skettino, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, J. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanley, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meluzin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuch, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pepine, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nelson, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hebert, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolff, A. A.</span><span> </span><span class="NLM_article-title">Anti-ischemic effects and long-term survival during ranolazine monotherapy in patients with chronic severe angina</span> <span class="citation_source-journal">J. Am. Coll. Cardiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">1375</span><span class="NLM_x">–</span> <span class="NLM_lpage">1382</span><span class="refDoi"> DOI: 10.1016/j.jacc.2003.11.045</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00939&amp;key=10.1016%2Fj.jacc.2003.11.045" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00939&amp;key=15093870" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00939&amp;key=1%3ACAS%3A528%3ADC%252BD2cXkt1Wksr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2004&pages=1375-1382&author=B.+R.+Chaitmanauthor=S.+L.+Skettinoauthor=J.+O.+Parkerauthor=P.+Hanleyauthor=J.+Meluzinauthor=J.+Kuchauthor=C.+J.+Pepineauthor=W.+Wangauthor=J.+J.+Nelsonauthor=D.+A.+Hebertauthor=A.+A.+Wolff&title=Anti-ischemic+effects+and+long-term+survival+during+ranolazine+monotherapy+in+patients+with+chronic+severe+angina&doi=10.1016%2Fj.jacc.2003.11.045"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Anti-ischemic effects and long-term survival during ranolazine monotherapy in patients with chronic severe angina</span></div><div class="casAuthors">Chaitman, Bernard R.; Skettino, Sandra L.; Parker, John O.; Hanley, Peter; Meluzin, Jaroslav; Kuch, Jerzy; Pepine, Carl J.; Wang, Whedy; Nelson, Jeanenne J.; Hebert, David A.; Wolff, Andrew A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American College of Cardiology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1375-1382</span>CODEN:
                <span class="NLM_cas:coden">JACCDI</span>;
        ISSN:<span class="NLM_cas:issn">0735-1097</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">The primary objective of the Monotherapy Assessment of Ranolazine In Stable Angina (MARISA) trial was to det. the dose-response relationship of ranolazine, a potentially new anti-anginal compd., on symptom-limited exercise duration.  Fatty acids rise precipitously in response to stress, including acute myocardial ischemia.  Ranolazine is believed to partially inhibit fatty acid oxidn., shift metab. toward carbohydrate oxidn., and increase the efficiency of oxygen use.  Patients (n = 191) with angina-limited exercise discontinued anti-anginal medications and were randomized into a double-blind four-period crossover study of sustained-release ranolazine 500, 1,000, or 1,500 mg, or placebo, each administered twice daily for one week.  Exercise testing was performed at the end of each treatment during both trough and peak ranolazine plasma concns.  Exercise duration at trough increased with ranolazine 500, 1,000, and 1,500 mg twice daily by 94, 103, and 116 s, resp., all greater (p < 0.005) than the 70-s increase on placebo.  Dose-related increases in exercise duration at peak and in times to 1 mm ST-segment depression at trough and peak and to angina at trough and peak were also demonstrated (all p < 0.005).  Ranolazine had negligible effects on heart rate and blood pressure.  One year survival rate combining data from the MARISA trial and its open-label follow-on study was 96.3 ± 1.7%.  In chronic angina patients, ranolazine monotherapy was well tolerated and increased exercise performance throughout its dosing interval at all doses studied without clin. meaningful hemodynamic effects.  One-year survival was not lower than expected in this high-risk patient population.  This metabolic approach to treating myocardial ischemia may offer a new therapeutic option for chronic angina patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoug0GtwKfosrVg90H21EOLACvtfcHk0lhFsTN0oaTUxQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXkt1Wksr4%253D&md5=507feda3da676474b0ea489837bd2a38</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fj.jacc.2003.11.045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jacc.2003.11.045%26sid%3Dliteratum%253Aachs%26aulast%3DChaitman%26aufirst%3DB.%2BR.%26aulast%3DSkettino%26aufirst%3DS.%2BL.%26aulast%3DParker%26aufirst%3DJ.%2BO.%26aulast%3DHanley%26aufirst%3DP.%26aulast%3DMeluzin%26aufirst%3DJ.%26aulast%3DKuch%26aufirst%3DJ.%26aulast%3DPepine%26aufirst%3DC.%2BJ.%26aulast%3DWang%26aufirst%3DW.%26aulast%3DNelson%26aufirst%3DJ.%2BJ.%26aulast%3DHebert%26aufirst%3DD.%2BA.%26aulast%3DWolff%26aufirst%3DA.%2BA.%26atitle%3DAnti-ischemic%2520effects%2520and%2520long-term%2520survival%2520during%2520ranolazine%2520monotherapy%2520in%2520patients%2520with%2520chronic%2520severe%2520angina%26jtitle%3DJ.%2520Am.%2520Coll.%2520Cardiol.%26date%3D2004%26volume%3D43%26spage%3D1375%26epage%3D1382%26doi%3D10.1016%2Fj.jacc.2003.11.045" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Fredj, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sampson, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kass, R. S.</span><span> </span><span class="NLM_article-title">Molecular basis of ranolazine block of LQT-3 mutant sodium channels: evidence for site of action</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">148</span><span class="NLM_x">, </span> <span class="NLM_fpage">16</span><span class="NLM_x">–</span> <span class="NLM_lpage">24</span><span class="refDoi"> DOI: 10.1038/sj.bjp.0706709</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00939&amp;key=10.1038%2Fsj.bjp.0706709" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00939&amp;key=16520744" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00939&amp;key=1%3ACAS%3A528%3ADC%252BD28XjvF2lt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=148&publication_year=2006&pages=16-24&author=S.+Fredjauthor=K.+J.+Sampsonauthor=H.+Liuauthor=R.+S.+Kass&title=Molecular+basis+of+ranolazine+block+of+LQT-3+mutant+sodium+channels%3A+evidence+for+site+of+action&doi=10.1038%2Fsj.bjp.0706709"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular basis of ranolazine block of LQT-3 mutant sodium channels: evidence for site of action</span></div><div class="casAuthors">Fredj, Sandra; Sampson, Kevin J.; Liu, Huajun; Kass, Robert S.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">148</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">16-24</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">We studied the effects of ranolazine, an antianginal agent with promise as an antiarrhythmic drug, on wild-type (WT) and long QT syndrome variant 3 (LQT-3) mutant Na+ channels expressed in human embryonic kidney (HEK) 293 cells and knock-in mouse cardiomyocytes and used site-directed mutagenesis to probe the site of action of the drug.  We find preferential ranolazine block of sustained vs peak Na+ channel current for LQT-3 mutant (ΔKPQ and Y1795C) channels (IC50=15 vs 135 μM) with similar results obtained in HEK 293 cells and knock-in myocytes.  Ranolazine block of both peak and sustained Na+ channel current is significantly reduced by mutation (F1760A) of a single residue previously shown to contribute critically to the binding site for local anesthetic (LA) mols. in the Na+ channel.  Ranolazine significantly decreases action potential duration (APD) at 50 and 90% repolarization by 23±5 and 27±3%, resp., in ΔKPQ mouse ventricular myocytes but has little effect on APD of WT myocytes.  Computational modeling of human cardiac myocyte elec. activity that incorporates our voltage-clamp data predicts marked ranolazine-induced APD shortening in cells expressing LQT-3 mutant channels.  Our results demonstrate for the first time the utility of ranolazine as a blocker of sustained Na+ channel activity induced by inherited mutations that cause human disease and further, that these effects are very likely due to interactions of ranolazine with the receptor site for LA mols. in the sodium channel.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpaWhoeH51HkbVg90H21EOLACvtfcHk0lhFsTN0oaTUxQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XjvF2lt74%253D&md5=1ce122373fe4cc948d6b4361b3f5301c</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0706709&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0706709%26sid%3Dliteratum%253Aachs%26aulast%3DFredj%26aufirst%3DS.%26aulast%3DSampson%26aufirst%3DK.%2BJ.%26aulast%3DLiu%26aufirst%3DH.%26aulast%3DKass%26aufirst%3DR.%2BS.%26atitle%3DMolecular%2520basis%2520of%2520ranolazine%2520block%2520of%2520LQT-3%2520mutant%2520sodium%2520channels%253A%2520evidence%2520for%2520site%2520of%2520action%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2006%26volume%3D148%26spage%3D16%26epage%3D24%26doi%3D10.1038%2Fsj.bjp.0706709" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Catteral, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldin, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waxman, S. G.</span><span> </span><span class="NLM_article-title">International union of pharmacology. XLVII. nomenclature and structure-function relationships of voltage-gated sodium channels</span> <span class="citation_source-journal">Pharmacol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">397</span><span class="NLM_x">–</span> <span class="NLM_lpage">409</span><span class="refDoi"> DOI: 10.1124/pr.57.4.4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00939&amp;key=10.1124%2Fpr.57.4.4" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2005&pages=397-409&author=W.+A.+Catteralauthor=A.+L.+Goldinauthor=S.+G.+Waxman&title=International+union+of+pharmacology.+XLVII.+nomenclature+and+structure-function+relationships+of+voltage-gated+sodium+channels&doi=10.1124%2Fpr.57.4.4"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1124%2Fpr.57.4.4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fpr.57.4.4%26sid%3Dliteratum%253Aachs%26aulast%3DCatteral%26aufirst%3DW.%2BA.%26aulast%3DGoldin%26aufirst%3DA.%2BL.%26aulast%3DWaxman%26aufirst%3DS.%2BG.%26atitle%3DInternational%2520union%2520of%2520pharmacology.%2520XLVII.%2520nomenclature%2520and%2520structure-function%2520relationships%2520of%2520voltage-gated%2520sodium%2520channels%26jtitle%3DPharmacol.%2520Rev.%26date%3D2005%26volume%3D57%26spage%3D397%26epage%3D409%26doi%3D10.1124%2Fpr.57.4.4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Abelman, M.; Elzein, E.; Jiang, R.; Kalla, R.; Kobayashi, T.; Li, X.; Perry, T.</span><span> </span><span class="NLM_article-title">Fused heterocyclic compounds as ion channel modulators</span>. WO2010056527, May 20,<span class="NLM_x"> </span><span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=M.+Abelman&author=E.+Elzein&author=R.+Jiang&author=R.+Kalla&author=T.+Kobayashi&author=X.+Li&author=T.+Perry&title=Fused+heterocyclic+compounds+as+ion+channel+modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAbelman%26aufirst%3DM.%26atitle%3DFused%2520heterocyclic%2520compounds%2520as%2520ion%2520channel%2520modulators%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Koltun, D. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parkhill, E. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elzein, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobayashi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Notte, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalla, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perry, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Avila, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, W. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith-Maxwell, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dhalla, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rajamani, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shryock, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mollova, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stafford, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belardinelli, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zablocki, J. A.</span><span> </span><span class="NLM_article-title">Discovery of triazolopyridine GS-458967, a late sodium current inhibitor (Late INai) of the cardiac NaV 1.5 channel with improved efficacy and potency relative to ranolazine</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">3202</span><span class="NLM_x">–</span> <span class="NLM_lpage">3206</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2016.03.101</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00939&amp;key=10.1016%2Fj.bmcl.2016.03.101" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=3202-3206&author=D.+O.+Koltunauthor=E.+Q.+Parkhillauthor=E.+Elzeinauthor=T.+Kobayashiauthor=G.+Notteauthor=R.+H.+Jiangauthor=R.+Kallaauthor=X.+Liauthor=T.+Perryauthor=B.+Avilaauthor=W.+Q.+Wangauthor=C.+Smith-Maxwellauthor=A.+K.+Dhallaauthor=S.+Rajamaniauthor=J.+Shryockauthor=N.+Mollovaauthor=B.+Staffordauthor=J.+Tangauthor=L.+Belardinelliauthor=J.+A.+Zablocki&title=Discovery+of+triazolopyridine+GS-458967%2C+a+late+sodium+current+inhibitor+%28Late+INai%29+of+the+cardiac+NaV+1.5+channel+with+improved+efficacy+and+potency+relative+to+ranolazine&doi=10.1016%2Fj.bmcl.2016.03.101"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2016.03.101&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2016.03.101%26sid%3Dliteratum%253Aachs%26aulast%3DKoltun%26aufirst%3DD.%2BO.%26aulast%3DParkhill%26aufirst%3DE.%2BQ.%26aulast%3DElzein%26aufirst%3DE.%26aulast%3DKobayashi%26aufirst%3DT.%26aulast%3DNotte%26aufirst%3DG.%26aulast%3DJiang%26aufirst%3DR.%2BH.%26aulast%3DKalla%26aufirst%3DR.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DPerry%26aufirst%3DT.%26aulast%3DAvila%26aufirst%3DB.%26aulast%3DWang%26aufirst%3DW.%2BQ.%26aulast%3DSmith-Maxwell%26aufirst%3DC.%26aulast%3DDhalla%26aufirst%3DA.%2BK.%26aulast%3DRajamani%26aufirst%3DS.%26aulast%3DShryock%26aufirst%3DJ.%26aulast%3DMollova%26aufirst%3DN.%26aulast%3DStafford%26aufirst%3DB.%26aulast%3DTang%26aufirst%3DJ.%26aulast%3DBelardinelli%26aufirst%3DL.%26aulast%3DZablocki%26aufirst%3DJ.%2BA.%26atitle%3DDiscovery%2520of%2520triazolopyridine%2520GS-458967%252C%2520a%2520late%2520sodium%2520current%2520inhibitor%2520%2528Late%2520INai%2529%2520of%2520the%2520cardiac%2520NaV%25201.5%2520channel%2520with%2520improved%2520efficacy%2520and%2520potency%2520relative%2520to%2520ranolazine%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D26%26spage%3D3202%26epage%3D3206%26doi%3D10.1016%2Fj.bmcl.2016.03.101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Kobayashi, T.; Koltun, D.; Notte, G.; Parkhill, E.; Zablocki, J.</span><span> </span><span class="NLM_article-title">Fused heterocyclic compounds as ion channel modulators</span>. WO 2012/003392, January 5,<span class="NLM_x"> </span><span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=T.+Kobayashi&author=D.+Koltun&author=G.+Notte&author=E.+Parkhill&author=J.+Zablocki&title=Fused+heterocyclic+compounds+as+ion+channel+modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DKobayashi%26aufirst%3DT.%26atitle%3DFused%2520heterocyclic%2520compounds%2520as%2520ion%2520channel%2520modulators%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Koltun, D. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parkhill, E. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elzein, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobayashi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perry, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Avila, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, W. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirakawa, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith-Maxwell, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dhalla, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rajamani, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mollova, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stafford, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belardinelli, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zablocki, J. A.</span><span> </span><span class="NLM_article-title">Discovery of triazolopyridinone GS-462808, a late sodium current inhibitor (Late INai) of the cardiac Na<sub>v</sub>1.5 channel with improved efficacy and potency relative to ranolazine</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">3207</span><span class="NLM_x">–</span> <span class="NLM_lpage">3211</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2016.03.096</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00939&amp;key=10.1016%2Fj.bmcl.2016.03.096" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=3207-3211&author=D.+O.+Koltunauthor=E.+Q.+Parkhillauthor=E.+Elzeinauthor=T.+Kobayashiauthor=R.+H.+Jiangauthor=X.+Liauthor=T.+D.+Perryauthor=B.+Avilaauthor=W.+Q.+Wangauthor=R.+Hirakawaauthor=C.+Smith-Maxwellauthor=L.+Wuauthor=A.+D.+Dhallaauthor=S.+Rajamaniauthor=N.+Mollovaauthor=B.+Staffordauthor=J.+Tangauthor=L.+Belardinelliauthor=J.+A.+Zablocki&title=Discovery+of+triazolopyridinone+GS-462808%2C+a+late+sodium+current+inhibitor+%28Late+INai%29+of+the+cardiac+Nav1.5+channel+with+improved+efficacy+and+potency+relative+to+ranolazine&doi=10.1016%2Fj.bmcl.2016.03.096"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2016.03.096&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2016.03.096%26sid%3Dliteratum%253Aachs%26aulast%3DKoltun%26aufirst%3DD.%2BO.%26aulast%3DParkhill%26aufirst%3DE.%2BQ.%26aulast%3DElzein%26aufirst%3DE.%26aulast%3DKobayashi%26aufirst%3DT.%26aulast%3DJiang%26aufirst%3DR.%2BH.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DPerry%26aufirst%3DT.%2BD.%26aulast%3DAvila%26aufirst%3DB.%26aulast%3DWang%26aufirst%3DW.%2BQ.%26aulast%3DHirakawa%26aufirst%3DR.%26aulast%3DSmith-Maxwell%26aufirst%3DC.%26aulast%3DWu%26aufirst%3DL.%26aulast%3DDhalla%26aufirst%3DA.%2BD.%26aulast%3DRajamani%26aufirst%3DS.%26aulast%3DMollova%26aufirst%3DN.%26aulast%3DStafford%26aufirst%3DB.%26aulast%3DTang%26aufirst%3DJ.%26aulast%3DBelardinelli%26aufirst%3DL.%26aulast%3DZablocki%26aufirst%3DJ.%2BA.%26atitle%3DDiscovery%2520of%2520triazolopyridinone%2520GS-462808%252C%2520a%2520late%2520sodium%2520current%2520inhibitor%2520%2528Late%2520INai%2529%2520of%2520the%2520cardiac%2520Nav1.5%2520channel%2520with%2520improved%2520efficacy%2520and%2520potency%2520relative%2520to%2520ranolazine%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D26%26spage%3D3207%26epage%3D3211%26doi%3D10.1016%2Fj.bmcl.2016.03.096" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Belardinelli, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith-Maxwell, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, W. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">El-Bizri, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirakawa, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karpinski, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crumb, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koltun, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zablocki, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dhalla, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rajamani, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shryock, J. C.</span><span> </span><span class="NLM_article-title">A novel, potent, and selective inhibitor of cardiac late sodium current suppresses experimental arrhythmias</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">344</span><span class="NLM_x">, </span> <span class="NLM_fpage">23</span><span class="NLM_x">–</span> <span class="NLM_lpage">32</span><span class="refDoi"> DOI: 10.1124/jpet.112.198887</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00939&amp;key=10.1124%2Fjpet.112.198887" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00939&amp;key=23010360" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00939&amp;key=1%3ACAS%3A528%3ADC%252BC3sXms1Cluw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=344&publication_year=2013&pages=23-32&author=L.+Belardinelliauthor=G.+Liuauthor=C.+Smith-Maxwellauthor=W.+Q.+Wangauthor=N.+El-Bizriauthor=R.+Hirakawaauthor=S.+Karpinskiauthor=C.+H.+Liauthor=L.+Huauthor=X.+J.+Liauthor=W.+Crumbauthor=L.+Wuauthor=D.+Koltunauthor=J.+Zablockiauthor=L.+Yaoauthor=A.+K.+Dhallaauthor=S.+Rajamaniauthor=J.+C.+Shryock&title=A+novel%2C+potent%2C+and+selective+inhibitor+of+cardiac+late+sodium+current+suppresses+experimental+arrhythmias&doi=10.1124%2Fjpet.112.198887"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">A novel, potent, and selective inhibitor of cardiac late sodium current suppresses experimental arrhythmias</span></div><div class="casAuthors">Belardinelli, Luiz; Liu, Gongxin; Smith-Maxwell, Cathy; Wang, Wei-Qun; El-Bizri, Nesrine; Hirakawa, Ryoko; Karpinski, Serge; Li, Cindy Hong; Hu, Lufei; Li, Xiao-Jun; Crumb, William; Wu, Lin; Koltun, Dmitry; Zablocki, Jeff; Yao, Lina; Dhalla, Arvinder K.; Rajamani, Sridharan; Shryock, John C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">344</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">23-32</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Inhibition of cardiac late sodium current (late INa) is a strategy to suppress arrhythmias and sodium-dependent calcium overload assocd. with myocardial ischemia and heart failure.  Current inhibitors of late INa are unselective and can be proarrhythmic.  This study introduces GS967 (6-[4-(trifluoromethoxy)phenyl]-3-(trifluoromethyl)-[1,2,4]triazolo[4,3-a]pyridine), a potent and selective inhibitor of late INa, and demonstrates its effectiveness to suppress ventricular arrhythmias.  The effects of GS967 on rabbit ventricular myocyte ion channel currents and action potentials were detd.  Anti-arrhythmic actions of GS967 were characterized in ex vivo and in vivo rabbit models of reduced repolarization reserve and ischemia.  GS967 inhibited Anemonia sulcata toxin II (ATX-II)-induced late INa in ventricular myocytes and isolated hearts with IC50 values of 0.13 and 0.21 μM, resp.  Redn. of peak INa by GS967 was minimal at a holding potential of -120 mV but increased at -80 mV.  GS967 did not prolong action potential duration or the QRS interval.  GS967 prevented and reversed proarrhythmic effects (after-depolarizations and torsades de pointes) of the late INa enhancer ATX-II and the IKr inhibitor E-4031 in isolated ventricular myocytes and hearts.  GS967 significantly attenuated the proarrhythmic effects of methoxamine + clofilium and suppressed ischemia-induced arrhythmias.  GS967 was more potent and effective to reduce late INa and arrhythmias than either flecainide or ranolazine.  Results of all studies and assays of binding and activity of GS967 at numerous receptors, transporters, and enzymes indicated that GS967 selectively inhibited late INa.  In summary, GS967 selectively suppressed late INa and prevented and/or reduced the incidence of exptl. induced arrhythmias in rabbit myocytes and hearts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYy-fqILCzlrVg90H21EOLACvtfcHk0lgCEhG4HECUvw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXms1Cluw%253D%253D&md5=40b1168a154190ef13ca312e473be7e2</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1124%2Fjpet.112.198887&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.112.198887%26sid%3Dliteratum%253Aachs%26aulast%3DBelardinelli%26aufirst%3DL.%26aulast%3DLiu%26aufirst%3DG.%26aulast%3DSmith-Maxwell%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DW.%2BQ.%26aulast%3DEl-Bizri%26aufirst%3DN.%26aulast%3DHirakawa%26aufirst%3DR.%26aulast%3DKarpinski%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DC.%2BH.%26aulast%3DHu%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DX.%2BJ.%26aulast%3DCrumb%26aufirst%3DW.%26aulast%3DWu%26aufirst%3DL.%26aulast%3DKoltun%26aufirst%3DD.%26aulast%3DZablocki%26aufirst%3DJ.%26aulast%3DYao%26aufirst%3DL.%26aulast%3DDhalla%26aufirst%3DA.%2BK.%26aulast%3DRajamani%26aufirst%3DS.%26aulast%3DShryock%26aufirst%3DJ.%2BC.%26atitle%3DA%2520novel%252C%2520potent%252C%2520and%2520selective%2520inhibitor%2520of%2520cardiac%2520late%2520sodium%2520current%2520suppresses%2520experimental%2520arrhythmias%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2013%26volume%3D344%26spage%3D23%26epage%3D32%26doi%3D10.1124%2Fjpet.112.198887" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Corkey, B. K.; Elzein, E.; Jiang, R. H.; Kalla, R. V.; Koltun, D.; Li, X.; Martinez, R.; Parkhill, E. Q.; Perry, T.; Zablocki, J.; Venkataramani, C.; Graupe, M.; Guerrero, J.</span><span> </span><span class="NLM_article-title">Fused benzoxazepinones as ion channel modulators</span>. WO 2013/006485, January 10,<span class="NLM_x"> </span><span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=B.+K.+Corkey&author=E.+Elzein&author=R.+H.+Jiang&author=R.+V.+Kalla&author=D.+Koltun&author=X.+Li&author=R.+Martinez&author=E.+Q.+Parkhill&author=T.+Perry&author=J.+Zablocki&author=C.+Venkataramani&author=M.+Graupe&author=J.+Guerrero&title=Fused+benzoxazepinones+as+ion+channel+modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCorkey%26aufirst%3DB.%2BK.%26atitle%3DFused%2520benzoxazepinones%2520as%2520ion%2520channel%2520modulators%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Corkey, B. K.; Elzein, E.; Jiang, R. H.; Kalla, R. V.; Koltun, D.; Li, X.; Martinez, R.; Parkhill, E. Q.; Perry, T.; Zablocki, J.; Venkataramani, C.; Graupe, M.; Guerrero, J.</span><span> </span><span class="NLM_article-title">Fused heterocyclic compounds as sodium channel modulators</span>. WO 2012/154760, November 15,<span class="NLM_x"> </span><span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=B.+K.+Corkey&author=E.+Elzein&author=R.+H.+Jiang&author=R.+V.+Kalla&author=D.+Koltun&author=X.+Li&author=R.+Martinez&author=E.+Q.+Parkhill&author=T.+Perry&author=J.+Zablocki&author=C.+Venkataramani&author=M.+Graupe&author=J.+Guerrero&title=Fused+heterocyclic+compounds+as+sodium+channel+modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCorkey%26aufirst%3DB.%2BK.%26atitle%3DFused%2520heterocyclic%2520compounds%2520as%2520sodium%2520channel%2520modulators%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Smart, B. E.</span><span> </span><span class="NLM_article-title">Fluorine substituent effects (on bioactivity)</span> <span class="citation_source-journal">J. Fluorine Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">109</span><span class="NLM_x">, </span> <span class="NLM_fpage">3</span><span class="NLM_x">–</span> <span class="NLM_lpage">11</span><span class="refDoi"> DOI: 10.1016/S0022-1139(01)00375-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00939&amp;key=10.1016%2FS0022-1139%2801%2900375-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00939&amp;key=1%3ACAS%3A528%3ADC%252BD3MXksFKltbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2001&pages=3-11&author=B.+E.+Smart&title=Fluorine+substituent+effects+%28on+bioactivity%29&doi=10.1016%2FS0022-1139%2801%2900375-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Fluorine substituent effects (on bioactivity)</span></div><div class="casAuthors">Smart, B. E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Fluorine Chemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">3-11</span>CODEN:
                <span class="NLM_cas:coden">JFLCAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-1139</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science S.A.</span>)
        </div><div class="casAbstract">A review, with 32 refs.,.  The characteristic effects of F and fluoroalkyl substituents on the physicochem. properties of mols. that are important to biol. activity of fluorinated compds. are highlighted.  The influence of fluorination on acidity, H-bonding, and lipophilicity that affect compd. absorption and distribution is described.  The current perspectives on F steric interactions and the controversial role of H-bonding involving the C-F bond are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr6E1WbRFxuJ7Vg90H21EOLACvtfcHk0ljql2O_Yz2NzA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXksFKltbY%253D&md5=bd8cda675e305cd19c4a4eb8db59e107</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2FS0022-1139%2801%2900375-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0022-1139%252801%252900375-X%26sid%3Dliteratum%253Aachs%26aulast%3DSmart%26aufirst%3DB.%2BE.%26atitle%3DFluorine%2520substituent%2520effects%2520%2528on%2520bioactivity%2529%26jtitle%3DJ.%2520Fluorine%2520Chem.%26date%3D2001%26volume%3D109%26spage%3D3%26epage%3D11%26doi%3D10.1016%2FS0022-1139%2801%2900375-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Muller, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faeh, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diederich, F.</span><span> </span><span class="NLM_article-title">Fluorine in pharmaceuticals: looking beyond intuition</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">317</span><span class="NLM_x">, </span> <span class="NLM_fpage">1881</span><span class="NLM_x">–</span> <span class="NLM_lpage">1886</span><span class="refDoi"> DOI: 10.1126/science.1131943</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00939&amp;key=10.1126%2Fscience.1131943" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00939&amp;key=17901324" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00939&amp;key=1%3ACAS%3A280%3ADC%252BD2srnvVOnuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=317&publication_year=2007&pages=1881-1886&author=K.+Mullerauthor=C.+Faehauthor=F.+Diederich&title=Fluorine+in+pharmaceuticals%3A+looking+beyond+intuition&doi=10.1126%2Fscience.1131943"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Fluorine in pharmaceuticals: looking beyond intuition</span></div><div class="casAuthors">Muller Klaus; Faeh Christoph; Diederich Francois</div><div class="citationInfo"><span class="NLM_cas:title">Science (New York, N.Y.)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">317</span>
        (<span class="NLM_cas:issue">5846</span>),
    <span class="NLM_cas:pages">1881-6</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Fluorine substituents have become a widespread and important drug component, their introduction facilitated by the development of safe and selective fluorinating agents.  Organofluorine affects nearly all physical and adsorption, distribution, metabolism, and excretion properties of a lead compound.  Its inductive effects are relatively well understood, enhancing bioavailability, for example, by reducing the basicity of neighboring amines.  In contrast, exploration of the specific influence of carbon-fluorine single bonds on docking interactions, whether through direct contact with the protein or through stereoelectronic effects on molecular conformation of the drug, has only recently begun.  Here, we review experimental progress in this vein and add complementary analysis based on comprehensive searches in the Cambridge Structural Database and the Protein Data Bank.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQekuTGhVzexmgRQsDqrjW_fW6udTcc2eYkZmuqnbe-P7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2srnvVOnuw%253D%253D&md5=f624ab3733f7fc9d4b1711f2f3566ca2</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1126%2Fscience.1131943&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1131943%26sid%3Dliteratum%253Aachs%26aulast%3DMuller%26aufirst%3DK.%26aulast%3DFaeh%26aufirst%3DC.%26aulast%3DDiederich%26aufirst%3DF.%26atitle%3DFluorine%2520in%2520pharmaceuticals%253A%2520looking%2520beyond%2520intuition%26jtitle%3DScience%26date%3D2007%26volume%3D317%26spage%3D1881%26epage%3D1886%26doi%3D10.1126%2Fscience.1131943" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Muller, K.</span><span> </span><span class="NLM_article-title">Simple vector considerations to assess the polarity of partially fluorinated alkyl and alkoxy groups</span> <span class="citation_source-journal">Chimia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">356</span><span class="NLM_x">–</span> <span class="NLM_lpage">362</span><span class="refDoi"> DOI: 10.2533/chimia.2014.356</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00939&amp;key=10.2533%2Fchimia.2014.356" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00939&amp;key=25198745" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00939&amp;key=1%3ACAS%3A528%3ADC%252BC2cXht1emsLrI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2014&pages=356-362&author=K.+Muller&title=Simple+vector+considerations+to+assess+the+polarity+of+partially+fluorinated+alkyl+and+alkoxy+groups&doi=10.2533%2Fchimia.2014.356"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Simple vector considerations to assess the polarity of partially fluorinated alkyl and alkoxy groups</span></div><div class="casAuthors">Muller, Klaus</div><div class="citationInfo"><span class="NLM_cas:title">Chimia</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">356-362</span>CODEN:
                <span class="NLM_cas:coden">CHIMAD</span>;
        ISSN:<span class="NLM_cas:issn">0009-4293</span>.
    
            (<span class="NLM_cas:orgname">Swiss Chemical Society</span>)
        </div><div class="casAbstract">A review.  While H/F exchange at aryl groups or introduction of CF3 units have dominated medicinal chem. for decades, the use of partially fluorinated alkyl and alkoxy groups has come into focus more recently.  A simple bond vector anal. scheme, based on the assumption of context-independent bond polarities as well as idealized configurational and conformational geometries, is applied to small alkyl and alkoxy groups with prototypic fluorination patterns for qual. assessments of relative polarities as well as polarity modulation by conformational change.  Combined with a const. vol. increase for each hydrogen/fluorine exchange these polarity ests. can be translated into expected lipophilicity shifts (ΔlogP), using a simple parameterization scheme derived from exptl. logP values.  While terminal monofluoro- and gem-difluoromethyl groups in small aliph. units are correctly predicted to show lower lipophilicity compared to their tri- or non-fluorinated congeners, vicinal difluoro and bis-vicinal trifluoro patterns are identified to exhibit significantly lower lipophilicities than their resp. geminal di- and trifluoro substituted counterparts.  The trifluoromethoxy group is diagnosed as an intrinsically lipophilic unit compared to the parent methoxy group.  The difluoromethoxy group is of particular interest as it can easily interconvert between a highly lipophilic and a polar conformation, thus enabling this unit to adjust to polarity changes of the mol. environment.  For di- and trifluoroalkoxy groups, again the vic-difluoro and bis-vic-trifluoro substitution patterns stand out as most promising to keep lipophilicity low.  The 1,3-difluoro pattern next to an ether moiety shows an interesting conformational dependence of polarity, similar to the difluoromethoxy group.  While very qual. in nature, the simple bond vector anal. promises to be a useful tool for the identification of lipophilicity-lowering fluorinated alkyl or alkoxy groups and particularly those groups that display marked conformation-dependent lipophilicity and thus potentially serve as 'environmental adaptors'.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr6yZ2IogEjkrVg90H21EOLACvtfcHk0lgnP40tetJYBg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXht1emsLrI&md5=073bd4a2d1d9dcc5f1540296263dda62</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.2533%2Fchimia.2014.356&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2533%252Fchimia.2014.356%26sid%3Dliteratum%253Aachs%26aulast%3DMuller%26aufirst%3DK.%26atitle%3DSimple%2520vector%2520considerations%2520to%2520assess%2520the%2520polarity%2520of%2520partially%2520fluorinated%2520alkyl%2520and%2520alkoxy%2520groups%26jtitle%3DChimia%26date%3D2014%26volume%3D68%26spage%3D356%26epage%3D362%26doi%3D10.2533%2Fchimia.2014.356" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Payandeh, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scheuer, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Catterall, W. A.</span><span> </span><span class="NLM_article-title">The crystal structure of a voltage-gated sodium channel</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">475</span><span class="NLM_x">, </span> <span class="NLM_fpage">353</span><span class="NLM_x">–</span> <span class="NLM_lpage">358</span><span class="refDoi"> DOI: 10.1038/nature10238</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00939&amp;key=10.1038%2Fnature10238" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00939&amp;key=21743477" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00939&amp;key=1%3ACAS%3A528%3ADC%252BC3MXos1OmsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=475&publication_year=2011&pages=353-358&author=J.+Payandehauthor=T.+Scheuerauthor=N.+Zhengauthor=W.+A.+Catterall&title=The+crystal+structure+of+a+voltage-gated+sodium+channel&doi=10.1038%2Fnature10238"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">The crystal structure of a voltage-gated sodium channel</span></div><div class="casAuthors">Payandeh, Jian; Scheuer, Todd; Zheng, Ning; Catterall, William A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">475</span>
        (<span class="NLM_cas:issue">7356</span>),
    <span class="NLM_cas:pages">353-358</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Voltage-gated sodium (NaV) channels initiate elec. signalling in excitable cells and are the mol. targets for drugs and disease mutations, but the structural basis for their voltage-dependent activation, ion selectivity and drug block is unknown.  Here, we report the crystal structure of a voltage-gated Na+ channel from Arcobacter butzleri (NavAb) captured in a closed-pore conformation with four activated voltage sensors at 2.7 Å resoln.  The arginine gating charges make multiple hydrophilic interactions within the voltage sensor, including unanticipated hydrogen bonds to the protein backbone.  Comparisons to previous open-pore potassium channel structures indicate that the voltage-sensor domains and the S4-S5 linkers dilate the central pore by pivoting together around a hinge at the base of the pore module.  The NavAb selectivity filter is short, ∼4.6 Å wide, and water filled, with four acidic side chains surrounding the narrowest part of the ion conduction pathway.  This unique structure presents a high-field-strength anionic coordination site, which confers Na+ selectivity through partial dehydration via direct interaction with glutamate side chains.  Fenestrations in the sides of the pore module are unexpectedly penetrated by fatty acyl chains that extend into the central cavity, and these portals are large enough for the entry of small, hydrophobic pore-blocking drugs.  This structure provides the template for understanding elec. signalling in excitable cells and the actions of drugs used for pain, epilepsy and cardiac arrhythmia at the at. level.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWTPZUI8wqg7Vg90H21EOLACvtfcHk0lgnP40tetJYBg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXos1OmsLs%253D&md5=b24b729f516809e422a526b9b7727ee7</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1038%2Fnature10238&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature10238%26sid%3Dliteratum%253Aachs%26aulast%3DPayandeh%26aufirst%3DJ.%26aulast%3DScheuer%26aufirst%3DT.%26aulast%3DZheng%26aufirst%3DN.%26aulast%3DCatterall%26aufirst%3DW.%2BA.%26atitle%3DThe%2520crystal%2520structure%2520of%2520a%2520voltage-gated%2520sodium%2520channel%26jtitle%3DNature%26date%3D2011%26volume%3D475%26spage%3D353%26epage%3D358%26doi%3D10.1038%2Fnature10238" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Jensen, M.Ø.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jogini, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borhani, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leffler, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dror, R. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaw, D. E.</span><span> </span><span class="NLM_article-title">Mechanism of voltage gating in potassium channels</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">336</span><span class="NLM_x">, </span> <span class="NLM_fpage">229</span><span class="NLM_x">–</span> <span class="NLM_lpage">233</span><span class="refDoi"> DOI: 10.1126/science.1216533</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00939&amp;key=10.1126%2Fscience.1216533" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00939&amp;key=22499946" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00939&amp;key=1%3ACAS%3A528%3ADC%252BC38Xlt1ehsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=336&publication_year=2012&pages=229-233&author=M.%C3%98.+Jensenauthor=V.+Joginiauthor=D.+W.+Borhaniauthor=A.+E.+Lefflerauthor=R.+O.+Drorauthor=D.+E.+Shaw&title=Mechanism+of+voltage+gating+in+potassium+channels&doi=10.1126%2Fscience.1216533"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanism of voltage gating in potassium channels</span></div><div class="casAuthors">Jensen, Morten O.; Jogini, Vishwanath; Borhani, David W.; Leffler, Abba E.; Dror, Ron O.; Shaw, David E.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">336</span>
        (<span class="NLM_cas:issue">6078</span>),
    <span class="NLM_cas:pages">229-233</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">The mechanism of ion channel voltage gating, i.e., how channels open and close in response to voltage changes, has been debated since Hodgkin and Huxley's seminal discovery that the crux of nerve conduction is ion flow across cellular membranes.  Here, using all-atom mol. dynamics simulations, the authors show how a voltage-gated K+ channel (KV) switches between activated and deactivated states.  On deactivation, pore hydrophobic collapse rapidly halts ion flow.  Subsequent voltage-sensing domain (VSD) relaxation, including inward, 15-Å S4-helix motion, completes the transition.  On activation, outward S4 motion tightens the VSD-pore linker, perturbing linker-S6-helix packing.  Fluctuations allow water, then K+ ions, to reenter the pore; linker-S6 repacking stabilizes the open pore.  The authors propose a mechanistic model for the Na+/K+/Ca2+ voltage-gated ion channel superfamily that reconciles apparently conflicting exptl. data.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTW9w1jb4_Q7Vg90H21EOLACvtfcHk0lgnP40tetJYBg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xlt1ehsrc%253D&md5=41e537127531e9d78853ac2dcc5e2019</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1126%2Fscience.1216533&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1216533%26sid%3Dliteratum%253Aachs%26aulast%3DJensen%26aufirst%3DM.%25C3%2598.%26aulast%3DJogini%26aufirst%3DV.%26aulast%3DBorhani%26aufirst%3DD.%2BW.%26aulast%3DLeffler%26aufirst%3DA.%2BE.%26aulast%3DDror%26aufirst%3DR.%2BO.%26aulast%3DShaw%26aufirst%3DD.%2BE.%26atitle%3DMechanism%2520of%2520voltage%2520gating%2520in%2520potassium%2520channels%26jtitle%3DScience%26date%3D2012%26volume%3D336%26spage%3D229%26epage%3D233%26doi%3D10.1126%2Fscience.1216533" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Rohl, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boeckman, F. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scheuer, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Catterall, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klevit, R. E.</span><span> </span><span class="NLM_article-title">Solution structure of the sodium channel inactivation gate</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">855</span><span class="NLM_x">–</span> <span class="NLM_lpage">861</span><span class="refDoi"> DOI: 10.1021/bi9823380</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi9823380" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00939&amp;key=1%3ACAS%3A528%3ADyaK1cXotVOmtrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1999&pages=855-861&author=C.+A.+Rohlauthor=F.+A.+Boeckmanauthor=C.+Bakerauthor=T.+Scheuerauthor=W.+A.+Catterallauthor=R.+E.+Klevit&title=Solution+structure+of+the+sodium+channel+inactivation+gate&doi=10.1021%2Fbi9823380"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Solution Structure of the Sodium Channel Inactivation Gate</span></div><div class="casAuthors">Rohl, Carol A.; Boeckman, Faye A.; Baker, Carl; Scheuer, Todd; Catterall, William A.; Klevit, Rachel E.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">855-861</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The sodium channel initiates action potentials by opening in response to membrane depolarization.  Fast channel inactivation, which is required for proper physiol. function, is mediated by a cytoplasmic loop proposed to occlude the ion pore via a hinged lid mechanism with the triad IFM serving as a hydrophobic "latch".  The NMR soln. structure of the isolated inactivation gate reveals a stably folded core comprised of an α-helix capped by an N-terminal turn, supporting a model in which the tightly folded core contg. the latch motif pivots on a more flexible hinge region to occlude the pore during inactivation.  The structure, in combination with substituted cysteine mutagenesis expts., indicates that the IFM triad and adjacent Thr are essential components of the latch and suggests differing roles for the residues of the IFMT motif in fast inactivation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrss-kaPoPG07Vg90H21EOLACvtfcHk0lguJE9-VH6rfQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXotVOmtrs%253D&md5=313a8eb96c8bdbaa81c5cf6209901c37</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fbi9823380&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi9823380%26sid%3Dliteratum%253Aachs%26aulast%3DRohl%26aufirst%3DC.%2BA.%26aulast%3DBoeckman%26aufirst%3DF.%2BA.%26aulast%3DBaker%26aufirst%3DC.%26aulast%3DScheuer%26aufirst%3DT.%26aulast%3DCatterall%26aufirst%3DW.%2BA.%26aulast%3DKlevit%26aufirst%3DR.%2BE.%26atitle%3DSolution%2520structure%2520of%2520the%2520sodium%2520channel%2520inactivation%2520gate%26jtitle%3DBiochemistry%26date%3D1999%26volume%3D38%26spage%3D855%26epage%3D861%26doi%3D10.1021%2Fbi9823380" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Heinemann, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terlau, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stühmer, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imoto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Numa, S.</span><span> </span><span class="NLM_article-title">Calcium channel characteristics conferred on the sodium channel by single mutations</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">356</span><span class="NLM_x">, </span> <span class="NLM_fpage">441</span><span class="NLM_x">–</span> <span class="NLM_lpage">443</span><span class="refDoi"> DOI: 10.1038/356441a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00939&amp;key=10.1038%2F356441a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00939&amp;key=1313551" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00939&amp;key=1%3ACAS%3A528%3ADyaK38XktVartbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=356&publication_year=1992&pages=441-443&author=S.+H.+Heinemannauthor=H.+Terlauauthor=W.+St%C3%BChmerauthor=K.+Imotoauthor=S.+Numa&title=Calcium+channel+characteristics+conferred+on+the+sodium+channel+by+single+mutations&doi=10.1038%2F356441a0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Calcium channel characteristics conferred on the sodium channel by single mutations</span></div><div class="casAuthors">Heinemann, Stefan H.; Terlau, Heinrich; Stuehmer, Walter; Imoto, Keiji; Numa, Shosaku</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">356</span>
        (<span class="NLM_cas:issue">6368</span>),
    <span class="NLM_cas:pages">441-3</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    </div><div class="casAbstract">The sodium channel, one of the family of structurally homologous voltage-gated ion channels, differs from other members, such as the calcium and the potassium channels, in its high selectivity for Na+.  This selectivity presumably reflects a distinct structure of its ion-conducting pore.  Two clusters of predominantly neg. charged amino-acid residues, located at equiv. positions in the four internal repeats of the sodium channel, were recently identified as the main determinants of sensitivity to the blockers tetrodotoxin and saxitoxin.  All site-directed mutations reducing net neg. charge at these positions also caused a marked decrease in single-channel conductance.  Thus these two amino acid clusters probably form part of the extracellular mouth and/or the pore wall of the sodium channel.  Here the effects on ion selectivity of replacing lysine at position 1,422 in repeat III and/or alanine at position 1,714 in repeat IV of rat sodium channel II, each located in one of the two clusters, by glutamic acid, which occurs at the equiv. positions in calcium channels, are reported.  These amino-acid substitutions, unlike other substitutions in the adjacent regions, alter ion-selection properties of the sodium channel to resemble those of calcium channels.  This result indicates that lysine 1,422 and alanine 1,714 are crit. in detg. the ion selectivity of the sodium channel, suggesting that these residues constitute part of the selectivity filter of the channel.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpaUozzNzBhobVg90H21EOLACvtfcHk0lguJE9-VH6rfQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38XktVartbc%253D&md5=69e3fab07a67600cf48ba960a1b23125</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1038%2F356441a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F356441a0%26sid%3Dliteratum%253Aachs%26aulast%3DHeinemann%26aufirst%3DS.%2BH.%26aulast%3DTerlau%26aufirst%3DH.%26aulast%3DSt%25C3%25BChmer%26aufirst%3DW.%26aulast%3DImoto%26aufirst%3DK.%26aulast%3DNuma%26aufirst%3DS.%26atitle%3DCalcium%2520channel%2520characteristics%2520conferred%2520on%2520the%2520sodium%2520channel%2520by%2520single%2520mutations%26jtitle%3DNature%26date%3D1992%26volume%3D356%26spage%3D441%26epage%3D443%26doi%3D10.1038%2F356441a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Moss, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zareba, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwarz, K. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosero, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McNitt, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robinson, J. L.</span><span> </span><span class="NLM_article-title">Ranolazine shortens repolarization in patients with sustained inward sodium current due to type-3 Long-QT syndrome</span> <span class="citation_source-journal">J. Cardiovasc. Electrophysiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">1289</span><span class="NLM_x">–</span> <span class="NLM_lpage">1293</span><span class="refDoi"> DOI: 10.1111/j.1540-8167.2008.01246.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00939&amp;key=10.1111%2Fj.1540-8167.2008.01246.x" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2008&pages=1289-1293&author=A.+J.+Mossauthor=W.+Zarebaauthor=K.+Q.+Schwarzauthor=S.+Roseroauthor=S.+McNittauthor=J.+L.+Robinson&title=Ranolazine+shortens+repolarization+in+patients+with+sustained+inward+sodium+current+due+to+type-3+Long-QT+syndrome&doi=10.1111%2Fj.1540-8167.2008.01246.x"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1111%2Fj.1540-8167.2008.01246.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1540-8167.2008.01246.x%26sid%3Dliteratum%253Aachs%26aulast%3DMoss%26aufirst%3DA.%2BJ.%26aulast%3DZareba%26aufirst%3DW.%26aulast%3DSchwarz%26aufirst%3DK.%2BQ.%26aulast%3DRosero%26aufirst%3DS.%26aulast%3DMcNitt%26aufirst%3DS.%26aulast%3DRobinson%26aufirst%3DJ.%2BL.%26atitle%3DRanolazine%2520shortens%2520repolarization%2520in%2520patients%2520with%2520sustained%2520inward%2520sodium%2520current%2520due%2520to%2520type-3%2520Long-QT%2520syndrome%26jtitle%3DJ.%2520Cardiovasc.%2520Electrophysiol.%26date%3D2008%26volume%3D19%26spage%3D1289%26epage%3D1293%26doi%3D10.1111%2Fj.1540-8167.2008.01246.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Zareba, W.; Rosero, S.; Zeng, D.; Moss, A. J.; Couderc, J.-P.; Layug, B.; Belardinelli, L.</span><span> </span><span class="NLM_article-title">Sustained QTc shortening by GS-6615 in patients with LQT3</span>. Heart Rhythm Society 35th Annual Meeting May 7–10, 2014, San Francisco,<span class="NLM_x"> </span><span class="NLM_year">2014</span><span class="NLM_x">; </span> <span class="NLM_fpage">Abstract AB-34-05</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&pages=Abstract+AB-34-05&author=W.+Zareba&author=S.+Rosero&author=D.+Zeng&author=A.+J.+Moss&author=J.-P.+Couderc&author=B.+Layug&author=L.+Belardinelli&title=Sustained+QTc+shortening+by+GS-6615+in+patients+with+LQT3"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DZareba%26aufirst%3DW.%26atitle%3DSustained%2520QTc%2520shortening%2520by%2520GS-6615%2520in%2520patients%2520with%2520LQT3%26jtitle%3DHeart%2520Rhythm%2520Society%252035th%2520Annual%2520Meeting%2520May%25207%25E2%2580%259310%252C%25202014%252C%2520San%2520Francisco%26date%3D2014%26spage%3DAbstract%2520AB-34-05" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Le Grand, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pignier, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Létienne, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cuisiat, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rolland, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mas, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vacher, B.</span><span> </span><span class="NLM_article-title">Sodium late current blockers in ischemia reperfusion: is the bullet magic?</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">3856</span><span class="NLM_x">–</span> <span class="NLM_lpage">3866</span><span class="refDoi"> DOI: 10.1021/jm800100z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm800100z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00939&amp;key=1%3ACAS%3A528%3ADC%252BD1cXmslamtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=3856-3866&author=B.+Le+Grandauthor=C.+Pignierauthor=R.+L%C3%A9tienneauthor=F.+Cuisiatauthor=F.+Rollandauthor=A.+Masauthor=B.+Vacher&title=Sodium+late+current+blockers+in+ischemia+reperfusion%3A+is+the+bullet+magic%3F&doi=10.1021%2Fjm800100z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Sodium Late Current Blockers in Ischemia Reperfusion: Is the Bullet Magic?</span></div><div class="casAuthors">Le Grand, Bruno; Pignier, Christophe; Letienne, Robert; Cuisiat, Florence; Rolland, Francoise; Mas, Agnes; Vacher, Bernard</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">3856-3866</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We describe the discovery of the first selective, potent, and voltage-dependent inhibitor of the late current mediated by the cardiac sodium channel NaV1.5.  The compd. 3,4-dihydro-N-[(2S)-3-[(2-methoxyphenyl)thio]-2-methylpropyl]-2H-(3R)-1,5-benzoxathiepin-3-amine (I)(F 15845), was identified from a novel family of 3-amino-1,5-benzoxathiepine derivs.  The late sodium current inhibition and antiischemic effects of I were studied in various models in vitro and in vivo.  In a rabbit model of ischemia-reperfusion, I exhibited more potent antiischemic effects than ref. compds. KC 12291, ranolazine, and ivabradine.  Thus, after a single administration, I almost abolished ST segment elevation in response to a transient coronary occlusion.  Further, the antiischemic activity of I is maintained over a wide range of doses and is not assocd. with any hemodynamic changes, contrary to conventional antiischemic agents.  The unique pharmacol. profile of I opens new and promising opportunities for the treatment of ischemic heart diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqalBdranKqqbVg90H21EOLACvtfcHk0lguJE9-VH6rfQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXmslamtL0%253D&md5=6436bf6c98d7cfce8eec3feaf2dfa9f2</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fjm800100z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800100z%26sid%3Dliteratum%253Aachs%26aulast%3DLe%2BGrand%26aufirst%3DB.%26aulast%3DPignier%26aufirst%3DC.%26aulast%3DL%25C3%25A9tienne%26aufirst%3DR.%26aulast%3DCuisiat%26aufirst%3DF.%26aulast%3DRolland%26aufirst%3DF.%26aulast%3DMas%26aufirst%3DA.%26aulast%3DVacher%26aufirst%3DB.%26atitle%3DSodium%2520late%2520current%2520blockers%2520in%2520ischemia%2520reperfusion%253A%2520is%2520the%2520bullet%2520magic%253F%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D3856%26epage%3D3866%26doi%3D10.1021%2Fjm800100z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Le Grand, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pignier, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Létienne, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colpaert, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cuisiat, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rolland, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mas, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borras, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vacher, B.</span><span> </span><span class="NLM_article-title">Na+ currents in cardioprotection: better to be late</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">4149</span><span class="NLM_x">–</span> <span class="NLM_lpage">4160</span><span class="refDoi"> DOI: 10.1021/jm900296e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm900296e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00939&amp;key=1%3ACAS%3A528%3ADC%252BD1MXntVGjsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=4149-4160&author=B.+Le+Grandauthor=C.+Pignierauthor=R.+L%C3%A9tienneauthor=F.+Colpaertauthor=F.+Cuisiatauthor=F.+Rollandauthor=A.+Masauthor=M.+Borrasauthor=B.+Vacher&title=Na%2B+currents+in+cardioprotection%3A+better+to+be+late&doi=10.1021%2Fjm900296e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Na+ Currents in Cardioprotection</span></div><div class="casAuthors">Le Grand, Bruno; Pignier, Christophe; Letienne, Robert; Colpaert, Francis; Cuisiat, Florence; Rolland, Francoise; Mas, Agnes; Borras, Maud; Vacher, Bernard</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">4149-4160</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We report the discovery of a selective, potent inhibitor of the late current mediated by the cardiac isoform of the sodium channel (NaV1.5).  The compd., 3,4-dihydro-N-[(2S)-3-[(2-hydroxy-3-methylphenyl)thio]-2-methylpropyl]-2H-(3R)-1,5-benzoxathiepin-3-amine (F15741), blocks the late component of the Na+ currents and greatly reduces veratridine- or ischemia-induced contracture in isolated tissue and whole heart.  The cardioprotective action of F15741 was further established in a model of myocardial infarction in the pig in which F15741 prevents ischemia-reperfusion damage after 60 min of coronary occlusion and 48 h reperfusion.  Under these exptl. conditions, only F15741 and cariporide reduce infarct size.  Remarkably, myocardial protection afforded by F15741 occurs in the absence of hemodynamic effects.  These data expand the therapeutic potential of late INa blockers and suggest that 2d could be useful in pathologies for which pharmacol. treatments are not yet available.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWdnKNuOcBorVg90H21EOLACvtfcHk0lgJko_a6TGfXQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXntVGjsrw%253D&md5=8e1e7b4c97f9ec034397a86d483f92a4</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fjm900296e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900296e%26sid%3Dliteratum%253Aachs%26aulast%3DLe%2BGrand%26aufirst%3DB.%26aulast%3DPignier%26aufirst%3DC.%26aulast%3DL%25C3%25A9tienne%26aufirst%3DR.%26aulast%3DColpaert%26aufirst%3DF.%26aulast%3DCuisiat%26aufirst%3DF.%26aulast%3DRolland%26aufirst%3DF.%26aulast%3DMas%26aufirst%3DA.%26aulast%3DBorras%26aufirst%3DM.%26aulast%3DVacher%26aufirst%3DB.%26atitle%3DNa%252B%2520currents%2520in%2520cardioprotection%253A%2520better%2520to%2520be%2520late%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D4149%26epage%3D4160%26doi%3D10.1021%2Fjm900296e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Echt, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liebson, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitchell, L. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peters, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Obias-Manno, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barker, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arensberg, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedman, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greene, H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huther, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richardson, D.</span><span> </span><span class="NLM_article-title">W Mortality and morbidity in patients receiving encainide, flecainide, or placebo — the Cardiac Arrhythmia Suppression Trial</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">324</span><span class="NLM_x">, </span> <span class="NLM_fpage">781</span><span class="NLM_x">–</span> <span class="NLM_lpage">788</span><span class="refDoi"> DOI: 10.1056/NEJM199103213241201</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00939&amp;key=10.1056%2FNEJM199103213241201" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00939&amp;key=1900101" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00939&amp;key=1%3ACAS%3A280%3ADyaK3M7kvVKluw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=324&publication_year=1991&pages=781-788&author=D.+S.+Echtauthor=P.+R.+Liebsonauthor=L.+B.+Mitchellauthor=R.+W.+Petersauthor=D.+Obias-Mannoauthor=A.+H.+Barkerauthor=D.+Arensbergauthor=A.+Bakerauthor=R.+Friedmanauthor=H.+L.+Greeneauthor=M.+L.+Hutherauthor=D.+Richardson&title=W+Mortality+and+morbidity+in+patients+receiving+encainide%2C+flecainide%2C+or+placebo+%E2%80%94+the+Cardiac+Arrhythmia+Suppression+Trial&doi=10.1056%2FNEJM199103213241201"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial</span></div><div class="casAuthors">Echt D S; Liebson P R; Mitchell L B; Peters R W; Obias-Manno D; Barker A H; Arensberg D; Baker A; Friedman L; Greene H L; et al</div><div class="citationInfo"><span class="NLM_cas:title">The New England journal of medicine</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">324</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">781-8</span>
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    </div><div class="casAbstract">BACKGROUND AND METHODS:  In the Cardiac Arrhythmia Suppression Trial, designed to test the hypothesis that suppression of ventricular ectopy after a myocardial infarction reduces the incidence of sudden death, patients in whom ventricular ectopy could be suppressed with encainide, flecainide, or moricizine were randomly assigned to receive either active drug or placebo.  The use of encainide and flecainide was discontinued because of excess mortality.  We examined the mortality and morbidity after randomization to encainide or flecainide or their respective placebo.  RESULTS:  Of 1498 patients, 857 were assigned to receive encainide or its placebo (432 to active drug and 425 to placebo) and 641 were assigned to receive flecainide or its placebo (323 to active drug and 318 to placebo).  After a mean follow-up of 10 months, 89 patients had died: 59 of arrhythmia (43 receiving drug vs. 16 receiving placebo; P = 0.0004), 22 of nonarrhythmic cardiac causes (17 receiving drug vs. 5 receiving placebo; P = 0.01), and 8 of noncardiac causes (3 receiving drug vs. 5 receiving placebo).  Almost all cardiac deaths not due to arrhythmia were attributed to acute myocardial infarction with shock (11 patients receiving drug and 3 receiving placebo) or to chronic congestive heart failure (4 receiving drug and 2 receiving placebo).  There were no differences between the patients receiving active drug and those receiving placebo in the incidence of nonlethal disqualifying ventricular tachycardia, proarrhythmia, syncope, need for a permanent pacemaker, congestive heart failure, recurrent myocardial infarction, angina, or need for coronary-artery bypass grafting or angioplasty.  CONCLUSIONS:  There was an excess of deaths due to arrhythmia and deaths due to shock after acute recurrent myocardial infarction in patients treated with encainide or flecainide.  Nonlethal events, however, were equally distributed between the active-drug and placebo groups.  The mechanisms underlying the excess mortality during treatment with encainide or flecainide remain unknown.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTwCM0PKDJ7n2gRQsDqrjW_fW6udTcc2eYee3iezT5MQrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK3M7kvVKluw%253D%253D&md5=c6bfa1e251d3306b843a03933e450939</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1056%2FNEJM199103213241201&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJM199103213241201%26sid%3Dliteratum%253Aachs%26aulast%3DEcht%26aufirst%3DD.%2BS.%26aulast%3DLiebson%26aufirst%3DP.%2BR.%26aulast%3DMitchell%26aufirst%3DL.%2BB.%26aulast%3DPeters%26aufirst%3DR.%2BW.%26aulast%3DObias-Manno%26aufirst%3DD.%26aulast%3DBarker%26aufirst%3DA.%2BH.%26aulast%3DArensberg%26aufirst%3DD.%26aulast%3DBaker%26aufirst%3DA.%26aulast%3DFriedman%26aufirst%3DR.%26aulast%3DGreene%26aufirst%3DH.%2BL.%26aulast%3DHuther%26aufirst%3DM.%2BL.%26aulast%3DRichardson%26aufirst%3DD.%26atitle%3DW%2520Mortality%2520and%2520morbidity%2520in%2520patients%2520receiving%2520encainide%252C%2520flecainide%252C%2520or%2520placebo%2520%25E2%2580%2594%2520the%2520Cardiac%2520Arrhythmia%2520Suppression%2520Trial%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D1991%26volume%3D324%26spage%3D781%26epage%3D788%26doi%3D10.1056%2FNEJM199103213241201" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Diamond, I.; Belardinelli, L.; Shryock, J.; Rajamani, S.</span><span> </span><span class="NLM_article-title">Use of ranolazine for treating pain</span>. WO 2009/100380 Aug 13,<span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=I.+Diamond&author=L.+Belardinelli&author=J.+Shryock&author=S.+Rajamani&title=Use+of+ranolazine+for+treating+pain"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DDiamond%26aufirst%3DI.%26atitle%3DUse%2520of%2520ranolazine%2520for%2520treating%2520pain%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i36"><a href="/doi/suppl/10.1021/acs.jmedchem.6b00939">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_67064"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.6b00939">10.1021/acs.jmedchem.6b00939</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Experimental for compounds <b>22</b>–<b>40</b>, additional pharmacological data for <b>4</b> including ion channel panel, in vitro selectivity panel results, methoxyamine–clofilium induced VT–VF model with <b>4</b>, mexilitine data in a LCX ligation model of VT–VF, details of homology model including sequence analysis of sodium channel isoforms (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.6b00939/suppl_file/jm6b00939_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.6b00939/suppl_file/jm6b00939_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b00939/suppl_file/jm6b00939_si_001.pdf">jm6b00939_si_001.pdf (792.21 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b00939/suppl_file/jm6b00939_si_002.csv">jm6b00939_si_002.csv (5.43 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.6b00939&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2016.59.issue-19%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.6b00939" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.6b00939" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                2MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679a79feea7c3d5a","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
